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ABSTRACT 
The study of the interaction between matter and electromagnetic radiation which 
procreated the wide branch named as Spectroscopy has gained tremendous attention since 
the last century. Atoms and molecules respond to electromagnetic radiation to produce 
their unique spectra which can be used to detect, identify and quantify valuable information 
about the substance under study. Since, its conception, spectroscopy has been widely used 
in physical and analytical chemistry and has ramified various techniques depending on the 
different types of radiation. This dissertation focuses on implementation of various 
spectroscopic techniques such as Infrared, Raman and Nuclear Magnetic Resonance 
(NMR) spectroscopy in order to determine theoretical, conformational, qualitative and 
quantitative properties of different molecules under study. 
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Understanding the physical structure of a molecule is fundamental for function, 
dynamic, and mechanism studies. Infrared and Raman spectroscopy are two of the most 
widely used and powerful techniques for the accurate determination of molecular 
symmetry and conformational stability. They provide information of molecular vibrations 
and the two techniques complement each other to yield more complete information about 
the molecular structure than when they are evaluated separately. One of the focus of this 
dissertation is the determination of the structural parameters, conformational stability, 
vibrational assignments and ab initio calculations of organic molecules containing five 
membered ring and phosphorous by utilizing infrared and Raman spectral techniques. The 
findings of my spectroscopic, structural, and theoretical studies are based on infrared 
and/or Raman spectra of gas, liquid, solid as well as variable temperature xenon solutions, 
and microwave spectrum which are supported by ab initio and DFT calculations. 
Nearly four decades ago the potential of Nuclear Magnetic Resonance (NMR) 
spectroscopy for the quantitative analysis of organic chemicals was first demonstrated. 
Along with solution state NMR, for past two decades solid state NMR spectroscopy has 
also come to the forefront of quantitative analytical techniques in pharmaceutical research, 
as, both of these techniques have been successfully applied to the study of polymorphism 
in pharmaceutical drugs at both the qualitative and quantitative levels. The investigation of 
our research presented in this dissertation was initiated by selecting AIDS, the predominant 
pandemic of twenty-first century and Tenofovir (TFV), a well-tested antiretroviral drug 
that has proven its mettle against HIV/AIDS. In order to be able to accurately quantify the 
amount of drug being delivered in human body is a crucial requirement of any drug 
development process. We specifically focused on phosphorous containing drugs and hence, 
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a part of this dissertation describes about the development and implementation of a general 
31P qNMR method to achieve direct, real time quantification of in vitro drug release. We 
have effectively utilized both solution state and solid state 31P qNMR spectroscopic 
techniques to establish the kinetics of drug release and to determine the encapsulation 
efficiency of nano-formulation for a particular drug under study, respectively. The in vitro 
drug release profile has been studied in various human body fluids such as simulated 
vaginal & seminal fluids, plasma etc. depending on the drug under study. The results of 
method validation parameters for TFV in simulated vaginal & seminal fluid and human 
plasma obtained by using 31P solution state qNMR spectroscopy are presented in this 
dissertation. 
Another chapter of this dissertation explains the analysis of calcined clay as 
supplementary cementitious material, obtained from Ghana, a West African nation, which 
does not have an abundance of commonly used SCMs such as fly ash, silica fume, 
metakaolin, and slag. However, the abundance of clay minerals in the country could 
provide a sustainable alternative with respect to SCMs application. Qualitative techniques 
such as Thermal Gravimetric Analysis (TGA) and Forrier Transform Infrared 
Spectroscopy (FTIR), and quantitative tools like Nuclear Magnetic Resonance (NMR) are 
able to provide meaningful characterizing of thermally activated clays. In this study, clay 
from Ghana was thermally activated at temperatures of 600, 700, 800, 900 and 1000oC. 
The main objective was to characterize calcined clay using TGA, FTIR, NMR, and their 
relation to pozzolanic activity to best understand the potential of this abundant resource to 
alleviate cement supply burdens. 
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Dissertation Outline 
 
This dissertation includes the results obtained from the research that involved the 
implementation of spectroscopic techniques such as infrared, Raman and NMR and were 
utilized in diverse research projects. 
Chapter-2 discuses about the extensive use of both solid state and solution state 
NMR spectroscopy for both qualitative and quantitative determination of phosphorous 
containing drug (Tenofovir) encased in pH sensitive nano-particle shell and its subsequent 
release profile when in contact with human body fluids such as vaginal & seminal fluids 
and human plasma. 
Chapter-3 describes the implementation of solid state NMR as analytical tool for 
both qualitative and quantitative determination of bonding between Aluminum and Silicon 
sheets of calcined Ghanian clay samples which are used as supplementary cementitious 
material in construction. 
Chpater-4 on the other hand, focuses on infrared and Raman spectral studies to 
obtain structural parameters, conformational stability, vibrational assignments and ab initio 
calculations of organic molecules containing five membered ring and phosphorous.  
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Chapter 1 
INTRODUCTION 
The physical evolution of humans may have followed natural law of selection but 
the technological development can certainly be attributed to their curious minds, always 
engaged in discovering answers in a scientific manner. The logically inquisitive nature of 
humans, when was channeled to acquire knowledge in a systematic and organized manner 
was able to produce outstanding discoveries which in turn have immensely transformed 
our civilization and improved the way of life. The scientific revolution in 19th century, 
introduced the technology which cleared the pathway for advancements in instrumentation 
techniques that allowed the acquisition of more sensitive data than that was previously 
possible. Although, the availability of more data should help the scientific community in 
solving a problem; the usefulness of the conclusions reached is only realized if the data is 
interpreted as carefully and correctly as possible. Thus, the necessity of effective analytical 
tools which can efficiently be able to carry out both qualitative and quantitative analysis of 
the substance under study, eventually, led to the discovery of techniques such as 
Chromatography and Spectroscopy. The end of the nineteenth and beginning of the 
twentieth centuries was marked by significant efforts to quantify and explain the origin of 
spectral phenomena. This particular dissertation includes the implementation of few 
spectroscopic techniques which have aided me to contribute in the analysis of 
pharmaceutical, organic, cement samples at their molecular level.  
Spectroscopy in general can be explain as the study of the interaction of 
electromagnetic radiation with matter. Much of the scientific knowledge of the structure of 
the universe, from stars to atoms, can be derived from interpretations of the interaction of 
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radiation with matter. Spectroscopy is widely used in Chemistry 
because atoms and molecules have unique spectra by which the spectroscopic data is often 
represented. It is a powerful and sensitive form of chemical analysis, as well as a method 
of probing electronic and nuclear structure and chemical bonding. A spectrum is a plot of 
the response of interest as a function of wavelength or frequency, which can be used to 
detect, identify and quantify information about the atoms and molecules1. Spectroscopy is 
a sufficiently broad field where many sub-disciplines exist, each with numerous 
implementations of specific spectroscopic techniques. The various implementations and 
techniques can be classified in several ways. In many applications, the spectrum is 
determined by measuring changes in the intensity or frequency of the energy. 
Spectroscopic techniques are also distinguished by the type of radiative energy involved in 
the interaction. Understanding the physical structure of a molecule is fundamental for 
function, dynamic, and mechanism studies. Many methods, such as solution state and solid 
state Nuclear Magnetic Resonance (NMR) spectroscopy, X-ray crystallography, and 
molecular spectroscopy (IR/Raman), have been applied so far to study the molecular 
structures. In this very dissertation, I have utilized various spectroscopic techniques such 
as Infrared spectroscopy, Raman spectroscopy and Nuclear Magnetic Resonance (NMR) 
spectroscopy in order to determine theoretical, qualitative and quantitative properties of 
different molecules under study.  
The field of molecular structure determination has thrived from improvements in 
instrument design. The molecular structure is the orientation of atoms of molecules within 
free space. Conformational stability is a part of molecular structure which also includes 
bond lengths, bond angles, torsional angles etc. It is quite important to determine the 
3 
 
orientation of a molecule in space with respect to the rest of the molecule. The study of 
these quantitative elements is important as they provide information about the various 
forces acting upon the molecule, eventually defining molecular geometry. Chemical 
formula of a molecule all by its own does not provide the complete understanding of the 
real world system as the intermolecular forces exhibit strong influence on the bulk 
properties of the system. The study of conformational geometry is important because 
properties such as melting/boiling points, conductance etc. are dependent on the crystal 
structure of the molecule which further depends on conformational geometry. In order to 
be able to investigate motion and structure at the molecular level, determination of spatial 
orientations or conformers that are present in various physical states is critical. For a 
molecule with more than one conformer it is essential to determine the most stable 
conformer, energy difference between the conformers and energy necessary for 
interconversion between the conformers. 
Infrared and Raman spectroscopy are two of the most widely used and powerful 
techniques for the accurate determination of molecular symmetry and conformational 
stability. They provide information of molecular vibrations and the two techniques 
complement each other to yield more complete information about the molecular structure 
than when they are evaluated separately. The distinctive spectral features (vibrational 
frequency, band intensity, gas phase band envelope and rotational fine structure and Raman 
depolarization ratio, etc.) are unique fingerprints of the functionality and the organic 
molecules; in addition, they provide invaluable information about the symmetry and 
structure of individual conformations. 
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A large amount of information on the structure, bonding, and conformational 
stability of small molecules has become available through studies of their rotational and 
vibrational spectra. Vibrational spectroscopy has become an important method for the 
elucidation of molecular structure through the investigation of inter and intra-molecular 
forces of a molecule, as well as, the relative stability of the different molecular 
conformations, because the spectra can be investigated in all stages of aggregation (vapors, 
liquids, solutions, amorphous and crystalline solids, and in inert matrices at high pressure). 
Thus, infrared and Raman spectroscopy can provide reliable data for the determination of 
conformational stability, especially if the molecule has at least one element of symmetry2,3. 
Usually, the molecules selected for vibrational analysis are relatively simple ones which 
often contain one or more elements of symmetry and are capable of producing different 
conformations upon internal rotation. 
One of the focus of this dissertation is the determination of the structural 
parameters, conformational stability, vibrational assignments and ab initio calculations of 
organic molecules containing five membered ring and phosphorous by utilizing infrared 
and Raman spectral techniques. The findings of my spectroscopic, structural, and 
theoretical studies are based on infrared and/or Raman spectra of gas, liquid, solid as well 
as variable temperature xenon solutions, and microwave spectrum which are supported by 
ab initio and DFT calculations. The ab initio calculations are performed with the Gaussian 
03 program4 with Gaussian-type basis functions. The energy minima with respect to 
nuclear coordinates are obtained by the simultaneous relaxation of all geometric parameters 
by the gradient method of Pulay5. Several basis sets as well as the corresponding ones with 
diffuse functions are employed with the Møller-Plesset perturbation method6 to the second 
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order with full electron correlation (MP2(full)) along with the density functional theory by 
the B3LYP method. By utilizing the information, acquired through the experimental and 
theoretical studies carried out in the research laboratory, I have accomplished the following 
results for the molecules under study. Spectra obtained from infrared and Raman 
experiments are used in the vibrational studies to assign fundamental frequencies for all 
possible conformers as well as for the identification of the conformers. The MP2(full)/6-
31G(d) calculations are used to predict the force constants, frequencies, infrared intensities, 
Raman activities, band contours, potential energy distributions and depolarization values 
to support the vibrational assignment. Raman spectrum of liquid is used to obtain the 
experimental depolarization values. Determination of enthalpy difference values is carried 
out by using variable temperature, infrared or Raman spectra of xenon solutions or the 
liquid. From these experimentally obtained H values, the order of the stability of the 
conformers are determined. The experimentally determined enthalpy values are used to 
evaluate the quality of the predicted values of energies by ab initio and density functional 
theory calculations obtained from various basis sets up to aug-cc-pVTZ. Also % abundance 
of each conformer are determined by experimentally obtained H values. The r0 structural 
parameters can be obtained from utilizing the experimentally determined rotational 
constants from previously published microwave data or data obtained from my research. 
The experimentally determined values are then compared with the estimated values 
obtained from adjusted MP2(full)/6-311+G(d,p) calculations for the respective 
conformers. These physiochemical data should provide significant trends and affects to 
better understand the major factors controlling the relative stabilities of the conformers as 
well as the relative values of the structural parameters. 
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NMR spectroscopy, first discovered in 1938 is a non-destructive analytical tool 
which has been successfully applied to study molecular structure, sample purity, and 
reaction mechanisms at the atomic level. The application and development of NMR 
spectroscopy has demonstrated the great contribution of this technique on compound 
identification and has enabled a more thorough understanding of molecular structure and 
dynamics. 
Solid-State Nuclear Magnetic Resonance (SS NMR) has become one of the best 
techniques to determine molecular structure via inter/intra-molecular interactions. Unlike 
the well-known solution state NMR, solid-state NMR primarily elucidates the structural 
information by chemical shift anisotropy and dipolar coupling regardless of the solubility, 
crystallinity, and amorphousness of the target samples. The fascinating development of 
solid-state NMR methods in the past thirty years has contributed greatly to the level of our 
understanding of molecular structure and molecular interactions both quantitatively and 
qualitatively. This method has been applied in studying lyophilized samples, non-
crystalline solids, insoluble aggregates, and biopolymer frozen solutions to determine their 
physical, chemical, and biological properties. 
The story of evolution of human civilization would feel unfinished if the 
devastating role played by diseases is left untold. To name with, epidemics such as plague 
factually demonstrated a potential to cause mass extinction of human population. The 
dispersal of a majority of life threatening diseases has been put to leash as the development 
in medical sciences since the early twentieth century introduced a large number of 
lifesaving drugs. Nevertheless, even today diseases like AIDS, Hepatitis, Cancer, 
Alzheimer etc. are few notorious names to mention with where, therapy is still far from 
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curing the disease and a successful vaccine is yet to be developed, which renders, 
implementation of precautionary measures to prevent from infection to be the best strategy 
for survival. Since the beginning of current century, scientific community has been 
incessantly researching to invent and develop not only an effective drug against these 
diseases but also an efficient drug delivery system to administer the drug in infected human 
body. Years of tenacious research has finally yielded in the development of a means to 
resolve problems associated with delivery of therapeutic compound to the target site. We 
are now aware of a variety of drugs that are being effectively used against these diseases 
as a part of preventive treatment and to our surprise majority of these drugs contain 
phosphorous. 
Nearly four decades ago the potential of NMR spectroscopy for the quantitative 
analysis of organic chemicals was first demonstrated7–9 whereas, the first quantitative 
measurements have been described in the literature in 196310,11. Even though, most of these 
early qNMR studies have been performed with solution state NMR technique, for past two 
decades solid state NMR spectroscopy has come to the forefront of quantitative analytical 
techniques in pharmaceutical research. The Food and Drug Administration (FDA) has also 
recognized the need for solid state NMR characterization of drug substances as 
approximately 80–90% of pharmaceutical products on the market exist in the solid form. 
The possibility of decrease in stability and increase in interaction with excipients of active 
pharmaceutical ingredient (API) due to its alteration, caused by the extreme conditions of 
processing the formulation into dosage form makes it critical to study pharmaceutical 
compounds in the solid state both at the bulk level and for the final dosage form12,13. Thus, 
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SS NMR spectroscopy has also been successfully applied to the study of polymorphism in 
pharmaceutical drugs at both the qualitative and quantitative levels. 
  To be able to accurately quantify the amount of drug being delivered in human body 
is a crucial requirement of any drug development process. We cleverly decided to make 
use of a 31P atom present in these drugs and hence, in this dissertation we are primarily 
focusing on the development and implementation of a general 31P qNMR method to 
achieve direct, real time quantification of in vitro drug release. We have effectively utilized 
both solution state and solid state 31P qNMR spectroscopic techniques to establish the 
kinetics of drug release and to determine the encapsulation efficiency of nano-formulation 
for a particular drug under study, respectively. Taking into account the principles of 31P 
qNMR, the proposed method rather can be extensively applied to all the drug molecules 
that contain phosphorous, signifying a subsequent huge scope of this method. The in vitro 
drug release profile has been studied in various human body fluids such as simulated 
vaginal and seminal fluids, human plasma etc. depending on the drug under study. 
The investigation of our research presented in this dissertation was initiated by 
selecting AIDS, the predominant pandemic of twentieth century and Tenofovir (TFV), a 
well-tested antiretroviral drug that has proven its mettle against HIV/AIDS. To study this 
specific disease-drug pair, we have used a specific type of spray dried, mucoadhesive, pH 
sensitive nano-formulation, successfully developed by Zhang T. et al.14 that served as an 
encasing for TFV. The respective nano-formulation has proved to be efficient in 
administering TFV in human body through the epithelial cells of human genitals. 
Previously, Zhang C. et al.15 developed and implemented 1H qNMR spectroscopic method 
to quantify the amount of TFV being delivered whereas, we are introducing 31P qNMR 
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spectroscopic method for quantification purposes. The results of method validation 
parameters for TFV in simulated vaginal & seminal fluid and human plasma obtained by 
using 31P solution state qNMR spectroscopy are presented in this dissertation. The 
encapsulation efficiency of the respective nano-formulation encasing TFV in solid form 
was estimated by integrated 31P (144.597 MHz) Bloch decays and is also well conversed 
herein. FTIR spectroscopy has been extensively used to aid in determining the structural 
components of the nano-formulations used. 
Another chapter of this dissertation explains the analysis of calcined clay as 
supplementary cementitious material, obtained from Ghana, a West African nation, which 
does not have an abundance of commonly used SCMs such as fly ash, silica fume, 
metakaolin, and slag. However, the abundance of clay minerals in the country could 
provide a sustainable alternative with respect to SCMs application. Qualitative techniques 
such as Thermal Gravimetric Analysis (TGA) and Forrier Transform Infrared 
Spectroscopy (FTIR), and quantitative tools like Nuclear Magnetic Resonance (NMR) are 
able to provide meaningful characterizing of thermally activated clays. In this study, clay 
from Ghana was thermally activated at temperatures of 600, 700, 800, 900 and 1000oC. 
The main objective was to characterize calcined clay using TGA, FTIR, NMR, and their 
relation to pozzolanic activity to best understand the potential of this abundant resource to 
alleviate cement supply burdens. 
In this study, clay from Ghana was thermally activated at temperatures of 600, 700, 
800, 900 and 1000oC. The main objective was to characterize calcined clay using TGA, 
FTIR, NMR, and their relation to pozzolanic activity to best understand the potential of 
this abundant resource to alleviate cement supply burdens. 
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Chapter 2 
QUANTITATIVE ANALYSIS OF PHOSPHOROUS CONTAINING DRUG 
MOLECULES ENCAPSULATED IN pH-SENSITIVE NANOPARTICLE 
FORMULATIONS TO ESTABLISH DRUG LOADING AND DRUG RELEASING 
PROFILE BY UTILIZING 31P SOLID STATE AND SOLUTION STATE 
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPIC TECHNIQUES 
Introduction 
The story of evolution of human civilization would feel unfinished if the 
devastating role played by diseases is left untold. Since, the dawn of the civilization in the 
known history, human race has been afflicted by several infectious and autoimmune 
diseases. To name with, epidemics such as plague factually demonstrated a potential to 
cause mass extinction of human population. The beginning of 20th century introduced a 
new era where significant development in medical sciences promised greater life 
expectancy as either cure or acute preventive therapies were invented to triumph over large 
number of medical conditions. The dispersal of a majority of life threatening diseases has 
been put to leash as the development in medical sciences since the early 20th century 
introduced a large number of lifesaving drugs. In spite of these achievements, to the date, 
a therapy is still far from curing the life-threatening diseases such as AIDS, hepatitis, 
cancer, Alzheimer etc. These are few notorious names to mention a successful vaccine is 
yet to be developed, which renders, implementation of precautionary measures to prevent 
from infection to be the best strategy for survival. These diseases affect people not only 
physically, but also emotionally, as contracting and living with a disease can alter one's 
personality as well as perspective on life. Hence, scientific community has been engaged 
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in intense research to invent measures, if not cure, to prevent the infection from these 
diseases and cease the further spread of the disease in human body after being diagnosed.  
Since the beginning of current century, scientific community has been incessantly 
researching to invent and develop not only an effective drug against these diseases but also 
an efficient drug delivery system to administer the drug in infected human body. Hats off 
to the perseverance of scientific community as now we are aware of quite a few number of 
drugs which have proven ability against these diseases. Years of tenacious research has 
finally yielded in the development of a means to resolve problems associated with delivery 
of therapeutic compound to the target site. We are now aware of a variety of drugs that are 
being effectively used against these diseases as a part of preventive treatment. It is rather 
interesting to know that majority of these drugs contain phosphorous atom and we have 
ingeniously come up with a plan to take an advantage of this 31P atom for the quantitative 
measurements of the drug under study. In this research, we have projected the use of 
nuclear magnetic resonance spectroscopy as an analytical tool that aided us to quantify the 
amount of drug being delivered by conducting in vitro studies. Our major objectives 
enlisted the development of a quantitative NMR method that can be further implemented 
to determine the amount of drug released from its placebo-encasing in the simulated human 
body fluids. As a matter of fact, it is not only the drugs but also their delivery systems in 
human body that are exclusively being researched and are under development.  
The extensive research in the field of nanotechnology has provided scientific 
community with a plausible solution to overcome the problems faced while developing 
suitable drug delivery system. Nano-formulations are now being synthesized using 
numerous types of materials which are designed to release the encased drug strictly when 
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triggered by change in the pH of the surrounding media. Hence, it is also quintessential to 
understand the encapsulation capacity of these nano-formulations in their solid form. 
Modern research showed that the problems such as limited effectiveness, poor bio-
distribution, and lack of selectivity encountered during conventional ways of application 
of drug can be overcome by controlling drug delivery1. Recent developments in 
nanotechnology revealed nanoparticles (structures smaller than 100 nm) to have a great 
potential as drug carriers, as drug molecule encapsulated in nano-formulation can be 
delivered directly to the site of action. Liposomes, solid lipids nanoparticles, dendrimers, 
polymers, silicon or carbon materials, and magnetic nanoparticles are the examples of 
nano-carriers that have been tested as drug delivery systems. The nanostructures exhibit 
unique physicochemical and biological properties due to their small size2. Properties such 
as an enhanced reactive area as well as an ability to cross cell and tissue barriers made 
nanoparticles a favorable material for biomedical applications. Nano-carriers have 
effectively proven potential applications in solubilizing poorly soluble drug candidates, 
reducing drug toxicity, prolonging circulation times, controlling drug release kinetics, drug 
targeting, and monitoring drug delivery to enhance therapeutic efficacy3–7. Thus, in recent 
years interest in nanoparticle drug delivery systems has grown dramatically as they have 
shown improvement in the pharmacological and therapeutic properties of conventional 
drugs. Nevertheless, in vivo delivery process exhibited the challenges such as minimal drug 
leakage during the initial period and triggered drug release at the target site which were 
needed to overcome. 
Pharmacokinetics and pharmacodynamics are undoubtedly the main pillars that 
must be thoroughly studied while designing any drug.  Pharmacokinetics deals with the 
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quantitative aspect of drug handling by a body which in turn defines the temporal 
relationship between dose of the drug to be administered and a respective drug 
concentration in the body. On the other hand, pharmacodynamics establishes relationship 
between drug concentration at the pharmacological receptor and its respective 
pharmacological response. The new drug designed to be considered useful as a medicine 
must be capable of being delivered to its site of action achieving concentrations sufficient 
to initiate and maintain the appropriate pharmacological response. ADME, stands for 
absorption, distribution, metabolism and excretion, describes the qualitative process by 
which the body handles the drug as soon as it is administered in the body. The thorough 
knowledge of ADME provides a systematic podium to understand relationship between 
pharmacokinetics and pharmacodynamics. The studies of ADME process have suggested 
that once the administered drug reaches to equilibrium within the body, the time profile of 
drug-plasma concentration is observed to be quite parallel to that of drug-tissue 
concentration if not of absolutely equal magnitude. This makes the issue of time required 
to achieve equilibrium, rather critical in establishing relationship between 
pharmacokinetics and pharmacodynamics. Hence, learning pharmacokinetics is vital when 
launching new drug-body profile as it offers a quantitative outline for the prospective 
optimization of therapeutic dosage treatments8.  
Also, prior to the actual administration of a drug in human body the quality control 
of drug delivery system is an extremely important step which makes understanding the 
factors influencing drug release, from both in vivo and in vitro perspective, quintessential. 
Hence, a variety of meaningful in vitro drug release testing methods were developed and 
implemented to predict the in vivo pharmacokinetics and performance specifications. 
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Methods introduced in earlier years such as ultrafiltration and ultracentrifugation 
incorporated significant errors in measurement and proved to be inefficient9,10. The most 
prevalently used method to establish the kinetics of drug release from nanoparticles was 
dynamic dialysis where the amount of drug released from nanoparticle was assumed to be 
directly proportional to the disappearance of drug from donor compartment and its 
appearance in receiver compartment. Also, the elimination of the additional step of 
separating nanoparticles from free drug at various time points during the kinetic study 
surpassed the popularity of dynamic dialysis over ultrafiltration and ultracentrifugation. 
Soon, potential sources of errors discovered in the experimental data obtained, put the 
authenticity and reliability of dynamic dialysis method to question. The rate of the drug 
release in receiving chamber was attributed to the driving force for drug transport across 
the dialysis membrane and its barrier properties. The driving force on the other hand was 
influenced by the reversible drug binding to the nano-carrier and the issue of drug 
partitioning between the phases present in dispersed systems11–15. The idea of 
compensating for the misinterpretation of release rate of dialysis method by implementing 
the reverse dialysis method was also proven to be not so effective due to its poor sensitivity 
and specificity16,17. Even though, the methods such as HPLC and LCMS utilized for the 
quantification of drug released in receiving chamber proved to be highly accurate18–21, the 
experimental demonstration of the practical limitations incorporated within the dialysis 
method rendered it to be far from being tagged flawless22. Thus, the demand for an ideal 
solution compelled scientific community to search for the direct, accurate, and if possible, 
real time method for the detection and quantification of drug molecule. 
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Facts discussed so far, motivated us to develop qNMR method which can 
effectively establish kinetic release profile of the phosphorous containing drug under study, 
encapsulated in nano-formulation. We planned to initiate the pharmacokinetics studies of 
the drug under consideration, in vitro, imitating the in vivo scenario. This provided us 
sufficient information about the actual performance of the drug before being tested on 
animals or humans. 
Nuclear magnetic resonance (NMR) spectroscopy is perhaps the most important, 
powerful, and widely used form of spectroscopy in both academic and industrial research 
since its discovery in early 1950s. It probes atomic environments based on the different 
resonance frequencies exhibited by nuclei in a strong magnetic field. An increase of 
sensitivity due to stronger static magnetic fields allowed not only independent and 
intrinsically reliable determination of chemical purity but also the determination of amount 
of substance in the sample under study by utilizing NMR spectroscopy. NMR is an 
effective spectroscopic tool for quantitative analysis, as the intensity of a resonance line is 
directly proportional to the number of resonant nuclei or spins. In contrast to 
chromatography, quantitative NMR (qNMR) employs a universal reference standard as an 
internal standard for majority of chemical products assayed, as NMR response can be made 
the same for all chemical components including an internal standard by optimizing certain 
instrumental parameters. Thus, qNMR competes effectively with chromatographic 
methods by avoiding a need for a reference standard for each analyte while maintaining 
higher standards of sensitivity, speed, precision, and accuracy. These facts enabled qNMR 
to find applications in various fields like Physics, Chemistry, Bio-Chemistry, Pharmacy, 
Food Science, Medicine & Veterinary23–26.  
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Nearly four decades ago the potential of NMR spectroscopy for the quantitative 
analysis of organic chemicals was first demonstrated27,28 whereas, the first quantitative 
measurements have been described in the literature in 196329,30. Even though, most of these 
early qNMR studies have been performed with solution state NMR technique, for past two 
decades solid state NMR spectroscopy has come to the forefront of quantitative analytical 
techniques in pharmaceutical research. The Food and Drug Administration (FDA) has also 
recognized the need for solid state NMR characterization of drug substances as 
approximately 80–90% of pharmaceutical products on the market exist in the solid form. 
The possibility of decrease in stability and increase in interaction with excipients of active 
pharmaceutical ingredient (API) due to its alteration, caused by the extreme conditions of 
processing the formulation into dosage form makes it critical to study pharmaceutical 
compounds in the solid state both at the bulk level and for the final dosage form31,32. Thus, 
SSNMR spectroscopy has also been successfully applied to the study of polymorphism in 
pharmaceutical drugs at both the qualitative and quantitative levels. 
In pharmaceutical research, NMR spectroscopy has been primarily used in classical 
organic chemistry framework as typical investigation focused on (i) structural 
determination and chirality studies of drug substances, (ii) studies that included cellular 
metabolism and proteins. Quantitative NMR being universal and highly specific, proved to 
be a remarkably successful analytical tool in structural analysis. A systematic validation of 
qNMR method, performed in a manner consistent with the Good Laboratory Practice 
guidelines of the United States and international government regulatory agencies, have 
been reported33–35. United States Pharmacopoeia36 and the British Pharmacopoeia37 have 
also reported the general qNMR as a primary ratio method of measurement in which the 
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analyte can be correlated directly to the calibration standard and hence to be compendial. 
The widespread acceptance of NMR for quantitative measurements can be attributed to 
specific advantages like, (i) the possibility to determine structures at a molecular level, (ii) 
no need for intensity calibrations in case of determination of ratios (signal area is directly 
proportional to the number of nuclei), (iii) relatively short measuring times, (iv) its non-
destructive character, (v) no prior isolation of the analyte in a mixture, which means rather 
easy sample preparation and handling and (vi) the possibility of a simultaneous 
determination of more than one analyte in a mixture. 
We have absolutely focused our study on the phosphorous containing drugs as our 
research plan included the development of qNMR method that will target 31P nuclei in the 
drug under study for the quantification purposes. Solution state qNMR technique will be 
utilized to establish the kinetics of the drug release in the simulated human body fluids 
whereas, solid state qNMR spectroscopic technique will help us determine the 
encapsulation efficiency of the nano-formulation. The concomitant theoretical discussion 
to corroborate our hypotheses is presented herein.  
Finally, through these quantitative analysis, we aim to provide medical field with a 
better understanding of the drug loading and drug releasing profiles of the large number of 
phosphorus containing drugs. To summarize our broader perspective, we strongly believe 
that our results will aid scientific community, build improved versions of drug delivery 
systems that will further decrease the probability of infection or spreading of the disease in 
human body. In due course, the use of more efficient drug delivery systems will result in 
saving greater number of human lives. We are quite determined to take the battle to the 
doorsteps of the life threatening diseases such as AIDS, hepatitis B, cancer, Alzheimer and 
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thus, we are confident that our research contribution will benefit significantly to the entire 
human society. 
General Research Approach 
 
We envisioned and meticulously designed this research project with certain 
objectives in mind, presented as follows- 
1] Development and validation of a method for quantitative analysis of drug 
molecules containing 31P nuclei utilizing solid state and solution state NMR spectroscopic 
techniques: We focused our study on phosphorus containing drug molecules which have 
proven their effectiveness against AIDS. A method was required to be developed and 
validated that would aid us in carrying out direct and real time quantitative analysis of the 
drug by using nuclear magnetic resonance spectroscopic technique which will target the 
31P nuclei in the molecule under study. 
2] Application of solution state NMR spectroscopic technique to establish kinetics 
of drug release from nano-formulation in various body fluids: It is crucial to establish the 
profile of drug release from its nano-formulation encasing in vitro and hence, solution state 
qNMR spectroscopy was implemented to serve the purpose. The release study was carried 
out in several human body fluids such as vaginal & seminal fluids, plasma etc. 
3] Application of solid state NMR spectroscopic technique to determine the 
encapsulation efficiency of a drug and nano-formulation pair: A variety of nano-
formulations was used to encase the drugs under study and hence, we were also interested 
to learn the actual amount of a drug that gets encased in certain type of nano-formulation. 
Solid state NMR spectroscopy was put to use to determine the encapsulation efficiency of 
the nano-formulation. 
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4] Investigation of phosphorus containing drugs that have proven ability in the 
treatment of the four direst diseases of current era by utilizing proposed qNMR 
spectroscopy: We commenced our studies by choosing to investigate a phosphorous 
containing drug- Tenofovir (TFV) which has been widely utilized in the treatment against 
AIDS. We have taken into consideration the proven effectiveness of a specific type of spray 
dried, mucoadhesive, pH sensitive nano-formulations that will serve as an encasing for 
TFV. We are interested in learning the rate of in vitro release of TFV in various human 
body fluids as well as the amount of TFV in solid form, encapsulated in the nano-
formulation during the various stages of encapsulation process. We have been effectively 
implementing both solution state and solid state NMR spectroscopic techniques. The 
respective results obtained on in vitro release of TFV in vaginal simulated fluid (VFS) are 
discussed herein. Results obtained on encapsulation efficiency of a particular nano-
formulation under study with respect to TFV are also presented. 
Previously, Zhang et al.38 developed and validated for the first time 1H solution 
state NMR method to perform a real-time detection and quantification of Tenofovir. The 
drug release profile was established in VFS and VSFS by integrating the two peaks (δ = 
8.00 & 8.09 ppm) generated from the aromatic protons in Tenofovir to quantify its 
respective amount. Their results have demonstrated a good sensitivity as well as specificity 
that allowed the direct quantification of in vitro Tenofovir release from a spray-dried 
mucoadhesive and pH-sensitive MS formulation based on polymethacrylate salt without 
the membrane diffusion technique.  
Taking into consideration of our own research interests both solution state and solid 
state NMR spectroscopic techniques were utilized in order to obtain quantitative 
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measurements of Tenofovir which is at the core of our studies. Hence, in this study we 
implemented a real time 31P solution state NMR method to be a simple, rapid and precise 
way to quantify the in vitro release of Tenofovir from an encapsulated nanoparticle 
formulation. We also quantified Tenofovir in a solid form encapsulated inside of 
nanoparticle formulation by utilizing 31P solid state NMR spectroscopic method in order 
to obtain encapsulation efficiency. The presence of a single phosphorous atom in Tenofovir 
was put to the advantage of our analysis. A single peak produced in NMR spectra, 
exclusively indicative of this phosphorous with natural isotopic abundance of 100% 
allowed high signal-to-noise (S/N) ratio and thus will be directly proportional to the amount 
of Tenofovir. 
One of the very important fundamental aspect of qNMR is that the signal intensity 
for a compound X (Ix) is directly proportional to the number of nuclei (Nx) producing the 
NMR signal34. 
Ix = Ks Nx   (Ks is an independent spectrometer constant). 
Usually the NMR signal of a single substance consists of several resonance lines. 
However, Tenofovir is observed to produce a specific single resonance line corresponding 
to its single phosphorous atom at δ = 15.7 ppm. Therefore, either the raw integrated signal 
(Ix) or a ratio of relative integrated peak areas for two compounds X and Y (Ix/Iy) could be 
used to quantify a molecular concentration. If multiple 31P NMR experiments are 
performed, Ks being a spectrometer constant across the spectrum, the relative integrated 
signal area is equivalent to the concentrations. In our project, the integrated peak area of 
the phosphorous in Tenofovir was used to estimate the amount of drug. 
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The determination of relative area ratios Ix/Iy is the easiest way to obtain 
quantitative results. For 31P single pulse NMR experiments with correct acquisition 
parameters Ks is the same constant for all resonance lines within the same spectrum, such 
that it cancels for the ratio- 
Ix
Iy
=
Nx
Ny
 
The molar ratio Nx/Ny of two compounds X and Y can be calculated straightforward 
using- 
nx
ny
=
Ix Ny
Iy Nx
 
Consequently, the amount fraction of a compound X in a mixture of m components is 
given by- 
nx
∑ nimi=1
=  
Ix/Nx
∑ Ii/Nimi=1
 
without any need to consider the solvent signal in which the mixture is dissolved as the 
only sample preparation step. For the purity determination of a substance an internal 
standard with known purity is needed. The purity of the analyte Px can be calculated as 
follows- 
Px =
Ix Nstd Mx mstd
Istd Nx Mstd m
 Pstd 
Here, Mx and MStd are the molar masses of the analyte and the standard, 
respectively, ‘m’ the weighed mass of the investigated sample, mStd and PStd are the 
weighed mass and the purity of the standard and NStd and IStd correspond to the number of 
spins and the integrated signal area of a typical NMR line of the standard, as described 
above. 
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In our study, integrations of the 31P peak of TFV will be used to quantify the amount 
of TFV in various media under study. The linewidth of NMR signal directly depends on T2 
(spin-spin relaxation time) which varies from different molecules (Linewidth = (T2)-1). T2 is 
usually very small for large molecules such as polymers or proteins, which gives rise to 
very broad peaks. Therefore, if TFV would be free in the solution, the phosphorous signal 
could be easily detected. However, if TFV would be encapsulated inside the polymer, the 
peak generated from TFV will be very broad because of the slow tumbling.  
This whole project was a collaborative effort that was carried out congenially by 
Department of Chemistry, UMKC and School of Pharmacy, UMKC. Syntheses of spray 
dried, mucoadhesive, pH sensitive nano-formulations took place at School of Pharmacy, 
UMKC whereas, Department of Chemistry, UMKC was responsible for the quantitative 
solid state and solution state NMR spectroscopic experimentation to establish kinetics of 
drug release and encapsulation efficiency. 
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PROJECT-1 
Real-Time Analysis of Tenofovir Release in Biological Fluids Using Quantitative 
Phosphorus (31P) Nuclear Magnetic Resonance Spectroscopy 
Introduction 
AIDS undoubtedly remains the deadliest epidemic of our time. 
WHO/UNAIDS/UNICEF global report of 2011 has estimated an average of 2.7 million 
new infections and 1.8 million AIDS related deaths in 2010 whereas, the report of 2013 
estimated 35.3 (32.2–38.8) million people living with HIV in 2012. Since its discovery, 
AIDS has yet caused an estimated 37 million deaths worldwide39. HIV is a single stranded 
RNA retrovirus responsible for AIDS. It uses reverse transcriptase enzyme to replicate 
single stranded DNA in a host cell through the process of reverse transcription. Body fluids 
such as semen, vaginal fluid and blood are the crucial media for transmitting HIV. There 
is yet no cure or vaccine invented. The five major types of drugs are usually used in 
combination, to treat HIV infection. One of these types of drugs known as ‘reverse 
transcriptase inhibitors’ (RTI) have been specifically designed to disrupt the process of 
reverse transcription and thereby suppresses the growth of HIV. A study has shown that 
combinations comprising of three drugs from at least two different types can slow the 
course of the disease and may lead to a near normal life expectancy. This type of 
combination treatment is referred as anti-retroviral therapy (ART), combination anti-
retroviral therapy (cART) or highly active anti-retroviral therapy (HAART)40. Since 2001, 
expanded access to antiretroviral therapy and declining incidences of HIV infection have 
led to a steep fall globally by 33% in the number of adults and children dying from HIV-
related causes39. 
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Reverse transcriptase inhibitors, further categorized in three forms consist of their 
respective nucleoside and nucleotide analogues (NRTI & NtRTI) and non-nucleoside 
reverse transcriptase inhibitor (NNRTI). In 1987, US FDA approved the first effective 
therapy against HIV which was the nucleoside reverse transcriptase inhibitor41. Since then 
number of drugs have been synthesized under RTI class. Tenofovir (TFV), a drug marketed 
by Gilead Sciences (trade name Viread) belongs to the category of NtRTI has proven to be 
effective against HIV as it blocks the reverse transcriptase enzyme42,43. It is administered 
as the fumarate salt of its disoproxil prodrug called as Tenofovir disoproxil fumarate (TDF) 
and alafenamide prodrug called as Tenofovir alafenamide fumarate (TAF). 
 
 
 
Figure 2.1. Tenofovir molecule. 
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The recommended oral dose (tablet form/powder form) of {[(2R)-1-(6-amino-9H-
purin-9-yl)propan-2-yl]oxy}methyl phosphonic acid, also known as Tenofovir in adults is 
300 mg/day. Tenofovir gets eliminated from patient’s body by renal elimination. 
Pharmacokinetic studies following oral administration have shown the oral bioavailability 
of Tenofovir to be 39% along with food and 25% in fasted state based on urinary recovery 
data and intravenous data in patients44. Certain adverse effects such as lactic acidosis and 
liver problems are commonly incorporated with oral route with typical symptoms including 
stomach and muscle pain, nausea, headache, diarrhea and flatulence45. The treatment of 
HIV disease was realized to be quite difficult considering the problems associated with 
delivery of therapeutic compound to the target site. As oral administration of Tenofovir 
proved to be less efficient as a drug delivery method, the urgent need for alternative pre-
exposure prophylaxis (PrEP) methods is a self-indicative of antiretroviral therapy being 
still far from curing the disease and a successful HIV vaccine is yet to be developed. 
The idea of PrEP methods though started with the oral application of antiretroviral 
drugs was later focused on the vaginal/rectal application of anti-HIV substances, known as 
microbicides which are currently the principal focus for HIV prevention strategies46,47. To 
the date a great variety of HIV microbicides candidates have been studied and tested in 
clinical trials for their safety and microbicidal effects48–51. Infections caused by HIV and 
other enveloped viruses and sexually transmitted pathogens can be prevented by these 
microbicides which are the agents used topically within the vagina or rectum. In terms of 
formulation, a lot of the emphasis has been put on to the first generation gel formulation. 
According to some of the recent studies Tenofoir is approved as a microbicide in its 
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effectiveness and safety for the prevention of HIV infections and its formulations as solid- 
lipid nanoparticles, vaginal gel, and vaginal ring have already been developed52–57. 
Recently, 1% vaginal gel formulation of Tenofovir has been developed. It has been 
proven effective in clinical trials as, HIV incidence was reduced by 54% in the high gel 
adherence (>80%) group52. In the light of this promising results emanated the prospect of 
a possible total protection against HIV, if a sustainable concentration of the active drug can 
be maintained. Unfortunately, this topical gel formulation was observed to suffer from 
several disadvantages such as leakage, poor patient compliance and the most significant 
one being its low retention time within the vaginal cavity. Thus, the coital dependence not 
only proved to limit the effectiveness, acceptability and adherence of aqueous gel system 
but also demanded a high dosing frequency52. These limitations compelled a microbicide 
formulation that could be administered in a coital independent fashion to become an ideal 
prevention strategy against sexually-acquired HIV.  
The requirement to overcome the practical limitations pushed the scientific study 
in a direction to prepare a formulation that essentially possess high vaginal retention time 
and can release a high dose of microbicide when sexual intercourse occurs. Nano-
formulations such as hydrogels, mucin like polymers and spray dried mucoadhesive 
microspheres based on polymethacrylate salt were invented and reported. These topical 
microbicide formulations designed for vaginal delivery are site retentive, pH and 
temperature sensitive, non-cytotoxic and non-immunogenic to vagina epithelium and 
vaginal flora and can be triggered to burst release in the presence of human semen58–63. 
Collectively, these data presented potentially effective strategy for intravaginal delivery of 
microbicides for the prevention of HIV transmission. Impressive facts discussed so far thus 
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pushed us to choose Tenofovir which contains single phosphorus atom to obtain the in vitro 
kinetic release profile in seminal & vaginal fluids, plasma and blood along with its 
encapsulation efficiency in various nano-formulations by implementing 31P-qNMR 
spectroscopy. 
 
 
 
 
 
 
Figure 2.2. Dialysis membrane method of quantitative in vitro drug release analysis from drug 
formulations in biological media. (A) Initial state. (B) Equilibrium state. 
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Accurately quantifying the amount of drug being delivered in the human body is a 
crucial requirement of any drug development process. Most quantitative techniques such 
as liquid chromatography (LC) and UV-Vis spectrometry require a dialysis membrane to 
separate the free drug released from their formulations and to determine the drugs in 
biological fluids. In the dialysis method, the drug formulation is enclosed in a dialysis bag 
with appropriate molecular weight cutoff (MWCO) membrane in the donor compartment 
(Figure 2). A sink condition has to be maintained to separate the drug in donor compartment 
with respect to the receiving compartment. The amount of drug detected in the receiving 
compartment is generally considered as the amount of drug released from the drug 
formulations. However, the experimental results of release quantification methods utilizing 
dialysis membrane can be misleading since most of the times donor compartment does not 
satisfy the sink condition64–66. In addition, dialysis method is not capable of direct and real-
time quantification of the drug release kinetics. Moreover, in dialysis approach the drug 
release is governed by the partition between two phases separated by the dialysis 
membrane64–66  (Figure 3). There are some further limitations of the dialysis membrane 
method (Table 1) that makes it a less than ideal choice in drug quantification and depending 
on the drug/carrier systems, significant errors may be introduced. For example, there are 
several process parameters such as diffusion coefficients, pH, temperature, time, 
concentration, volume of release media, dialysis membrane surface area and thickness, 
molecular charges, and stirring speed that can potentially affect the dialysis rate64–66 and 
the quantification of in vitro drug release kinetics. Hence, there is a critical need for 
developing a direct, real-time, and specific method for the quantification of drug release 
kinetics in bulk and in its nanoformualtions.
  
 
3
0
 
Table 2.1 Considerations and limitations in dialysis method of drug quantitation. 
Parameters Consideration Limitation 
Volume of 
the release 
media 
Volume of media inside the dialysis membrane 
should be at least 6- to 10-fold less to provide a 
driving force for drug transport to the outside and 
maintaining sink conditions. 
Concentration gradient between the inside and 
outside of the dialysis bag may affects the observed 
release rate. 
 
 Outer media must be agitated to prevent the 
accumulation of polymer degradants, especially for 
the protein formulations. 
Agitation can affects the release kinetics of drug 
formulations. 
 Two/three media changes over the period of 12-24 
hrs. 
Time to equilibrate is prolonged if the bulk media 
is not stirred due to the formation of unstirred water 
layer). 
Dialysis 
membrane 
surface 
Appropriate membrane surface molecular weight 
cutoff and surface area must be selected. 
Achievement of equilibration with the outer media 
is slow if membrane surface area is small or too 
quick if surface area is very large. 
Drug 
diffusion 
process 
Two step process: diffusion of drug from the carrier 
to the interior of the dialysis membrane and then to 
the reservoir. 
Due to two diffusion barriers, the measured drug 
release kinetics is slower, and depending on the 
drug/carrier systems, significant errors may be 
introduced.  
 Dialysis bag with a higher drug concentration require 
a longer time for the drug to diffuse out of the bag.  
Cannot be used if the drug binds to the polymer or 
dialysis membrane. 
Process 
variables 
Several process variables has to be optimized 
including the pH, temperature, time, concentration, 
volume, stirring speed, sampling time).  
Many process factors affecting the dialysis rate 
(diffusion coefficients, pH, temperature, time, 
concentration, volume, membrane surface area, 
thickness, molecular charges, stirring speed). 
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Figure 2.3. Membrane partitioning in dialysis method of quantitative in vitro drug release analysis 
from drug formulations in biological media. 
 
 
 
Recently, Zhang et al., have published a proton (1H) NMR method38 to quantify an anti-
HIV topical vaginal microbicide drug (Tenofovir: TFV) in vaginal fluid simulant (VFS) 
and in a mixture of vaginal and seminal fluid simulant (VSFS) buffers. The authors have 
compared the NMR method with the dialysis membrane method to analyze the drug release 
pattern by high performance liquid chromatography (HPLC) assay. Although, the 1H-NMR 
method was fully validated and well analyzed, the requirement of using deuterated solvents 
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in 1H-NMR spectroscopy makes this method less economic and not easily feasible 
routinely in biological fluids analysis.  
Carbon NMR (13C-NMR) spectroscopy is another commonly used NMR approach. The 
width of the 13C-NMR spectrum is wider than that of the 1H-NMR spectrum. This is due 
to the fact that the carbon resonance is 0-220 ppm relative to the tetramethylsilane (TMS) 
standard, while the resonance of protons is 0-12 ppm. It thus makes it possible to be able 
to identify the distinguishable peaks of each carbon atom. However, most of the drugs and 
release media components contain more than one carbon, some of these carbons are in very 
similar environments. As a result, the overlap of the 13C signal is inevitable, especially in 
the relatively large compound. Also, if 1H-NMR is compared with 13C-NMR while 
considering their respective NMR active nuclei then the abundance of 13C is very low 
(~1.1%) and the use of higher sample concentrations or amount is required. The 
implementation of 13C-NMR spectroscopy thus proves to be a drawback as it is less 
economical in routine analysis especially for in vivo assays67.  
The 31P-qNMR is an excellent technique for studying phosphorus containing 
compounds and typically gives rise to single sharp peak that corresponds to the single 
phosphorous atom being a part of the drug molecule and is the case in most of the drugs. 
The 31P nucleus is useful in NMR spectroscopy due to its relatively high gyromagnetic 
ratio (17.235 MHzT-1) in comparison to that of 13C (10.705 MHz T-1)67,68. Furthermore, 31P 
has a 100% natural isotopic abundance67. Moreover, like the 1H nucleus, the 31P nucleus 
has a nuclear spin of 1/2, which makes spectra relatively easy to interpret. The major 
advantage of 31P-qNMR compared to 1H NMR is that there is no need of expensive 
deuterated solvents, which simplifies the sample preparation process.  
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Therefore, considering the above aspects, in this study, a rapid, specific, and direct 31P-
qNMR method for the real-time quantification of TFV in vaginal fluid simulant (VFS), 
semen fluid simulant (SFS), and human plasma was developed and validated. TFV is a 
nucleotide reverse-transcriptase inhibitor under the category of antiretroviral drugs. It is a 
weakly acidic, water-soluble, stable, and low molecular weight (MW: 287.213 Da) 
drug69,70. TFV is a Food and Drug Administration (FDA) approved microbicide (in its pro-
drug form) and has been proven to prevent HIV transmission through the vagina52. The 
developed NMR method of TFV was further applied for the real-time quantification of 
TFV in its nanofiber (NF) based formulations in these biological fluids. 
Experimental and Theoretical Methods 
1] Chemicals 
Tenofovir (TFV) was purchased from Beijing Zhongshuo Pharmaceutical 
Technology Development Co. Ltd. (Beijing, China). Chitosan (MW 50-190 kDa), 
thioglycolic acid, poly (ethylene oxide) (MW 900 kDa), were purchased from Sigma 
Aldrich (St. Louis, MO, USA). Sodium triphosphate penta-basic (TPP) was from Thermo 
Fisher Scientific (Pittsburgh, PA, USA). Poly (DL-lactide) was obtained from Purac 
Biomaterials (Lincoln, IL, USA). Pooled normal human plasma was purchased from 
Innovative Research, Inc., (Novi, MI, USA). Deionized water for all the experiments was 
obtained through a Millipore Milli Q water purification system (Millipore Corp., Danvers, 
MA, USA). All other chemicals were of analytical grades and used as obtained from the 
suppliers. The pH of all the solutions was adjusted using either hydrochloric acid (HCl) or 
sodium hydroxide (NaOH) solutions prepared accordingly and measured using a 
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SevenEasy pH meter (Mettler Toledo, Schwerzenbach, Switzerland) under ambient 
temperature conditions (23-24°C). 
2] Preparation of Multilayer Microparticles (MPs)  
2a] Synthesis of Hyaluronic Acid Nanofibers (HA-NF) 
The respective microparticles were synthesized by a published method63. 
2b] Synthesis of Chitosan Nanofibers (TCS-NF) 
The TFV loaded chitosan NFs were prepared by using a coaxial electrospinning 
method71,72. Chitosan is a water-soluble, linear amino-polysaccharide, which is composed 
of 2-amino-2-deoxy-β-D-glucan combined with glycosidic linkages. Chitosan exhibits 
many advantages in formulation development, including biocompatibility, 
biodegradability, and low-immunogenicity73,74. Chitosan-thioglycolic acid conjugate was 
synthesized by introducing thioglycolic acid to chitosan via amide bond formation 
mediated by a carbodiimide73. Briefly, Chitosan-thioglycolic acid conjugate was mixed 
with PLA in a ratio of 1:1 (w/w) and used as the shell material. A blend of TFV and PEO 
was used as the core material. A coaxial spinneret was used to allow for the injection of 
core solution into the shell solution at the tip. An electrospinning system was used for NF 
production. The core and shell composite solutions were placed in two glass syringes 
(Becton, Dickinson and Company, NJ, USA), and pushed by two syringe pumps (Cole-
Parmer Instrument Company, IL, USA) with the feeding rate of 0.05 ml/h for the two 
solutions. A high voltage power supply (Gamma High Voltage Research, Inc., FL, USA) 
was used to provide a voltage of 15 kV to the nozzle. The chitosan NFs were collected onto 
an aluminum collector connected to the ground electrode. The NFs mat was peeled from 
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the collector, vacuum dried at room temperature and stored in a vacuum desiccator until 
further uses. 
3a] Quantitative Solution State 31P-qNMR Spectroscopic Analysis of TFV 
The experimental procedure for solution state 31P-qNMR spectroscopy were carried out 
on a Varian (Palo Alto, California) 400 MHz spectrometer with a Varian two channel 
probe. The Vnmrj software (version 2.2) was used to process the data. Preliminary analyses 
were performed to get the optimized NMR conditions. Typically, the spectra were acquired 
with a 45º pulse length that was 5.05 μs. The relaxation delay and the number of scans were 
seen at 5 sec and 256, respectively. Relaxation delay is considered to be one of the most 
important parameters in qNMR assays and in order to make most nuclei fully relaxed, 5 
times of the maximum T1 (Spin-lattice relaxation time) is required. The T1 of the 
phosphorous atom of TFV was 5 s that typically requires up to 25 s (5 × T1) for relaxation 
delay time. However, as the experimental parameters were fixed between all spectra 
(specifically the number of scans), the effect of short relaxation delay was consistent in all 
experiments, eventually making the integral calculations also consistent. The short 
relaxation delay was primarily applied because of the limited acquisition time between for 
each experiment during the in vitro drug release study.   Shimming (adjusting the resolution 
of the NMR signals by optimizing the homogeneity of the magnetic field) was applied to 
every sample in order to obtain a similar linewidth in each spectrum. Baseline correction, 
phase adjustment, and integral calculation was carried out manually using MestReNova 
Lite 5.2.5-4731 software (Escondido, California). The assay was performed in triplicate at 
37°C and spinning speed of 20 Hz. Kinetics experiments were applied where intensities of 
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the 31P peak of TFV was utilized to quantify the amount of TFV released from nano-
formulations. The total time for one release experiment was 12 hours. 
The linewidth of NMR signal directly depends on T2 (spin-spin relaxation time) which 
varies for different molecules (Linewidth = (T2)-1). T2 is usually very small for large 
molecules such as polymers or proteins, which gives rise to very broad peaks. Therefore, 
if the drug is free in the solutions, the phosphorous signal can be easily detected. However, 
if drug is encapsulated inside the polymeric formulations, the peak generated from drug 
could be very broad because of the slow tumbling. The NMR spectra of free TFV was 
observed to produce a specific single resonance line corresponding to its single 
phosphorous atom at ~15 ppm. The integrated peak area of the phosphorous atom in TFV 
was used to estimate its amount. 
3b] Sample Preparation for Solution State 31P-qNMR Spectroscopic Analysis 
VFS (pH 4.2) and SFS (pH 7.6) will be prepared individually according to 
published method75,76. Serial dilutions of stock solution with the same diluents will lead to 
the sample solutions in the concentration range of 0.1–5 mM for 31P NMR analysis. TFV 
samples were prepared at the concentrations of 0.1 - 5.0 mM in VFS, SFS, and human 
plasma. However, a commercially available human plasma was used. A stock solution of 
TFV (1 M) in respective biological fluids was diluted with the same fluids to yield the 
solutions in the above concentrations range. The samples were analyzed by taking 500 μL 
of each sample in a 5-mm outer diameter NMR tubes (Wilmad-LabGlass, Vineland, NJ, 
USA) and analyzed using the 31P-qNMR method. Orthophosphoric acid (OPA: 85% v/v) 
was used as the external reference compound. 
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4] Method Validation for Solution State 31P-qNMR Spectroscopic Analysis 
Seven different samples with TFV concentrations from 0.075 to 5 mM were 
selected to construct the standard curves of the method. Three concentrations (0.2, 0.75, 
and 5 mM) were utilized to validate the method according to International Conference of 
Harmonization (ICH Q2:R1) guidelines77. The variation within the 31P NMR peak areas 
were presented as percentage of relative standard error (%RSE) for each validation 
parameters. 
4a] Specificity 
Specificity is typically a required precondition for qNMR and is hence always 
tested prior to the other validation parameters. The specificity of the method measures the 
proportion of positives that are identified correctly, it was determined by analyzing the 
potential interference of formulation/biological fluid components peaks to the TFV peak. 
The 31P NMR spectrum of standard TFV solution in VFS/SFS/human plasma was 
compared with that of drug-free VFS/SFS/human plasma as well as TFV loaded 
nanoformulations suspended in these biological fluids to ensure the specificity of the NMR 
method. All the measurements were carried out at 37ºC temperature. 
4b] Linearity and Calibration Curve 
Linearity is the ability of the method to elicit test results that are directly 
proportional to the analyte concentration within a given concentration range. A calibration 
plot was prepared in the concentration range of 0.2 - 5.0 mM in VFS, SFS, and 0.3 - 5.0 
mM in human plasma by analyzing the peak areas of 31P in each TFV solution. The 
intercept, slope, and correlation coefficient (R) values were determined by linear regression 
analysis. All the measurements were carried out at 37ºC temperature.  
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4c] Limit of Quantification (LOQ) and Limit of Detection (LOD) 
The LOQ and LOD values represent the lowest quantity of a substance that can be 
distinguished from the absence of that substance, and the concentration at which 
quantitative results can be reported with a high degree of confidence within a stated 
confidence limit, respectively77. The LOQ and LOD values were determined using the 
signal-to-noise (S/N) ratios of 10:1 and 3:1, respectively. All the measurements were 
carried out at 37ºC temperature. 
4d] Precision and Accuracy 
Precision and accuracy represent the level of measurement that yields consistent 
results (no random errors) and true result (no systematic errors) when repeated, 
respectively. Accuracy is the percent of therapeutic molecule recovered by the assay. 
Accuracy of the 31P-qNMR method was calculated for three quality control (QC) samples 
(0.2 mM, 0.75 mM, and 5.0 mM) in VFS, and SFS, and 0.3 mM, 0.75 mM, and 5.0 mM in 
human plasma. The results were reported as percent mean recovery. Precision was assessed 
using the same QC samples and reported as percent relative standard error (%RSE). The 
intra-day (within-day) and inter-day precision and mean recovery (over a period of one 
week) were determined. All the measurements were carried out at 37ºC temperature. 
4e] Robustness 
The robustness of an analytical assay is its ability to remain unaffected by small 
variations in the assay parameters. The following changes in the solution state 31P-qNMR 
method parameters were examined: temperature (in ºC), relaxation delay (in seconds), and 
45º pulse width (in µs). The variation in the 31P NMR peak area of TFV at the concentration 
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of 5.0 mM was calculated and the acceptance criteria of %RSE ˂ 2% was considered for 
each parameter. 
4f] Repeatability 
Repeatability expresses the precision of the method under the same operating 
conditions over a short time interval. The repeatability of the method was performed by 
analyzing three QC concentrations of TFV (n = 3), three times a day in VFS, SFS and 
human plasma. 
5] Analysis and Characterization 
5a] Real Time in vitro Drug Release Analysis of Chitosan NFs using 31P-qNMR 
(Direct) Method 
Chitosan NFs loaded with TFV at the concentration of 1 mg/mL were dispersed in 
VFS, SFS and human plasma. The samples were prepared in NMR glass tubes and 
analyzed by taking 1 mL of each sample using the solution state 31P-qNMR method at 37°C 
with a spinning speed of 20 kHz. The data were collected at different time points in real 
time measurements up to 12 hours. The percent drug release profile of TFV was measured 
using a calibration curve of TFV. 
5b] In vitro Drug Release Analysis of Chitosan NFs using Dialysis Membrane 
(Indirect) Method 
Chitosan NFs at the concentration of 1 mg/mL in VFS, SFS and human plasma 
were added in the dialysis bag (Spectra/Por Float-A-Lyzer G2, MWCO 3.5-5 KD, 
Spectrum Laboratories Inc. Rancho Dominguze, CA, USA) were placed into a dialysis tube 
containing 20 ml of release media. The whole system was kept at 37°C water bath with a 
shaking speed of 60 rpm. At predetermined time intervals, up to 12 h, 1 mL of the sample 
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was taken out and replaced by fresh release media to maintain the sink conditions. The 
concentration of TFV in the dialysis solution was determined by the UV-Vis spectroscopy 
at the wavelength of 259 nm. Each experiment was run in triplicate (n = 3) together with a 
blank control. The percent cumulative drug release profile of TFV was measured using a 
calibration curve of TFV in the concentration range of 1 - 10 µg/mL18. 
5c] In vitro Drug Release Kinetics of NFs  
The drug release data of TFV loaded chitosan NFs were analyzed by using various 
in vitro kinetic models69,78 The previously described Microsoft Excel add-in DDSolver 
program79 was used for the data modeling. The kinetic models used were zero-order, first-
order, Higuchi, Korsmeyer-Peppas, Hixson-Crowell, Weibull and, Quadratic models. The 
criteria for selecting the most appropriate model were based on the coefficient of 
determination, (R2) and the Akaike information criterion (AIC)79. The Akaike Information 
Criterion is a measure of goodness of fit based on maximum likelihood. The selection of 
an appropriate model was based on a higher R2 values and lower AIC value. 
5d] Statistical Data Analysis 
The experimental values were generally presented as mean ± standard deviation 
(SD) of triplicate determinations (n = 3) unless otherwise mentioned.  
Results and Discussion 
1] Solution state 31P-qNMR Method Validation for TFV Analysis 
31P had a relatively high gyromagnetic ratio and an isotopic abundance of 100%. Thus 31P 
q-NMR spectroscopy was an analytical technique. 31P NMR shifts were primarily 
dominated by the paramagnetic shielding tensor includes the radial expansion (related to 
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charge), energies of excited states, and bond overlap. The solution state 31P-qNMR method 
of TFV was developed and validated according to the ICH guidelines77.  
The NMR method was found to be linear over the tested concentration range in VFS 
(Figure 4A), SFS (Figure 4C), and human plasma (Figure 4E) with the R value > 0.999, 
(Figure 4). The TFV peaks in VFS, SFS, and human plasma were shown in Figure 4B, 
Figure 4D, and Figure 4F, respectively. The LOD values of the developed solution state 
31P-qNMR method were found to be 0.075 mM (VFS), 0.1 mM (SFS), and 0.2 mM (human 
plasma), whereas, the LOQ values were 0.2 mM for VFS and SFS, and 0.3 mM for human 
plasma, respectively. The 31P-qNMR peak of TFV was observed at ~15.7 (Figure 5A), 
~15.1 (Figure 5C), ~13.7 (Figure 5E), and ~15.7 (Figure 5G) in VFS, SFS, plasma and 
water, respectively. 
Specificity analysis demonstrated the lack of interference peaks between the signal of 
interest (31P peak of TFV) and any other peak from the components of the VFS (Figure 
5B), SFS (Figure 5D), human plasma (Figure 5F), and OPA (Figure 5G), respectively. The 
chemical shifts in the TFV NMR peak were slightly different (varied between 15.7 to 13.7 
ppm) in different biological fluids which might be due to the interactions between the spins 
of phosphorus groups present in each biological fluids and the associated shielding and 
deshielding effects. Overall, the results showed that the TFV peak was well separated from 
all three biological fluid components (Figure 5). The components present in the VFS didn’t 
have any phosphorus groups and that could be the reason no other peak has been observed 
in the 31P NMR spectra of the blank VFS (Figure 5B). The components present in the VFS 
didn’t have any phosphorus containing groups75,76 and that is the reason no other peak has 
been observed in the 31P NMR spectra of the blank VFS (Figure 5B). However, the 
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presence of sodium phosphates in SFS75,76 showed a peak at ~1.7 ppm (Figure 5D) in blank 
SFS which had an interaction with the TFV phosphorus group and has been shifted to ~1.25 
ppm (Figure 5C). The presence of inorganic hydrogen and dihydrogen phosphates in the 
plasma80 showed the NMR peaks at ~2.5 ppm and in between 0-(-2) ppm (Figure 5F). 
These peaks have been shifted little bit in the presence of TFV and also had a significant 
effect on the chemical shift value of TFV (~13.7 ppm) (Figure 5G). 
 
  
Figure 2.4. Linearity assay of the 31P-NMR method in: (A) VFS. (C) SFS. (E) Human plasma. 
Representative 31P-NMR peak of TFV in: (B) VFS. (D) SFS. (F) Human plasma. 
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Figure 2.5. Specificity analysis of the 31P-NMR analysis: (A) TFV in VFS. (B) Blank VFS. (C) 
TFV in SFS. (D) Blank SFS. (E) TFV in plasma. (F) Blank plasma. (G) TFV with OPA in water. 
 
 
 
 
 
 
The results of the repeatability showed that the NMR method was reproducible and 
showed the consistent results in terms of the ppm value and area of TFV (data not shown). 
The method was accurate with a percent mean recovery value between 90% to 110% (Table 
2) and precise as the %RSE values for intra-day, and inter-day precision were less than 2% 
for all the QC samples tested in VFS, SFS, and human plasma (Table 3). The %RSE for 
each robustness parameters and tested concentration of 5.0 mM was found to be < 2% 
(Table 4) and the developed solution state 31P-qNMR method was considered robust.  
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Table 2.2. Accuracy (mean recovery) data for the 31P-NMR method in VFS, SFS, and human 
plasma. 
 
Biological 
Media 
Concentration 
(mM) 
Mean recovery ± RSE (%) (n  = 3) 
Intra-day Inter-day 
Within-a day Day-2 Day-3 
VFS 0.20 102.8 ± 2.7 102.1 ± 1.7 101.2 ± 1.7 
 0.75   96.0 ± 2.3 99.6 ± 0.9 97.6 ± 1.9 
 5.00 103.5 ± 0.2 103.8 ± 0.3 103.6 ± 0.3 
SFS 0.20   94.7 ± 1.6 98.9 ± 1.3 96.1 ± 1.4 
 0.75   95.6 ± 1.2 101.6 ± 1.5 93.8 ± 1.6 
 5.00 106.5 ± 0.3 107.9 ± 0.2 105.9 ± 0.2 
Human Plasma 0.30 105.2 ± 2.9 104.6 ± 2.1 103.5 ± 2.4 
 0.75   96.7 ± 1.9 96.7 ± 1.9 94.8 ± 1.5 
 5.00   99.9 ± 1.8 99.9 ± 1.8 99.3 ± 1.9 
 
 
 
Table 2.3. Precision data for the 31P-NMR method in VFS, SFS, and human plasma. 
Biological media Concentration 
(mM) 
Precision as %RSE (n  = 3) 
Intra-day Inter-day 
Within-a day Day-2 Day-3 
VFS 0.20 1.65 1.65 1.04 
 0.75 0.44 0.44 1.14 
 5.00 0.11 0.11 0.16 
SFS 0.20 1.70 1.70 1.49 
 0.75 1.25 1.25 1.63 
 5.00 0.31 0.31 0.19 
Plasma 0.30 1.64 1.22 1.37 
 0.75 1.11 1.11 0.81 
 5.00 1.05 1.05 1.09 
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Table 2.4. Robustness analysis data for the 31P-qNMR method in VFS, SFS, and human plasma. 
Biological Media 
(TFV Conc. 
5mM in each) 
  
  
Robustness Parameters 
Temperature  
(ºC) 
Relaxation Delay 
(sec) 
45º Pulse Width (µs)  
% RSE (n = 3) % RSE (n = 3) % RSE (n = 3) 
35 37 39 4.8 5.0 5.2 4.85 5.05 5.25 
VFS 0.30 0.43 0.34 0.22 0.43 0.15 0.12 0.43 0.28 
SFS 0.17 0.21 0.22 0.24 0.21 0.24 0.15 0.21 0.27 
Plasma  0.91 0.98 0.72 0.70 0.98 0.79 0.81 0.98 0.64 
 
 
 
 
 
2] Application of the developed solution state 31P-qNMR method in quantitative real 
time in vitro TFV release analysis from chitosan NFs 
The developed solution state 31P-qNMR method was applied for the real-time 
quantification and release profile of TFV from the above chitosan based NFs formulation 
using electrospinning method (Figure 6A). The SEM images revealed that the chitosan 
based NFs were successfully formulated (Figure 6B). The mean diameter of NFs was 
158.51 ± 59.20 nm (n = 100) (Figure 6C). The drug loading (DL), and yield of chitosan 
NFs was 14.20 ± 2.12 % w/w, and 63.18 ± 1.16 % w/w, respectively, (n = 3).  
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Figure 2.6. (A) Coaxial electrospinning chitosan nanofibers fabrication assembly setup. (B) 
Surface morphology of chitosan NFs; scale bar, 5 µm. (C) Size distribution histogram of chitosan 
NFs determined by image analysis software and averaged using at least 100 measurements per 
group. 
 
 
 
The results of the drug release data modeling showed that ~75%, ~72%, and ~70% w/w 
drug release was observed in case of NMR method in VFS (Figure 7A), SFS (Figure 7B), 
and human plasma (Figure 7C), respectively. To evaluate the magnitude of potential 
interference of the dialysis membrane with the quantification of the drug release from 
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nanoformulations, the concentration of TFV release from the chitosan NFs in the receiving 
compartment was measured using UV-Vis method. The results showed that only ~47%, 
~52%, and ~52% w/w of TFV release was observed using UV-Vis method in VFS (Figure 
7A), SFS (Figure 7B), and human plasma (Figure 7C), respectively. The relatively lower 
drug release (approximately 20% less) observed by UV-Vis method might be due to the 
interference of dialysis membrane with drug transport to the release media. From the 
results, it was reasonably speculated that TFV did not achieve equilibrium during the 
release period analyzed by dialysis membrane method. Therefore, the data obtained for a 
drug release using the dialysis method will not be accurate if the formulation has a burst 
release profile and the amount of drug measured in the receiving compartment will be 
significantly underestimated. The in vitro kinetic modeling of NFs showed that it followed 
Korsmeyer-Peppas model mostly expect in VFS where it follow the first order model in 
case of NMR measurements (Table 5). First order model described the amount of drug 
released by unit of time diminish. Korsmeyer-Peppas model represented drug release from 
a polymeric system, the value of n characterizes the mechanism of drug release from the 
formulation. As NF is a cylindrical system, when n h0.45 corresponds to a Fickian 
transport, 0.45 < n < 0.89 to non-Fickian diffusion mechanism81. In all of the three release 
media, the release mechanism seemed to be different when the release kinetic is determined 
by NMR and UV-Vis. Therefore, it is misleading to refer to the dialysis membrane method, 
where further demonstrated the importance of developing a real-time quantification 
method. 
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Figure 2.7. Percent cumulative drug release (%w/w) profile of TFV loaded chitosan NFs analyzed 
by solution state 31P-NMR and UV-Vis spectroscopy assay in A] VFS, B] SFS, and C] Human 
Plasma.
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Table 2.5. In vitro drug release kinetics models parameters of TFV loaded chitosan nanofibers. 
Biological fluid Kinetic model NMR UV-Vis 
  Parameters R2* AIC** Parameters R2* AIC** 
VFS Zero-order k0=7.227 0.8763 52.7264 k0=2.366 0.8261 21.8931 
 First-order k1=0.121 0.9759 39.6561 k1=0.027 0.8600 20.8996 
 Korsmeyer-Peppas kKP=13.608 
n=0.711 
0.9544 46.7385 kKP=5.323 
n=0.634 
0.9235 19.8759 
 Higuchi kH=20.810 0.8915 51.6773 kH=7.010 0.9008 19.1790 
 Weibull α=9.077 
β=1.050 
0.9772 41.2043 α=18.888 
β=0.692 
0.9200 20.1049 
SFS Zero-order k0=7.029 0.6530 65.2748 k0=4.958 0.3047 33.3906 
 First-order k1=0.120 0.9078 53.3421 k1=0.071 0.5532 31.1992 
 Korsmeyer-Peppas kKP=20.106 
n=0.511 
0.9976 22.4483 kKP=18.767 
n=0.393 
0.9700 19.6941 
 Higuchi kH=20.537 0.9973 21.4897 kH=15.149 0.9314 21.8282 
 Weibull α=4.789 
β=0.697 
0.9936 31.3369 α=4.824 
β=0.473 
0.9551 21.7076 
Plasma Zero-order k0=6.801 0.7160 63.3986 k0=5.040 0.4397 33.0646 
 First-order k1=0.112 0.9306 50.7188 k1=0.073 0.6776 30.3012 
 Korsmeyer-Peppas kKP=18.414 
n=0.537 
0.9991 13.9156 kKP=17.921 
n=0.423 
0.9804 18.2931 
 Higuchi kH=19.793 0.9960 25.0033 kH=15.346 0.9629 19.4869 
 Weibull α=5.335 
β=0.725 
0.9961 26.7440 α=5.147 
β=0.517 
0.9717 
 
20.1428 
* Coefficient of determination. ** Akaike Information Criterion.
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Comparing the NMR assay and indirect UV-Vis assay of drug release quantitation, 
NMR method appeared to have three distinct advantages: Firstly, the NMR method is a 
direct and real-time quantification method, where dialysis membrane was not required. If 
the in vitro profile was determined using an indirect method, such as UV-Vis or LC assay, 
the concentration of the drug in the release media might be underestimated due to the 
interactions between drug molecules and the dialysis membrane and the two step process. 
When it is converted to the in vivo study, the real blood concentration of drug would be 
lower than the predicted blood concentration, and therefore, leaded to a potential toxic 
effect.  Secondly, the NMR method allowed for more data points to be collected in real-
time quantitation scenario which provided a more accurate and dynamic measurement of 
release profile. Thirdly, no specific sample preparation method was required, thus saving 
valuate research time. The UV-visible spectroscopy measurements based on the Beer-
Lambert Law and absorbance can only be related to drug concentration if molar 
absorptivity was determined or known for a drug molecules82,83. Conversely, it is well 
known that the phosphorus atom plays an important role in physiological processes since 
it is part of genetic materials (DNA) as well as of ATP. Thus, solution state 31P-qNMR 
method for phosphorus quantitation can also be widely applied in the analysis of other 
biological agents. Moreover, the direct proportionality of the analytical response and 
concentration is a major advantage of NMR over UV-Vis and LC assays for quantitative 
analysis of therapeutic molecules. In addition, the UV-visible spectroscopy measurements 
based the Beer-Lambert Law and absorbance can only be related to drug concentration if 
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molar absorptivity was determined or known for a drug molecules. However, with q-NMR 
method, the information about molar absorptivity was not needed. 
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PROJECT-2 
Layer by Layer Engineering of HIV-1 rgp120 Responsive Nanomicrobicide: 
Physico-Chemistry and Biological Responses 
Introduction 
Since its discovery in  1983,  Human  Immunodeficiency  Virus  infection  and  Acquired  
Immune Deficiency Syndrome (HIV/AIDS) has remained a scientific mystery, given that 
a complete eradication, strategy is yet to be found. Owing to the Highly Active 
Antiretroviral Therapy (HAART), which decreases the risk of opportunistic infections and 
maintains the immune system function, HIV patients can now live longer. However, sexual 
transmission of HIV, which account for 75 to 85 % of the overall HIV infections, is still a 
major hurdle in the complete eradication of HIV. In addition to having multiple sexual 
partners and the lack of male circumcision, another major reason for the increase in HIV 
transmission is that 6 out of 10 people living with HIV do not know their HIV positive 
status making them a risk to their sexual partners84,85. Therefore, there is a crucial need to 
develop a topical drug delivery system capable of preventing HIV sexual transmission. 
Recently, various microbicide drug delivery strategies (gels, films, rings, etc.) have been 
proposed, attempting to address this need with limited success. Semisolid dosage forms 
(gels) which are the most common microbicide drug delivery systems, present major 
challenges of messiness, leakage and lack of controlled release46. Besides their lack of 
retention, which constantly leads to leakages  and  therefore  patience  adherence  and  
compliance  issues,  topical  microbicide  loaded  gel formulation, such as CAPRISA 004, 
have shown their lack of effectiveness against HIV86. Vaginal films which are less untidy 
than gels are fast dissolving with rapid drug clearance by mucus renewal cycle46. Moreover, 
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the ASPIRE study states that the silicone based vaginal ring Dapivirine, although 
promising, still has to address compliance issues with undesirable drug release kinetics. In 
fact, the major concern of a ring-based delivery system is a constant drug release even in 
absence of HIV virus, which will eventually lead to drug waste, drug resistance issues, and 
potential side effects. To address this problem, the present study hypothesizes that a 
Concanavalin A (Con A) based topical vaginal and rectal nanomedicine formulation  is  
capable  of  the  safe  and  effective  release  of  a  pre-encapsulated  HIV microbicide "on-
demand". Nanoparticles can serve not only to protect the active agent but also facilitate 
penetration into the vaginal and ectocervical mucosa, allowing drug to reach HIV target 
cells46. Such a delivery system will ultimately protect women since more than half of all 
new HIV infections worldwide occur in females.  
Carbohydrate-binding agents (CBAs) are a class of proteins that have high affinities 
for sugar moieties. They have been shown to be highly effective against HIV as 
microbicides87–89. Lectins, which represent a subclass of CBAs, are proteins that 
specifically recognize carbohydrate (glycan) structures90. One of the most studied lectins 
is Canavalia ensiformis (Concanavalin A (Con A)) extracted from jack beans. Con A is 
known to bind sugars, glycoproteins, and glycolipids, containing internal and nonreducing 
terminal α-D-mannosyl and α-D-glucosyl groups91,92. Like most lectins, Con A is a 
homotetramer with each subunit composed of 235 amino acids and having a molecular 
weight of 26.5 kDa. At pH below 6, Con A exists as a dimer and is in its tetrameric form 
at pH above 6. Con A has an isoelectric point (PI) that ranges from 4.5 to 5.5 depending 
on its isoforms. Like most proteins, above its PI, Con A is negatively charged and bears a 
positive charge at pH values below the PI value. Con A’s binding activity requires metal 
 54 
 
ions. Agrawal and Goldstein have shown that each Con A subunit has one Ca2+ and Mn2+ 
binding site91,93. Con A has previously been shown to bind HIV-1 and HIV-2 viruses’ 
envelope glycoprotein 120 (HIV-gp120)94. More recently, Con A-immobilized polystyrene 
nanospheres were successfully designed for HIV-1 virions captured through Con A/HIV-
1 gp120 binding interactions95. HIV-gp120 plays a critical role in HIV infection. In fact, 
the binding of HIV-gp120 (on HIV virus surface) to the CD4 receptors (on host cells 
surface) represents the first step in the course of HIV infection that leads to the fusion of 
both membranes and the incorporation of the virus material into the host cell cytoplasm96. 
This process ultimately leads to the production of new viruses and the spreading of the 
disease.  
  In the last few decades, HIV-gp120 has been extensively studied. To date, 
more is known about its structure than ever before. Indeed, several groups have shown that 
HIV-gp120 is composed of high proportions of carbohydrates. It is estimated that 50% of 
the apparent molecular mass of HIV-gp120 is composed of carbohydrates97. More 
specifically, Mizuochi et al. found that about 40% of the total oligosaccharide   structures   
released   from   HIV-gp120   are   hybrid   and/or   high   mannose-type oligosaccharides 
and 60% are of the complex type98,99. This study also highlighted the unique and high 
mannose oligosaccharides content in HIV-1 rgp120 compared to other Chinese hamster 
ovary-cell-derived glycoproteins.  Furthermore, Geyer et al.100 found that high mannose-
type oligosaccharides account for approximately 50% of the carbohydrate structures of 
HIV-gp120. More recently, Bonomelli et al.101 found that  HIV-gp120  derived  from  a  
virus  prepared  by  infection  of  peripheral  blood mononuclear cells (PBMCs) with viruses 
from clade A (92RW009), clade B (JRCSF), and clade C 93IN905, show a predominantly 
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oligomannose glycan composition (62–79%) Man5–9GlcNAc2 with a predominant 
population of Man5GlcNAc2. These oligo-mannoses bind to Con A with equilibrium 
dissociation constant (KD) values ranging from 0.05 μM to 1.5 μM102. Binding of Con A 
to HIV-gp120 glycans either prevent HIV virus binding to receptors on the cells or affect 
alterations of gp120 following binding103. Our group recently published Con A binding 
affinities to glycogen from Oyster (0.25 μM) and mannan from Saccharomyces cerevisiae 
(2.89 μM)104. In this study, it is hypothesized that a mannose sensitive Con A cross linked-
polysaccharide nanoparticle can be designed to target HIV-gp120 and deliver a pre-
encapsulated microbicide drug “on-demand”. We envisaged the HIV-gp120 responsive 
drug delivery system to address deficiencies shown by previous approaches in HIV 
prevention including retention, effectiveness and undesired drug release. One of the 
potential advantages of this delivery system is stopping the virus before the propagation of 
the infection. Thus, HIV virus migration is stopped in the vaginal or rectal cavity before it 
diffuses through the mucus layer and infects the immune cells and ultimately spreads to 
the entire body.  
Material and Methods 
1] Material  
Concanavalin A (Con A) from Canavalia ensiformis (Jack bean) type VI, glycogen 
from Oyster, polyethylenimine (PEI) 50 wt. % solution in water, poly(sodium 4-
styrenesulfonate) (PSS) average Mw ~70.000 powder, calcium chloride dehydrate  
(CaCl2.2H2O, ACS reagent, ≥99%), sodium carbonate anhydrous (≥99%), fluorescein  
isothiocyanate labeled Concanavalin A (FITC-Con A), type IV, lyophilized powder,  
tetramethylrhodamine isothiocyanate–Dextran (TRITC-Dextran), manganese (II) chloride 
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tetrahydrate (MnCl2.4H2O, Reagent Plus, ≥99%), methyl α-D-mannopyranoside (≥99%), 
and Tris  Buffer Saline (TBS) pH 8.0 are purchased from  Sigma-Aldrich (St. Louis, MO, 
USA). Ethylenediaminetetraacetic acid (EDTA free acid) is purchased from Fisher 
Scientific (Pittsburgh, PA, USA) and Human Immunodeficiency Virus type 1 recombinant 
envelope glycoprotein (HIV-1 rgp120) was purchased from Sino Biological Inc. (Beijing, 
P. R. China).  
2] Methods 
2.1] Mannose sensitive nanoparticles synthesis 
Mannose sensitive nanoparticles (MSN) are synthesized via the “layer-by-layer” method 
by alternatively coating a core template with the mannose specific lectin (Con A) and a 
polysaccharide (Glycogen)105,106. In this study, the core (calcium carbonate (CaCO3)) is 
prepared by mixing equal volume (15 ml) of 0.2 M calcium chloride (CaCl2) and 0.2 M 
sodium carbonate (Na2CO3) in presence of a dispersant (PSS) under vigorous stirring at 
13,500 rpm for 2 minutes with the IKA Ultra-Turax model T25 homogenizer (Wilmington, 
NC, USA). A preliminary screening test has led to the selection of PSS as the optimal 
dispersant at a concentration of 4 mg/ml. To encapsulate Tenofovir in the core particle, the 
drug is dissolved in CaCl2 at 3 mg/ml prior to the addition of Na2CO3-PSS solution. 
Particles prepared in the presence of PSS depict a net negative charge and are subsequently 
dispersed in a positively charged initiator solution (4 mg/ml PEI in 0.5 M NaCl, pH 8.0) 
for at least 30 minutes in order to achieve a net positive charge. This allows the negatively 
charged lectin (1 mg/l Con A in TBS, pH 8.0) to adhere to the previous molecular assembly 
after a 1-hour exposition time. After three washing steps in deionized water (DI water) and 
centrifugation (1000 rpm), Con A coated nanoparticles are re-dispersed in a glycogen 
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solution (1 mg/ml in TBS, pH 8.0) for 1 hour to allow the addition of the first 
polysaccharide layer. After a washing step, glycogen coated nanoparticles are dispersed in 
Con A solution and the process is repeated until a desired number of layers is reached. In 
this study, the core particle is coated with 5 alternating layers of Con A and glycogen 
excluding the layer initiator. In order to visualize the particles in confocal microscopy, 
FITC-Con A is used for the first lectin layer addition and TRITC- Dextran for the last 
polysaccharide layer. Figure 8, summarizes the layer-by-layer synthesis procedure of core 
dissolved (C-MSN) and core containing (C+MSN) MSN. The first lectin layer successfully 
adheres to the assembly through electrostatic interaction between the positively charged 
PEI and the negatively charged Con A whereas the glycogen layer is successfully added 
through the specific binding property of Con A to α-D-glucose based polysaccharides91. 
After this first phase of preparation, part of the layer-by-layer assembled nanoparticles are 
dispersed in 0.1 M EDTA solution under gentle stirring to dissolve the CaCO3 core. Core 
dissolved nanoparticles are then washed twice with DI water to remove residual EDTA and 
are then freeze dried for 12 hours (Labconco FreeZone 1 Liter Benchtop Freeze Dry 
System, Kansas City, MO). 
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Figure 2.8. Illustration of the layer by layer preparation of core dissolved (C-MSN) and core containing (C+MSN) mannose sensitive nanoparticles 
(MSN). CaCo3 core particle is coated with 6 layers including a PEI layer initiator.
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2.2] Encapsulation and loading efficiency determination 
 
Tenofovir encapsulation efficiency (EE%) and loading efficiency (LD%) in MSN 
are estimated by liquid state and solid state phosphorus (31P) Nuclear magnetic resonance, 
respectively.  
31P solution state NMR: Tenofovir %EE is measured by quantifying the drug amount in 
the supernatant by 31P Solution State NMR. Equation 1 is then used to compute %EE.  
Equation 1: %EE =
Total amount of TFV−Free TFV
Total amount of TFV
∗ 100 
31P solution  state  NMR  experiment  is  carried  out  on  a  Varian  (Palo  Alto,  California)  
400  MHz spectrometer with a Varian two channel probe and operated by Vnmrj 2.2. 
Typically, the spectra are acquired with a 45º pulse length of 5.05 μs. The relaxation delay 
and the number of scans are 5 and 256 seconds, respectively. The spin–lattice relaxation 
time (T1) of the target phosphorous in Tenofovir is 5 s and typically requires up to 25 s (5 
× T1) for relaxation. Shimming is applied to every sample in order to obtain a similar 
linewidth in each spectrum. Baseline correction, phase adjustment, and integral 
calculations are carried out using MestReNova Lite 5.2.5-4731 software (Escondido, CA, 
USA) and Matlab 6.1 (Natick, MA, USA) and all experimental measurements are 
conducted at 37ºC. To determine Tenofovir amount in the supernatant, a standard curve is 
performed across a concentration range of 0-500 μg/ml in DI water. Equation 2, that 
describes the calibration curve is Y = 9675.2X – 29.677. The coefficient of determination 
is R2 = 0.9999, indicating a very good correlation between 31P NMR peak area (Y) and 
Tenofovir concentration (X). 
31P Solid State NMR: After freeze drying, Tenofovir LD% in and is determined by 
comparing their 31P solid state NMR peak area to a pure Tenofovir standard of same mass. 
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Thus, solid state NMR spectra for 30 mg of C+MSN, C-MSN, and pure Tenofovir samples 
are taken at room temperature in triplicates and the signals are represented as chemical shift 
value δ: ppm. Equation 3 is used to compute the loading efficiency. 
Equation 3: %LD =
31P NMR Peak Area of 30 mg MSN
31P NMR Peak Area of 30 mg TFV standard
∗ 100 
Practically, 31P-P90 Solid-State Magic Angle Spinning (MAS SS) NMR spectra  are  
acquired  on a Tecmag Apollo console (Houston, TX, USA) operated by NTNMR software 
package (v.2.4.29, Houston, TX, USA) with 8.45 T magnet and a 3 mm homebuilt, 2-
channel, wide-bore NMR probes. The 1H and 31P Larmor frequencies are 357.2 MHz and 
144.596 MHz, respectively. The MAS spinning frequency and 45º pulse length are 8 KHz 
and 2 μs, respectively.  
2.3] Fourier Transform Infrared Spectroscopy 
The Agilent Cary 630 FTIR instrument (Newark, DE, USA) equipped with a diamond 
crystal having a single reflection and a nominal angle of 45° is used in its Attenuated Total 
Reflectance (ATR) mode for IR spectra acquisition. A resolution of 4 cm-1, a sample scan 
of 32 per second and an effective pathlength of 1.1 μm are set as parameters. IR spectra are 
acquired between 4000 and 400 cm-1.For better spectral resolution, all samples are allowed 
to make an intimate contact with the ATR diamond crystal surface by pressing them with 
a built-in pressure clamp. FTIR spectra are collected and analyzed with MicroLab PC and 
MicroLab Lite softwares (versions 4.0, Newark, DE, USA), respectively.  
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Results and Discussion 
1] Drug Encapsulation and Loading Efficiencies 
Tenofovir encapsulation efficiency in CaCO3-PSS core particle is 74.4%. Likewise, 
Tenofovir loading efficiency in C-MSN (6.0 % ± 0.1 w/w; n=3) is about 3 fold lower than 
the loading efficiency obtained for C+MSN (16.3% ± 0.1 w/w; n=3). The difference in 
loading efficiency is probably due to a lost in Tenofovir during core dissolution because of 
its relatively high water solubility (13.4 mg/mL). Figure 9 shows the 31P solid state NMR 
spectra. Tenofovir encapsulation in CaCO3-PSS particles is possible due to two major 
factors. Firstly, after the nucleation phase, leading to the formation of the CaCO3-PSS 
crystal precursors, the crystal growth phase involved a co-precipitation. Thus, drug 
molecule can be entrapped in the CaCO3-PSS particles during the crystallization process. 
Secondly, co-precipitation alone does not explain the overall drug entrapment level. In fact, 
along with aluminum hydroxide [Al(OH)3], calcium acetate [Ca(C2H3O2)2], lanthanum 
carbonate [La2(CO3)3], magnesium carbonate [MgCO3], calcium carbonate [CaCO3] is a 
member of the phosphate binders family107–109. As can be expected from their 
denomination, phosphate binders bind to phosphorus atoms through ionic interactions. In 
CaCO3, it is the calcium ion (Ca2+ ) that binds the phosphate group. Therefore, it is expected 
that Tenofovir, which structure contains a phosphate group, will be entrapped in the core 
particles. Ueno et al. were able to reach a 90% loading of betamethasone phosphate in 
nano-CaCO3 particles110. 
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Figure 2.9. 31P solid state NMR spectra of C-MSN, C+MSN. Tenofovir appears at 15.7 ppm and 
the spinning side bands are indicated by asterisks. 
 
 
 
 
 
 
 
  
63 
 
2] FTIR Analysis 
In order to further characterize MSN and confirm the composition of the coating layers; 
FTIR spectra of C-MSN, C+MSN, glycogen, Con A, CaCO3-PSS core particle and Con 
A/Glycogen agglutinate have been acquired in Figure 10. Glycogen IR spectrum shows 
distinctive weak peaks at 1160 cm-1 and 1080 cm-1 and a strong absorption at 1000 cm-1 
characteristic of polysaccharides C-O-C, C-O and C-H stretches111,112. The bands at 3300 
cm-1 and 2900 cm-1 are due to OH and CH2 stretches in glycogen, respectively. Con A 
spectrum shows strong bands at 1620 cm-1 and 1520 cm-1 attributed to  amide I and II, 
respectively113. Spectrum obtained for CaCO3-PSS core particle shows a strong peak at 
870 cm-1 characteristic of carbonate band in calcium carbonate114. Features at 1400 cm-1 -
1480 cm-1 are attributed to S=O asymmetric stretching vibration mode in PSS115. C+MSN 
spectrum shows Con A amide I band at around 1620 cm-1 confirming the presence of the 
lectin in the assembly. The bands between 1400 cm-1-1480 cm-1 as well as the strong 
absorption at 870 cm-1 in C+MSN spectrum confirm the presence of CaCO3-PSS core 
particle in the assembly. As expected, bands attributed to the carbonate band are not seen 
in C-MSN FTIR spectrum. The band at 1000 cm-1 and the amide I stretching band at 1620 
cm-1 further confirm the presence of Con A-Glycogen agglutinate in C-MSN assembly. The 
absorption band at 3300 cm-1 in Con A-Glycogen agglutinate spectrum is due to water 
residue in the preparation.
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Figure 2.10. FTIR spectra of glycogen, Con A, CaCO3-PSS core particle, C+MSN, C-MSN and Con A/glycogen agglutinate.
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Figure 2.11. Tenofovir release profile from C+MSN in the presence of methyl α-D-mannopyranoside (1000 μg/ml) and HIV-1 rgp120 (100-1000 
μg/ml). Data from each time point is triplicated (n=3).
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3] Drug Release from MSN 
The mannose responsive property of MSN is tested by monitoring Tenofovir release from 
up to 24h in the presence of methyl α-D-mannopyranoside as well as mannose-rich HIV-1 
recombinant envelope glycoprotein (HIV-1 rgp120) (Figure 11). In general, a maximum 
drug release is reached within 4h. An increasing dose response effect is also observed with 
increasing concentration of HIV-1 rgp120. HIV-1 virus is known to cross the mucosal 
barrier in 2 to 6 hours and, during the first 3 to 6 days, disseminates locally and reaches 
draining lymph nodes116. Thus, might offer the unique advantage of neutralizing HIV-1 
virus in the vaginal or rectal track before the completion of its migration through the 
mucosal barrier. The maximum drug release (75%) is observed in the presence of methyl 
α-D-mannopyranoside (1000 μg/ml) while HIV-1 rgp120 induces 61% and 39% drug 
release at 1000 μg/ml and 500 μg/ml, respectively. The maximal drug release observed in 
methyl α-D mannopyranoside might be due in part to a higher binding affinity of Con A 
for the oligosaccharide a previously shown by Goldstein et al.92. Although 22% of 
Tenofovir is released from when exposed to 100 μg/ml of HIV-1 rgp120, this is, however, 
not significantly different from the drug release observed in the control conditions 
[SFS:VSF/(3v:1v)].
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PROJECT-3 
Spray Dried Thiolated Chitosan Coated Sodium Alginate Multilayer Microparticles 
for Vaginal Anti-HIV Microbicide Delivery 
Introduction 
 
An ideal vaginal drug delivery system should be easy to administer, not cause 
discomfort to improve patient compliance and have a reduced number of doses required to 
the treatment117. To meet these requirements, various vaginal drug carriers have been 
developed69,73,74,118. However, in most of these formulations, the encapsulation of a water-
soluble small molecular drug is a serious problem associated with drug %payload. 
Recently, a special attention has been focused on the development of spray dried 
microparticles (MPs) as an alternative solution63. Spray drying is a rapid and simple 
process based on the solvent evaporation. The atomized polymeric droplets containing the 
drug are transformed in solid particles by a stream of heated air119. The spray drying method 
not only typically produces spherical MPs with a narrow size distribution, but also enables 
the encapsulation of both hydrophilic and hydrophobic drugs with relatively high 
efficiency and yield120,121. 
       The main advantages of MPs over traditional vaginal dosage forms such as gels, 
creams, rings, and films are: the generation of a sustained drug release profile following 
the application of a single dose, a proper spreading over the vaginal epithelium, the 
protection of the drugs and ability to reduce drug toxicity. To further prolong the residence 
time on the site of the treatment, a thiolated chitosan (TCS) is used to coat the MPs. It has 
been shown to possess high mucoadhesive properties due to the thiol groups present on the 
  
68 
 
chitosan backbone, which can form disulfide bonds with the thiol groups present on the 
mucus substructures122. 
       In this study, a hydrophilic anti-HIV microbicide, tenofovir (TFV) (water solubility 
1.87 mg.ml, logP -1.5), is encapsulated within the spray dried alginate MPs. The MPs are 
coated with TCS based on the charge-charge interaction between alginate and TCS. It is 
postulated that these MPs may prolonge the drug retention time as well as controlled 
release profile, and could be a potential vaginal drug delivery system with increased 
encapsulation efficiency of water-soluble small molecule drugs, such as TFV.  
Materials and Methods 
1] Materials 
       Sodium alginate, chitosan with the weight molecular weight of 50-190 KDa, mucin, 
periodic acid, Schiff reagent kit and benzalkonium chloride (BZK, 2 %w/v) are purchased 
from Sigma Aldrich (St. Louis, MO, USA). Tenofovir (TFV) is purchased from Zhongshuo 
Pharmaceutical Co. Ltd. (Beijing, China). Sodium triphosphate pentabasic (TPP) is 
supplied by Fisher Scientific (Pittsburgh, PA, USA). The CytoTox-ONE™ and CellTiter 
96™ Aqueous kits are purchased from Promega (Madison, WI, USA). 
2] Method 
2.a] Formulation of Spray Dried MPs 
      To prepare TFV loaded alginate MPs, different amounts of sodium alginate and TFV 
(Table 6) are dissolved in 40 ml of deionized water, the ratio of sodium alginate to TFV is 
5:1 (w/w). The solution is then spray dried using a Buchi Mini Spray Dryer, Model 290 
(Buchi Laboratoriums - Technik AG, Flawil, Switzerland). Then, the formulated MPs are 
stored at 4°C for further analysis. 
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In order to optimize the preparation conditions, a custom design with 3 factors and 16 
run is used to study the effect of the formulation parameters on the yield. The independent 
variables, molecular weight of sodium alginate, concentration of the sodium alginate 
solution, and inlet temperature, are represented by X1, X2 and X3, respectively. The percent 
(%) yield, which is the dependent variable is represented by Y. These variables and their 
coded factors are listed in Table 1. All independent variables in this work are selected based 
on preliminary experiments performed (data not shown). The yield is calculated using 
Equation 1 below: 
Yield(%) =
Total mass of MP powder collected
Total mass of initial components in the formulation
×100%            （1） 
2.b] Preparation of the Multilayered MPs 
       For the preparation of MPs by layer-by-layer is adapted from Li, et al. method123. The 
multilayer MPs are obtained by alternately coating alginate and TCS on the surface of the 
particles (Figure 12). Briefly, 40 mg of CaCl2 and 2 mg of TCS are dissolved in 1 ml of 
acidic acid solution (pH 5). A total of 1 mg of spray dried alginate MPs are subsequently 
suspended into the above solution. After the resulting suspension is stirred for 2 h. The 
product is collected by centrifugation at 10,000 rpm for 10 min (Beckman Coulter Inc., 
Pasadena, CA, USA) and washed thoroughly with water once. This product is TCS coated 
single layer MPs (SLMPs). To prepare the double layer MPs (DLMPs), alginate and TCS 
are dissolved in 0.1% acetic acid solution (pH 5) at a concentration of 2 mg/ml, 
respectively. At this pH, both TCS (weak acid, pKa 6.5) and alginate (weak base, pKa 4.2) 
mainly exist in ionized form124. Then the SLMPs are suspended in 1 ml of alginate solution, 
stirred, centrifuged, and washed as described above, followed by suspending in
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1 ml of TCS solution for 10 min. The resulting DLMPs are collected by centrifugation. The triple layer MPs (TLMPs) could thus be 
obtained by repeating the above operations of DLMPs. The percent drug loading is determined using 31P SS NMR as follows. 
 
 
 
 
Figure 2.12. Schematic preparation scheme of the TCS coated multilayer MPs.
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 2.c] Percent Drug Loading Determination using 31P SS NMR 
31P MAS SS NMR spectra are acquired on a Tecmag Apollo console (Houston, TX) 
with 8.45 T magnet and homebuilt, 2-channel, wide-bore NMR probes. The 1H and 31P 
Larmor frequencies were 357.2 MHz and 144.596 MHz respectively. 31P spectra are 
acquired on 3 mm probe with MAS spinning frequency and 45º pulse length is 8 KHz and 
2 μs, respectively and signals are represented as chemical shift value; δ: ppm. About 40 mg 
of the MPs sample is taken for each analysis. All experiments are performed at ambient 
temperature without any corrections for sample heating. 
2.d] Surface Characteristics Determination using FT-IR Spectroscopy 
       The surface chemistry is determined by FT-IR spectroscopy. Before analyzing each 
sample, the background spectrum is collected at ambient conditions. The MPs are then 
scanned over the range of 650 and 4000 cm−1. The FT-IR spectra are recorded by OMNIC 
V 7.0 spectra software. 
 
 
 
 
Table 2.6. Independent and dependent variables and their levels in custom design. 
 
 
 
Variables Value 
Independent Molecular weight of sodium alginate (X1) Low High 
Concentration of sodium alginate (X2) 5 mg/ml 15 mg/ml 
Inlet temperature (X3) 100 °C 150 °C 
Dependent  Yield (Y)   
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Figure 2.13. Drug Loading Analysis of MPs using 31P SS NMR Spectroscopy. A single peak for 
TFV appears at 15.7 ppm. Spinning side bands are shown by Asterisks.  
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Figure 2.14. FT-IR spectra of oppositely charged TCS and Alginate coatings (n=3). 
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Results and Discussion 
1] Characterization of MPs using 31P SS NMR Spectroscopy 
The amount of TFV encapsulated in MPs with different layers was detected by 
implementing 31P SS NMR spectroscopy (Figure 13). The amount is presented as a 
percentage, in comparison with pure TFV (considered as 100 %). Three trials for each type 
of MPs are carried out in order to be able to calculate the standard deviation by utilizing 
31P solid state NMR spectroscopic technique. The drug loading slightly decreases when a 
new layer, which increases the total mass of polymer, is coated. The MPs are washed after 
each coating step, this may also lead to the loss of drug dye to the high water solubility of 
TFV. The percent drug loading slightly decreases due to new layers that increase the total 
mass of polymer, and drug loss during washing.  
2] Characterization of MPs using FT-IR Spectroscopy 
Layer by layer deposition also results in a slight increase in the particle size. The 
coating by these different layers is further confirmed by FT-IR spectroscopy (Figure 14). 
Both native alginate and native TCS exhibit a broad absorption peak at around 3100 to 
3650cm–1 and weak absorption peaks at 2890 cm–1, attributed to their hydrogen bond 
stretching vibration and the CH stretch, respectively. TCS shows two characteristic peaks 
at 1520 and 1650 cm–1, due to the amide (CO-NH-) and the amine (-NH2) absorption band, 
respectively. The native alginate reveals two sharp and characteristic peaks at 1610 and 
1415 cm–1 assigned to the carboxylic acids (COO–). After coating by either TCS or 
alginate, the main component on the MPs surface exhibit relative FT-IR spectra.
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Chapter 3 
ANALYSIS OF CALCINED CLAY AS A SUPPLEMENTARY CEMENTITIOUS 
MATERIAL: A CASE STUDY OF CLAY FROM GHANA 
Introduction 
Calcined clay is an important and well-researched material which is used as a 
supplementary cementitious material (SCM) in concrete production. The construction 
industry around the globe has embraced SCMs as cement substitutes in promoting 
sustainable construction. SCMs reduce harmful anthropogenic gases contributed by cement 
manufacturing plants1, reduce the dependence on natural resources for cement production2, 
as well as significantly reducing cost of concrete production3. SCMs are classified into 
three categories namely; fillers, pozzolanic and hydraulic materials. Fillers are inert 
materials which contribute little to the hydration of cement. Pozzolanic materials are 
typically fine alumino-silicates that chemically react with calcium hydroxide to form 
additional calcium silicate hydrate and other cementitious compounds. Hydraulic materials 
chemically reacts with water to form cementitious compounds4. Examples of filler 
materials are chalk and limestone and that of pozzolanic materials include fly ash, silica 
fume, calcined clays, while steel slag and ground granulated blast furnace slag (slag 
cement) are primarily characterized as hydraulic materials. 
Clay minerals undergo thermal activation to become reactive with Portland cement 
during hydration. The thermal activation process is usually achieved through calcination. 
At appropriate calcination temperatures these thermally activated clays become more 
reactive with cement and can improve strength and durability of concrete. Generally it has 
been found that temperatures between 500oC and 900oC are suitable to produce reactive 
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clays5. However, the exact calcination temperature suitable to activate clay thermally is 
dependent on the clay origin, chemistry, and amount and type of impurities. Clays are 
classified into kaolinitic, smectite and the illite groups6. Kaolinitic group includes kaolinite, 
nacrite, and nickite whereas the smectite group includes montmorillonite, nontronite, 
biedelollite. The illite group are made of Illite and Glauconite7. Fundamentally a clay 
mineral has different structures and compositions, however the basic building blocks are 
all the same8. The building blocks form sheets of tetrahedral and octahedral layer which 
defines the atomic structure of every clay mineral. The kaolinitic group are made of a 1:1 
layer, i.e. a tetrahedral sheet and an octahedral sheet. Both the smectite and the illitic group 
also consist of a 2:1 layer, i.e. an octahedral sheet in-between two opposing tetrahedral 
sheets7. In a clay mineral, tetrahedral sheet is always combined with octahedral sheet.   
During heating, three processes occur which are dehydroxylization, calcination, 
and crystallization. During dehydroxylization octahedral sheets lose water and transform 
into a meta-stable state9. In the metastable state amorphous materials are produced which 
are more reactive to free calcium hydroxide present during hydration. The end of the 
dehydroxylization process marks the calcination temperature. The calcination temperature 
also influences the environment of the layered silicate which is also an indicative of the 
reactivity of calcined clays10. At high temperature the clay minerals begin to crystalize 
which decreases reactivity. At about 600oC kaolintic clays becomes fully dehydroxylize, 
whilst the smectite and the illitic groups dehydroxylizes above 600oC11. Hydroxyls are not 
as strongly bound in kaolinite clays compared to smectites and illites which explains the 
differences in the calcination temperature. Qualitative techniques such as Thermal 
Gravimetric Analysis (TGA) and Furrier Transform Infrared Spectroscopy (FTIR), and 
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quantitative tools like Nuclear Magnetic Resonance (NMR) are able to provide meaningful 
characterizing of thermally activated clays. TGA determines the extent of 
dehydroxylization whereas FTIR determines the anionic functional groups11,12. Solid state 
NMR is clearly a very powerful technique capable of looking at a variety of materials. It 
does not require crystalline materials like diffraction techniques, and can still determine 
local molecular environments. SS NMR helps in quantifying the structural features of 
amorphous materials10. NMR probes into the isotropic chemical shift of Silicon tetrahedral 
and Aluminum octahedral in either a calcined clay or a binder hydrate. Both qualitative 
and quantitative techniques uniquely support each other to limit the level of uncertainties 
in the characterization techniques and pozzolanic activity. 
Ghana, a West African nation, and other neighboring countries do not have an 
abundance of commonly used SCMs such as fly ash, silica fume, metakaolin, and slag. 
However, the abundance of clay minerals in the country could provide a sustainable 
alternative with respect to SCMs application3. Previous research has characterized the 
strength performance of thermally activated clay13,14. However there is little information 
on the phase transformation of thermally activated Ghanaian clay and their relation with 
strength activity. In this study, clay from Ghana was thermally activated at temperatures of 
600, 700, 800, 900 and 1000oC. The main objective was to characterize calcined clay using 
TGA, FTIR, NMR, and their relation to pozzolanic activity to best understand the potential 
of this abundant resource to alleviate cement supply burdens. 
Materials 
The materials used for the study were clay, cement, silica sand, polycarboxylate 
high range water reducer (HRWR), and potable water. The clay was obtained from 
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Nyamebekyere in the Ashanti Region area of Ghana. Portland cement conformed to ASTM 
C150 both Type I and Type II and was obtained from Ashgrove cement plant in Chanute, 
Kansas. Graded silica sand used conformed to ASTM.  A polycarboxylate HRWR, 
obtained from BASF Chemical Company conforming to ASTM C595 was used. 
Methods 
1] Thermal Analysis 
TGA results were obtained using a Mettler Toledo TGA/ SDTA 851 e analyzer 
heated to 1200oC, ramping 15oC per minute in N2 gas. 
2] Clay Calcination 
Calcination of clay samples were performed in a laboratory furnace (Barnstead 
Thermolyne 6000 furnace). A known mass was placed in ceramic bowls and heated at 
different temperatures of 600oC, 700oC, 800oC, 900oC and 1000oC for three hours. The 
calcined samples were then allowed to cool in the furnace to room temperature. 
3] FTIR 
Attenuated total reflectance infra-red spectroscopy was conducted using NICOLET 
iS10 FT-IR spectrometer equipped with a fast recovery deuterated triglycine sulfate 
(DTGS) detector and an extended KBr beamsplitter. Infra-red spectrum were obtained 
from 4000 to 600 cm-1 and 512 acquisitions were added at a spectral resolution of 2 cm-1. 
All spectral measurements were carried out at room temperature.  
4] 27Al and 29Si Solid State MAS NMR 
Tecmag Apollo Console (Houston, TX) with 8.45 T magnet and homebuilt, single 
channel, 4 mm wide-bore NMR probe was used to determine 27Al and 29Si spectra. About 
90 mg of sample was taken for each analysis and signals are represented as chemical shift 
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value; δ: ppm. The 27Al and 29Si Larmor frequencies were 93.074 MHz and 70.958 MHz 
respectively. 27Al spectra were acquired with MAS spinning frequency, last delay and 90º 
pulse length of 8 KHz, 1 s and 2.5 μs, respectively. 29Si spectra were acquired with MAS 
spinning frequency, last delay and 60º pulse length of 8 KHz, 20 s and 5.5 μs, respectively. 
Aluminum nitrate [Al(NO3)] and tetramethyl silane (TMS) were used as reference 
compounds for 27Al and 29Si NMR spectra respectively. All experiments were performed 
at ambient temperature without any corrections for sample heating.   
5] Pozzolanic Activity 
The pozzolana activity was determined according to the description of ASTM C618 
and ASTM C311. This standard explains the determination of pozzolanic activity using the 
strength activity index (SAI) as well as pozzolana replacement dosage. SAI were 
determined on mortar samples. Mortar samples were prepared in accordance with ASTM 
C109 and cured in lime water bath for a period of 7 and 28 days.  As per the ASTM C311, 
cement were replaced with calcined clay at 20%. The water-to-cement ratio was maintained 
at 0.485 and the ratio of cementitious material (Portland cement plus calcined clay) to sand 
was set at a ratio of 2.75 to 1. To achieve the desired flow according to ASTM C1437, the 
polycarboxylate HRWR was used. SAI was measured on an average of three mortar 
specimens. The SAI was calculated based on this formula- 
𝑆𝐴𝐼 = [1 − (
𝐶𝑆𝑜 − 𝐶𝑆𝑖
𝐶𝑆𝑜
)]×100% 
Where: CSo is the compressive strength without pozzolan, CSi is the compressive 
strength with calcined clay. 
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Results and Discussions 
Calcined Clay Characterization 
1] Thermal Analysis 
Figure 1 presents the TGA results of the clay powder showing that four different processes 
occurred. The first two peaks, A and B that preceded the dehydroxylization peak C 
represented the evaporation of adsorbed water and decomposition of organic particles. The 
dehydroxylization of the clay started from 325˚C to approximately 731˚C. Figure 1, shows 
that the effective calcination temperature was at 731˚C. The temperatures between 731˚C 
and 905˚C showed a complete dehydroxylization of the clay material. Complete 
dehydroxylization of clay mineral, indicated between 731˚C and 904˚C, shows that 
octahedral aluminium sheets dehydroxylized into a metastable disordered state, collapsing 
a higher quantity of crystalline clay minerals to produce a more reactive calcined clay9. 
The temperature between 905˚C and 1036˚C labelled as D also showed the formation of 
crystal growth of mullite phases. The growth of crystals shown between 905ºC and 1036˚C 
support the argument of Fernandez et al11 that at higher temperatures a metastable state 
transforms from amorphous condition into crystalline units which inhibits reactivity of 
calcined clays. 
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Figure 3.1. DTA results of powdered clay. 
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2] FTIR Analysis 
Figure 2, presents the FTIR results of the raw and clay calcined between 600˚C and 
1000˚C. The figure shows vibration band occurring between approximately 690 and 1800 
cm-1 and molecular vibration from 1800 to 3700 cm-1. The raw clay showed distinctive 
vibration bands at 3693, 3651 and 3619 cm-1 conforming a metal bonded to hydroxide 
group. This is most likely to be a kaolinite structure15. Absorption bands corresponding to 
Al-O and Si-O were also observed at 1162, 1109, 1025, 999, 910, 777 and 692 cm-1 16. The 
clay calcined between 600-1000oC showed the disappearance of the kaolinite structures as 
well as the water molecules. This indicates a change from a crystalline structure to an 
amorphous or metastable structure17. The vibrational atoms that corresponded to Al/Si-O 
at 1162, 1109, 1025, 999 and 910 cm-1 were seen disappearing after calcination, whilst 
absorption bands at 777 and 692 cm-1. The disappearance of the absorption bands meant a 
change from octahedral coordination of Al+3 to a tetrahedral coordinated environment18.   
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Figure 3.2. FTIR spectra of raw clay and clays calcined at temperatures 600-1000˚C. 
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3] 27Al SS MAS NMR 
27Al (spin = 5/2) is quite sensitive nucleus to perform SS NMR studies on and hence 
can be readily detected and hence, 27Al SS MAS NMR spectroscopy is widely used to 
characterize aluminate phases. One must also understand the disadvantage of using 27Al 
MAS NMR spectroscopy for 27Al is a quadrupolar nucleus which can pose difficulties in 
spectral interpretation as 27Al nucleus is affected by the quadrupolar interaction. 
Quadrupolar interaction is additionally affected by electric field gradients within the 
sample and leads to a field-dependent shift in resonance position and a broadening of the 
peaks. In the presence of overlapping quadrupolar resonances from several sites, the 
spectra can be very difficult to deconvolute, especially in the case of disordered solids 
where line shapes are not well defined.  
Solution state NMR of quadrupolar nuclei is often fashioned with complications, 
mainly because of the rapid relaxation of the quadrupolar nucleus due to the large 
quadrupolar interaction (which may be on the order of MHz). At best, very broad peaks 
are observed. NMR of half-integer quadrupolar nuclei has become quite commonplace, 
and allowed investigation of a broad array of materials. Recent technological 
advancements and new pulse sequences have opened up the periodic table (73% of NMR 
active nuclei are quadrupolar nuclei) to solid-state NMR. The strange broadening effects 
of quadrupolar nuclei, once viewed as a hindrance to performing such experiments in the 
solid state, are now exploited to provide invaluable information on solid state chemistry, 
structure and dynamics. Although, 4-coordinate and 6-coordinated aluminum can readily 
be distinguished it is rather essential to discuss the theoretical aspects of NMR of 
quadrupolar nucleus in order to be able to interpret its spectra. 
  
90 
 
Quadrupolar nuclei have a spin > 1/2, and an asymmetric distribution of nucleons 
giving rise to a non-spherical positive electric charge distribution; this is in contrast to spin-
1/2 nuclei, which have a spherical distribution of positive electric charge. The asymmetric 
charge distribution in the nucleus is described by the nuclear electric quadrupole moment, 
eQ, which is measured in barn (which is ca. 10-28 m2). eQ is an intrinsic property of the 
nucleus, and is the same regardless of the environment. Quadrupolar nuclei interact with 
electric field gradients in the molecule. Electric field gradients are spatial changes in 
electric field in the molecule. Like the dipolar interaction, the quadrupolar interaction is a 
ground state interaction, but is dependent upon the distribution of electric point charges in 
the molecule and resulting electric field gradients. For a quadrupolar nuclei in the center 
of a spherically symmetric molecule, electric field gradients cancel one another resulting 
in a very small final electric field gradient at the quadrupolar nucleus. As the spherical 
symmetry breaks down, the electric field gradients at the quadrupolar nucleus grow in 
magnitude. 
The 27Al solid state mass angle spinning (MAS) nuclear magnetic resonance 
(NMR) spectra of raw and calcined clay from 600˚C-1000˚C are presented in figure 3. The 
raw clay showed two distinct peaks which resonated at 68 ppm and -0.8 ppm respectively 
and indicated a 1:1 kaolinite group of clay. As it has already been explained from literature, 
a 1:1 group represents an octahedral and a tetrahedral sheets19, confirmed that tetrahedral 
sheet resonates from 50 ppm to 80 ppm whereas the octahedral sheet resonates from -20 
ppm to 20 ppm.  
Calcined clays exhibited an increase in the intensities of Al (iv) and decrease in the 
intensities at the Al (vi) environment with reference to the raw clay which indicated greater 
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reactivity of calcined clays20,21.  It was observed that calcined clays at 900˚C and 1000˚C 
had low and similar intensities at the Al (vi) environment. Again, from the results of the 
TGA shown in Figure 1, the most appropriate temperature that may give higher 
amorphousness or disorderliness of calcined clay could be attained either at 700˚C or 
800˚C. The intensities of the results at the four-coordinated environment of 27Al were very 
difficult to attain because of the nature of the reference clay peak. The nature of the peak 
shown at 68 ppm on the spectra of the reference clay is subjected to produce higher error 
of margin being merged with the adjacent spinning side band (indicated by Asterisk). This 
limitation hindered our interest in calculating the respective peak areas of all the peaks at 
68 ppm at various temperatures of calcination.  
 
 
 
 
 
 
Table 3.1 Solid State NMR spectra indicating position and peak areas of respective peaks of 27Al 
and 29Si.  Peak areas are calculated considering Raw Clay as a control. 
 
Dry Cement 27Al SS NMR  29Si SS NMR 
ppm Peak Area (%)  ppm Peak Area (%) 
Raw Clay -0.8 100  -126 100 
600˚C -0.3 13  -126 320 
700˚C -1.8 6  -126 328 
800˚C -0.3 9  -126 335 
900˚C -2.8 2  -126 800 
1000˚C -6.3 2  -126 726 
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Figure 3.3. 27Al SS MAS NMR spectra of raw clay and clays calcined at temperatures 600-1000˚C. 
The spinning side-bands are indicated by Asterisk.  
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4] 29Si SS MAS NMR 
29Si NMR spectra are normally interpreted in terms of the different silicon Q 
environments, where n denotes the number of bridging oxygens for each Q (SiO,) unit and 
hence, 29Si SS MAS NMR spectroscopy has proven to be extremely useful in the structural 
characterization of silicates and typical ordinary Portland cements, and also to investigate 
the hydration of pure C3S and β-C2S phases. In hydrated cements, these show the presence 
of Q˚ units due to orthosilicate groups, Q1 units from Si-O-SO3 groups in dimers or 
terminating polymers, and Q2 units from Si-O-Si-O-Si groups in trimers and higher 
polymers. 
Figure 4, presents the 29Si solid state mass angle spinning (MAS) nuclear magnetic 
resonance (NMR) of raw and calcined clay from 600˚C-1000˚C. Raw clay showed a 
chemical shift at -110 ppm and -126 ppm. This shift corresponds to Q4 silicon coordinated 
environment22. The process of calcination collapsed one of the Q4 population in the raw 
clay remaining another one Q4 population which increased progressively in intensities as 
calcined temperatures increased. Calcined temperatures at 900 and 1000˚C indicated a 
higher intensities which could be due to the presence of recrystallized quartz shown in the 
TGA graph. TGA results have already shown that calcined clay between 900 and 1000˚C 
may be less reactive because of crystalline products. Moreover the TGA has also shown 
that calcined materials at 700 and 800˚C may be more reactive. However, Figure 4 
confirms that calcined clay at 800˚C could possess more reactive phases than calcined 
materials at 700˚C due to the high intensity obtained at the Q4 silicon population.  
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Figure 3.4. 29Si SS MAS NMR spectra of raw and calcined clays. 
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5] Pozzolanic Activity 
Table 2, shows the mortar mixture proportions of calcined clay pozzolan. The table 
shows that the flow for the mortar mixtures were between 106 and 116 which was within 
the acceptable range specified in the ASTM C1437. HRWR content reduced at 
temperatures of 900oC and 1000oC compared with materials calcined from 600oC-800oC. 
The reduction of HRWR at 900oC and 1000oC indicate a reduction in the particle surface 
area and absorption properties of the powder materials which is confirmed from the TGA 
results. The formation of crystalline substances reduces the two, surface area and 
porosity23,24. 
Figure 5, provides the results of the SAI of the calcined clay pozzolan. Calcined 
clay at 800oC attained the maximum strength at 7 and 28 days as compared to the control 
mortar mixture. This shows that at 800˚C, the clay powder was completely calcined 
forming active pozzolanic phases which are very reactive with cement than the other 
temperatures used to calcine the clay. Tironi et al17, indicated that at optimum calcination 
temperature strength improves due to the pozzolanic active phases (amorphous phases) 
formed. 
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Table 3.2. Mortar mix proportion for strength activity index of calcined clays at 7 and 28 days. 
Temp 
(oC) 
Mix 
Name 
Mass (g) 
w/b 
HRWR 
(%) 
Flow 
(%) Cement Clay Sand Water  
Control C 500 0 1375 242 0.485 0 106 
600 20P600 400 100 1375 242 0.485 0.4 111 
700 20P700 400 100 1375 242 0.485 0.4 110 
800 20P800 400 100 1375 242 0.485 0.4 110 
900 20P900 400 100 1375 242 0.485 0.3 115 
1000 20P1000 400 100 1375 242 0.485 0.2 116 
 
 
 
 
Figure 3.5. Strength activity index of calcined pozzolan. 
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6] Influence of Calcined Clay (800˚C) on Cement Hydration using 27Al SS MAS NMR 
Spectroscopic Technique 
Figures 6,7,8, presents the 27Al SS MAS NMR results of hydrated binder paste 
mixture of the unblended cement as well as blended mixtures between cement and calcined 
clay at 800oC. Figures 6,7,8, presents hydration at 3, 7 and 28 days respectively showing 
two distinct peaks. The studies25,26 have shown that chemical shift between 8 and 11.8 ppm 
corresponds to monosulphates whereas chemical shifts between 66 and 72 ppm 
corresponds to Al environment replacing Silicon in the tetrahedral environment of 
Aluminum. The diffused peaks around 8 ppm shown in Figures 6,7,8, represents 
monosulphate (AFm) present in the aluminosilicate hydrates or stratlingite formed whereas 
around 68 ppm, it could be seen that Al substituted Silicon in the tetrahedral environment. 
The peak relating to Afm grew with age from 3 days to 28 days and this is indicative of 
more Aluminum passing into cement solution forming stratlingite containing Afm 
phases11. The intensity of the cement and calcined clay at 3 days which gave 114% as 
against 100% of the control, showed that the material was very reactive at early ages and 
even at the 7 day period of hydration.  
The performance of the cement blended mixture at early ages indicated that the 
calcined clay behaved as a filler material. At 28 days, the cement blended material showed 
the highest intensity of 194% as compared to 100% intensity of plain cement. This shows 
that pozzolanic reaction occurred at the late stage of 28 days forming more of the 
stratlingite phases. The figure also indicated that the presence of the Afm phases virtually 
diminished the presence of ettringite phases (Afm). This is very important because 
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expansion due to ettringite was seen to be eliminated with the case of using cement and 
calcined clay as alternative binder materials. 
 
  
Figure 3.6. 27Al SS MAS NMR spectra of hydrated cement ‘20 Clay Pozzolan’ at 3 days. 
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Figure 3.7. 27Al SS MAS NMR spectra of hydrated cement ‘20 Clay Pozzolan’ at 7 days. 
  
100 
 
 
Figure 3.8. 27Al SS MAS NMR spectra of hydrated cement ‘20 Clay Pozzolan’ at 28 days. 
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Overall in conclusion, there is a growing interest on the use of calcined clays as 
suitable supplementary cementitious materials (SCMs) for construction in recent times. 
However, the origin of clay presents some form of variations which therefore influences 
their use as supplementary cementitious material. This study seeks to analyze clay obtained 
from the Nyamebekyere area of Ghana. The Ghanaian clay was calcined at temperatures 
of 600, 700, 800, 900 and 1000˚C in a laboratory furnace. The properties of the raw and 
calcined clay were characterized using thermal gravimetric analysis (TGA) and, 27Al and 
29Si solid state magic angle spinning nuclear magnetic resonance (SS MAS NMR) and 
Fourier transformed infrared (FTIR) spectroscopic techniques. Pozzolanic strength activity 
indices (PSAI) were determined by replacing Portland cement with 20% of the calcined 
materials. The results from the 27Al SS MAS NMR showed that the clay was a 1:1 kaolinitic 
clay type.  The PSAI results were corroborated with the TGA, 27Al and 29Si SS MAS NMR 
and the FTIR spectra results to achieve the optimum calcination temperature, which 
indicated that clay calcined at 800˚C attained a more reactive pozzolanic phases which 
consequently influenced positively on the strength activity index. The study recommends 
calcination temperature of 800˚C as the most appropriate temperature for the 
Nyamebekyere clay in Ghana.   
Nyamebekyere clay used for the study could be classified as a 1:1 kaolinitic clay 
type from the 27Al SS MAS NMR studies. The optimum temperature that yielded more 
reactive pozzolanic phases was obtained at 800oC. The influence of calcined clay in the 
cement blended material showed that the calcined material behaved partly as a filler and 
partly as a pozzolanic material. The filler effect accelerates portlandite growth which 
enhances early strength whereas the pozzolanic effect enhances late strength. Calcined 
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clays at 800˚C used to replace Portland cement at 20% gave the maximum strength. This 
was attributed to the influence of the calcined clay which produced more stable aluminate 
phases including calcium aluminate hydrate (CAH), and stable form of monosulphate 
(AFm).  
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Chapter 4 
INFRARED AND RAMAN SPECTRAL STUDIES TO OBTAIN STRUCTURAL 
PARAMETERS, CONFORMATIONAL STABILITY, VIBRATIONAL 
ASSIGNMENTS AND AB INITIO CALCULATIONS OF ORGANIC 
MOLECULES CONTAINING FIVE MEMBERED RING AND PHOSPHOROUS  
Introduction 
The physiochemical properties of a molecule of interest are usually obtained from 
its molecular structure, and it involves the orientation of one part of the molecule about a 
particular bond with respect to the rest of the molecule. These properties depend mainly 
upon the three-dimensional arrangement of one part of the molecule in space with respect 
to the other and, additionally, the way the molecule will react chemically and its available 
reaction pathways are often critically dependent upon the orientation of the reactant 
molecule. The energy differences of various conformations generally strongly couple or 
interact by way of non-bonded interactions which even though are individually too weak 
to determine, any single geometric feature may nevertheless act together to uniquely 
determine the spatial structures of large and complicated molecules such as proteins and 
DNA. Therefore, conformational analysis can lead to significant improvement in the 
understanding of more complex system. 
The field of biochemistry and nano-chemistry has caused a great deal of interest in 
conformational stability due to its effects on binding sites of proteins in biochemistry and 
the use of conformer interchange to drive molecular motions and shapes in nano-chemistry. 
Examples of substituted five-membered rings are the backbone sugar groups of DNA and 
RNA. In the case of DNA and RNA the five-membered ring has an oxygen in the ring and 
  
105 
 
so it adopts a planar conformation which helped to determine the structure of both DNA 
and RNA.  
         The saturated five-membered ring molecules are structurally interesting, since 
they can be in one or more of the three stable conformers, i.e. twisted, envelope, and planar 
forms. Several monosubstituted cyclopentanes were determined to have two conformations 
at ambient temperature where the substituent occupies the axial and equatorial positions 
at the tip of the Cs symmetric envelope form of the five-membered ring 
1–5. For many of 
the molecules the vibrational spectra were used to first identify the two forms before they 
were identified by microwave spectra and electron diffraction investigations. Furthermore, 
the energy difference between these forms can be very small with the barrier for the 
molecule to go from one form to another also quite small. Thus, instead of going through 
the planar form, the molecule may go through a series of twisted forms where one atom 
moves perpendicular to a hypothetical plane of the rest of the atoms. This concept which 
was first proposed by Pitzer and he called it pseudorotation. 
Professor Pitzer’s reason for proposing the pseudo rotations for the five-membered 
rings was based on his thermodynamic information but this concept certainly was not 
accepted. Nevertheless, the five-membered saturated ring is an important unit in Organic 
Chemistry. It is also particularly interesting because the torsional forces about the single 
bonds are in opposition to the forces tending to retain tetrahedral bond angles. Thus the 
later forces tend to keep all five carbon atoms co-planar while the torsional forces tend to 
pucker the ring. To support the concept of pseudo rotations of the five-membered ring, 
Pitzer measured the heat capacity of gaseous cyclopentane in 19476. The experimental 
results were analyzed by the vibrational spectra of cyclopentane and the fundamental 
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vibrational assignments were provided form which the enthalpy was then evaluated. In the 
similar paper7 the pseudo rotations of ring puckering were investigated by utilizing the 
potential energy. It was shown that the potential energy curve is the function of deviation 
from planarity and it was proved to be the same for molecules with C2 or Cs symmetry. 
From this information it was concluded that the puckering suggested very probable 
intermediate types of motion which also shows the same potential curves. 
This paper7 was then followed by an additional study8 of the conformational strain 
energy of cyclopentane and its derivatives. Since there were considerable questions 
concerning the idea of pseudo rotation there was little research that followed. However, the 
experimental determination of pseudo rotation was eventually proved by a vibrational 
study published in 19689 i.e. more than 30 years after the motion was proposed. However, 
even at this time there is still a large amount of questions concerning why some molecules 
prefer the twisted form, over axial or equatorial forms, and additionally what affects the 
substitution of different elements in the ring or on the ring have on pseudo rotational motion 
of the substituted cyclopentane molecules. Therefore, I decided to undertake the research 
that involves investigations of various substitutions on the ring or in the ring to determine 
what factors most strongly affect pseudo rotations on the five-membered ring molecules. 
Currently, the factors that are the major contributors to the interchange and/or the 
structural stabilities of substituted five-membered rings are not understood. The molecule 
pyrrolidine is an interesting example, which received significant scientific attention due to 
its presence in biologically important molecules such as peptides, proteins and amino acids. 
It has been the subject of several experimental and theoretical conformational studies. From 
the first microwave study10 it was reported that there was only one form present and it was 
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the axial conformer. In the following electron diffraction11 study it was reported that a 
second conformer was observed and it was the equatorial conformer which was less stable 
than the axial form. Eventually, the equatorial form was reported in a later microwave 
study to be the more stable conformer than the axial form12. However, this conclusion was 
shown to be incorrect13 and the second conformer was experimentally determined to be the 
twist form and not axial form from the vibrational spectra. This result has led interest to 
determine the stable conformations of other five-membered rings. Therefore, my studies 
of five-membered rings began with one of the carbon atoms replaced with a silicon atom 
with a halogen (Br) atom attached, i.e. 1-bromo-1-silacyclopentane. The second five-
membered ring investigated was substituted cyclopentane, i.e. ethynylcyclopentane, c-
C5H9CCH. 
The conformational stability determination of 1,2-disubstituted ethane molecules 
have provided some interesting challenges for the structural scientists over the years. The 
1,2-disubstituted ethane molecules of YCH2CH2X type are of main interest since most of 
them have two conformers trans (anti) and gauche, present in the fluid states and their 
relative stabilities are believed to depend on the electronegativity and size of the 
substituents. Also, it is frequently difficult to determine the conformer with the lowest 
energy (with possible solvent interference) spectroscopically because of the low symmetry 
of these molecules. 
As a continuation of the studies of 1,2-substituted ethanes, we have investigated the 
conformational stability of 1,2-diaminoethane (ethylenediamine)14 and 1,2-
diphosphinoethane (ethylenediphosphine) to determine whether there is a significant 
difference in the conformer stabilities of these two molecules since both ethylamine15 and 
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ethylphosphine16 have the trans conformer as the lower energy form. I was particularly 
interested in the phosphine molecule since some of the phosphines have 
anticancer/antitumor properties17,18 and, therefore, their conformational stabilities could be 
important in the selection of the compounds which could have the most potential as 
biochemical materials. Hence, 1,2-diphosphinoethane (XCH2CH2X type) and 2-
cyanoethylphosphine (YCH2CH2X type) have received significant attention in my studies. 
General Methodology 
The findings of my spectroscopic, structural, and theoretical studies are based on 
infrared and/or Raman spectra of gas, liquid, solid as well as variable temperature xenon 
solutions, and microwave spectrum which are supported by ab initio and DFT calculations. 
The ab initio calculations are performed with the Gaussian 03 program19 with Gaussian-
type basis functions. The energy minima with respect to nuclear coordinates are obtained 
by the simultaneous relaxation of all geometric parameters by the gradient method of 
Pulay20. Several basis sets as well as the corresponding ones with diffuse functions are 
employed with the Møller-Plesset perturbation method21 to the second order with full 
electron correlation (MP2(full)) along with the density functional theory by the B3LYP 
method.  
By utilizing the information, acquired through the experimental and theoretical 
studies carried out in the research laboratory, I have accomplished the following results for 
the molecules under study. Spectra obtained from infrared and Raman experiments are 
used in the vibrational studies to assign fundamental frequencies for all possible 
conformers as well as for the identification of the conformers. The MP2(full)/6-31G(d) 
calculations are used to predict the force constants, frequencies, infrared intensities, Raman 
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activities, band contours, potential energy distributions and depolarization values to 
support the vibrational assignment. Raman spectrum of liquid is used to obtain the 
experimental depolarization values. Determination of enthalpy difference values is carried 
out by using variable temperature, infrared or Raman spectra of xenon solutions or the 
liquid. From these experimentally obtained H values, the order of the stability of the 
conformers are determined. The experimentally determined enthalpy values are used to 
evaluate the quality of the predicted values of energies by ab initio and density functional 
theory calculations obtained from various basis sets up to aug-cc-pVTZ. Also % abundance 
of each conformer are determined by experimentally obtained H values. The r0 structural 
parameters can be obtained from utilizing the experimentally determined rotational 
constants from previously published microwave data or data obtained from my research. 
The experimentally determined values are then compared with the estimated values 
obtained from adjusted MP2(full)/6-311+G(d,p) calculations for the respective 
conformers. These physiochemical data should provide significant trends and affects to 
better understand the major factors controlling the relative stabilities of the conformers as 
well as the relative values of the structural parameters. 
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PROJECT-1 
Infrared and Raman Spectra, ab initio Calculations, Conformational Stability and 
Vibrational Assignment of 1-bromo-1-silacyclopentane 
Introduction 
Several monosubstituted cyclopentanes were determined to have two 
conformations at ambient temperature where the substituent occupies the axial and 
equatorial positions at the tip of the Cs-symmetric envelope form of the five-membered 
ring1–5. For many of the molecules the vibrational spectra were used to first identify the 
two forms before they were identified by microwave spectra and/or electron diffraction 
investigations. The monohalocyclopentanes are interesting examples where initially the 
fluoride, chloride, and bromide1 were all reported to have these forms from analyses of 
their infrared spectra. Later, from an investigation of the Raman spectrum22 of the liquid, 
it was concluded that there was only one conformer present in the fluid states and it was 
the envelope-equatorial conformer which was supported from the theoretical predictions23 
from CNDO predictions. More recently, we24 have shown from the infrared spectra of the 
gas and variable temperature xenon solutions that there is, indeed, only one conformer in 
the fluid phases but it is the twisted (C1 symmetry) form which was supported by structural 
parameters obtained from the rotational constants obtained from the microwave spectrum. 
For chlorocyclopentane there was only the envelope-axial conformer initially found from 
the microwave spectrum25 and from a subsequent electron diffraction investigation26 of it, 
the authors indicated that the data could be explained equally well by either a mixture of 
axial and equatorial conformers or a dynamic model involving nearly free pseudorotation 
which lead to doubts about a second conformer. However, from a later re-investigation of 
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the microwave spectrum of chlorocyclopentane27, transitions for the equatorial conformer 
were observed and assigned. 
 There were no problems for bromocyclopentane concerning the early report28 of 
the two forms since the observed microwave spectrum was assigned for the two conformers 
with estimated structural parameters consistent with the axial and equatorial forms. 
Therefore, we began our vibrational and conformational study of the corresponding five-
membered rings with one of the carbon atoms replaced with a silicon atom which has a 
halogen atom attached, and for this study, the bromine atom, i.e. 1-bromo-1-
silacyclopentane. 
 The infrared spectra (3500-300 cm-1) of the gas and solid and the Raman spectrum 
(3500-60 cm-1) of the liquid have been recorded of 1-bromo-1-silacyclopentane from which 
the conformational stability has been determined and a vibrational assignment of the 
fundamentals is reported. To support the conformational stability determination and aid in 
the vibrational assignment, ab initio MP2 with full electron correlation and density 
functional theory by the B3LYP method calculations have been carried out by using a 
variety of basis sets. The results of these spectroscopic and theoretical studies are reported 
herein. 
Experimental and Theoretical Methods 
The sample of 1-bromo-1-silacyclopentane was prepared in two steps. First, 1,1-
dichloro-1-silacyclopentane was prepared by double Grignard of 1,4-dibromobutane and 
coupled with tetrachlorosilane. The product 1,1-dichlro-1-silacyclopentane was reduced 
with lithium aluminum hydride in dry dibutyl ether. The product 1-silacyclopentane was 
brominated with boron tribromide at 0°C for 18 hr. to produce 1-bromo-1-
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silacyclopentane, which, was first purified using trap to trap distillation and finally by a 
low pressure, low temperature sublimation column. The sample was identified by IR and 
NMR spectroscopy.   
The mid-infrared spectrum of the gas was obtained from 3500 to 300 cm-1 on a 
Perkin-Elmer model 2000 Fourier transform spectrometer equipped with a Ge/CsI 
beamsplitter and a DTGS detector.  Atmospheric water vapor was removed from the 
spectrometer housing by purging with dry nitrogen.  The theoretical resolution used to 
obtain the spectrum of the gas was 0.5 cm-1 and 128 interferograms were added and 
truncated with a boxcar function. For the spectrum of the solid the vapor was deposited on 
a CsI window cooled with boiling liquid nitrogen in a low temperature infrared cell. 
Typical spectra of the gas and solid are shown in Fig. 1.  
The Raman spectra (Fig. 2) were recorded on a Spex model 1403 
spectrophotometer equipped with a Spectra-Physics model 2017 argon ion laser operating 
on the 514.5 nm line. The laser power used was 1.5 W with a spectral bandpass of 3 cm-1. 
The spectrum of the liquid was recorded with the sample sealed in a Pyrex glass capillary. 
Depolarization measurements were obtained for the liquid sample using a standard Ednalite 
35 mm camera polarizer with 38 mm of free aperture affixed to the Spex instrument. 
Depolarization ratio measurements were checked by measuring the state of polarization of 
the Raman bands of CCl4 immediately before depolarization measurements were made on 
the liquid sample. The measurements of the Raman frequencies are expected to be accurate 
to  2 cm-1. All of the observed fundamental bands in the Raman spectrum of the liquid 
along with their proposed assignments and depolarization values are listed in Table 1. 
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 The LCAO-MO-SCF restricted Hartree-Fock calculations were performed with the 
Gaussian-03 program19 by using Gaussian-type basis functions.  The energy minima with 
respect to nuclear coordinates were obtained with the simultaneous relaxation of all 
geometric parameters by using the gradient method of Pulay20. Several basis sets as well 
as the corresponding ones with diffuse functions  up to the 6-311+G(2df,2pd) basis set 
were employed with the Møller-Plesset perturbation method21 to the second order 
(MP2(full)) as well as with the density functional theory by the B3LYP method.  The 
predicted conformational energy differences are listed in Table 6.  
In order to obtain a complete description of the molecular motions involved in the 
fundamental modes of c-C4H8SiBrH, a normal coordinate analysis has been carried out.  
The force field in Cartesian coordinates was obtained with the Gaussian 03 program19 at 
the MP2(full) level with the 6-31G(d) basis set.  The internal coordinates used to calculate 
the G and B matrices are listed in Table 5 with the atomic numbering shown in Fig. 3.  By 
using the B matrix29, the force field in Cartesian coordinates was converted to a force field 
in internal coordinates.  Subsequently, scaling factors of 0.88 for CH2 stretches and 
deformations, and 0.90 for other coordinates except for the heavy atom bends were applied, 
along with the geometric average of the scaling factors for the interaction force constants, 
to obtain the fixed scaled force field and resultant wavenumbers. A set of symmetry 
coordinates was used (Table 6) to determine the corresponding potential energy 
distributions (P.E.D.s). A comparison between the observed and calculated wavenumbers, 
along with the calculated infrared intensities, Raman activities, depolarization ratios and 
potential energy distributions for the twisted conformer are listed in Table 1. 
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The vibrational spectra were predicted from the MP2(full)/6-31G(d) calculations.  
The predicted scaled frequencies were used together with a Lorentzian function to obtain 
the simulated spectra.  Infrared intensities were obtained based on the dipole moment 
derivatives with respect to Cartesian coordinates.  The derivatives were transformed with 
respect to normal coordinates by (u/Qi) =
j
(u/Xj)Lij, where Qi is the ith normal 
coordinate, Xj is the j
th Cartesian displacement coordinate, and Lij is the transformation 
matrix between the Cartesian displacement coordinates and the normal coordinates.  The 
infrared intensities were then calculated by (N)/(3c2) [(x/Qi)2 + (y/Qi)2 + 
(z/Qi)2].  A comparison of experimental and simulated infrared spectra of c-C4H8SiBrH 
is shown in Fig. 1. The predicted spectrum is in good agreement with the experimental 
spectrum which shows the utility of the scaled predicted frequencies and predicted 
intensities for supporting the vibrational assignment.  
Additional support for the vibrational assignments was obtained from the simulated 
Raman spectrum. The evaluation of Raman activity by using the analytical gradient 
methods has been developed30–32 and the activity Sj can be expressed as: Sj = gj(45αj2 + 
7βj2), where gj is the degeneracy of the vibrational mode j, αj is the derivative of the 
isotropic polarizability, and βj is the anisotropic polarizability. To obtain the Raman 
scattering cross sections, the polarizabilities are incorporated into Sj by multiplying Sj with 
(1-ρj)/ (1+ρj) where ρj is the depolarization ratio of the jth normal mode. The Raman 
scattering cross sections and calculated wavenumbers obtained from the Gaussian 03 
program were used together with a Lorentzian function to obtain the simulated Raman 
spectra. Comparison of experimental Raman spectrum of the liquid and the predicted 
Raman spectrum are shown in Fig. 2.  
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Figure 4.1. Comparison of experimental and calculated infrared spectra of 1-bromo-1-
silacyclopentane: (A) observed IR spectrum of gas; (B) observed IR spectrum of solid; 
(C) simulated IR spectrum of twist (C1) conformer. 
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Figure 4.2. Comparison of experimental and calculated Raman spectra of 1-bromo-1-
silacyclopentane: (A) observed Raman spectrum of liquid; (B) simulated Raman 
spectrum of twist (C1) conformer.
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Table 4.1.  Calculateda and observed frequencies (cm-1) for 1-bromo-1-silacyclopentane twist (C1) form. 
Vib. 
No. 
Approx. description 
ab 
initio 
fixed 
scaledb 
B3LYP c 
IR 
gas 
Raman 
liquid 
IR 
solid 
P.E.D.d 
 
Band 
Contour 
A B C 
1 α-CH2 antisymmetric 
stretch 
   3186 2988  3101 2
9
8
9 
2981 - 47S1,39S2 5
5 
15 30 
2 α-CH2 antisymmetric 
stretch 
318
2 
2985  3095 2
9
8
0 
2972 - 52S2,42S1 1
3 
16 71 
3 β-CH2 antisymmetric 
stretch 
315
9 
2963  3067 2
6
8 
2960 2957 92S3 2
4 
39 37 
4 β-CH2 antisymmetric 
stretch 
315
3 
2957  3062 2
9
5
3 
2944 2949 85S4,11S8 6
9 
- 31 
5 α-CH2 symmetric 
stretch 
311
9 
2926  3045 2
9
1
8 
2915 - 50S5,46S6 3
5 
62 3 
6 α-CH2 symmetric 
stretch 
310
3 
2911  3024 2
9
0
6 
2902 2911 42S6,39S5 - 2 98 
7 β-CH2 symmetric 
stretch 
309
8 
2906  3020 2
8
2 
2869 2900/
2897 
88S7 1
2 
36 52 
8 β-CH2 symmetric 
stretch 
309
5 
2903  3014 2
7
5 
2862 64/
2856 
82S8,11S4 9
7 
- 3 
9 Si-H stretch 231
1 
2193  2231 2
1
7
6 
2173 197/
2179 
100S9 2 3 95 
10 β-CH2 deformation 156
4 
1470  1505 
4
7
0 
1463 1456 94S10 5
4 
3 43 
11 β-CH2 deformation 155
6 
1463  1496 1
4
5
9 
1452 1448/
1446 
99S11 2
3 
14 63 
12 α-CH2 deformation 151
3 
1423  1456 1
4
0
8 
1407 02 78S12,19S13 1 74 25 
13 α-CH2 deformation 150
8 
1418  1452 1
4
0
3 
1402 1395 74S13,21S12 1
8 
67 15 
14 β-CH2 wag
 140
0 
1329  1351 1
3
2
7 
1325 1353 62S14,23S16 
1 
- 19 
15 β-CH2 wag 138
2 
1312  1340 1
1
6 
1318 1316 88S15 5
7 
9 34 
16 β-CH2 twist 13
5 
1259 (1284) 1
2
6 
1262 1250 47S16,33S20 6
4 
1 35 
17 β-CH2 twist 132
3 
1255 (1280) 
2
5
3 
1250 1244 51S17,19S21,18S19 9
4 
6 - 
18 α-CH2 twist 126
6 
1202  1224 - 1195 1192 36S18,32S24,12S20 2 82 16 
19 α-CH2 wag
 123
0 
1172  1184 1
1
5
7 
1153 1151/
1144 
54S19,17S33,10S23,10S21 1
6 
73 11 
20 α-CH2 wag 114
7 
1089  1108 
0
8
0 
1079 078/
1071 
39S20,21S16,10S31,10S14 8
2 
- 18 
21 α-CH2 twist 108
4 
1029  1056 1
0
3
3 
1033 35/
1026 
50S21,26S17 6
1 
1 38 
22 ring deformation 108
1 
1026  1028 1
1
9 
1019 18 41S22,20S31,16S14 9
9 
- 1 
23 ring deformation 996 950    957 - 945 941 32S23,20S19,13S33,10S25 2 98 - 
24 β-CH2 rock 985 935    949 9
3
2 
930 927/9
21 
39S24,39S18 1 90 9 
25 ring deformation 923 885    882 8
7
1 
870 873/8
70 
53S25,29S28 1
3 
84 3 
26 ring breathing 898 857   (858) 8
5
1 
851 849 41S26,20S31,14S22 7
7 
17 6 
27 α-CH2 rock 891 849   (853) 8
4
3 
840 840/8
32 
36S27,16S30,13S37 
0 
17 13 
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28 β-CH2 rock 805 764    776 7
6
7 
765 761/7
54 
13S28,33S32,19S30,14S29 5
2 
45 3 
29 α-CH2 rock 780 743    744 7
3
7 
738 736 21S29,23S30,12S26,11S31 9
3 
5 2 
30 Si-H parallel bend
* 729 694    699 6
9
4 
693 695/6
88 
19S30,22S27,14S23,10S32,10S
33 
1
1 
70 19 
31 ring deformation 704 672    673 6
8
5 
682 6 0/6
78 
21S31,22S26,17S25,10S23 6
8 
13 19 
32 Si-H perpendicular 
bend* 
649 618    619 6
2
0 
621 620/6
17 
26S32,25S29,17S25,10S26 
4 
12 4 
33 ring deformation 512 498    499 4
9
3 
496 495/4
93 
53S33,18S28,15S39,10S23 6
2 
15 23 
34 ring deformation 471 459    453 4
5
2 
449 4 9 58S34,26S35 9
8 
2 - 
35 Si-Br stretch 389 373    356 
6
7 
364 370 51S35,20S34,12S37 5
2 
1 47 
36 ring twist
 298 285    269 - 268 - 80S36 73 25 
37 Si-Br parallel bend
* 215 208    205 - 210 - 36S37,19S39,13S35,12S30 6
0 
6 34 
38 Si-Br perpendicular 
bend* 
159 158    150 - 160 - 87S38 1 91 8 
39 ring puckering 63 60      61 - - - 59S39,27S37 2 9 89 
aMP2(full)/6-31G(d) ab initio calculations, B3LYP/6-311+G(d,p) density functional theory calculations, scaled 
frequencies, potential energy distributions (P.E.D.s). 
b Scaled frequencies with scaling factors of 0.88 for CH2 stretches and deformations and 0.90 for all other modes 
except heavy atom bends. 
c Values in parenthesis are reordered to match the MP2(full)/6-31G(d) ab initio values. 
d Symmetry coordinates with P.E.D. contribution less than 10% are omitted. 
*Bend parallel and perpendicular to the ring, respectively. 
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Table 4.2.  Calculateda frequencies (cm-1) for 1-bromo-1-silacyclopentane twisted (C1) form. 
Vib. 
No. 
Approx. description 
ab 
initio 
fixed 
scaledb 
IR 
int. 
Raman 
act. 
B3LYP 
6-31G(d)c 
IR 
int. 
Raman 
act. 
B3LYP 
6-311+G(d,p)c 
IR 
int. 
Raman 
act. 
1 α-CH2 antisymmetric 
stretch 
   3186 2988 6.8 60.0  3124 10.7 72.4  3101 9.9 77.7 
2 α-CH2 antisymmetric 
stretch 
3182 2985 9.0 73.7  3117 16.2 83.8  3095 15.2 88.3 
3 β-CH2 antisymmetric 
stretch 
3159 2963 27.0 57.8  3088 45.5 71.1  3067 42.7 73.1 
4 β-CH2 antisymmetric 
stretch 
3153 2957 25.6 148.0  3082 38.5 198.7  3062 38.3 259.5 
5 α-CH2 symmetric stretch 3119 2926 5.1 69.2  3065 10.2 67.1  3045 11.1 75.6 
6 α-CH2 symmetric stretch 3103 2911 10.6 68.7  3044 21.8 56.5  3024 23.1 60.2 
7 β-CH2 symmetric stretch 3098 2906 20.4 47.7  3039 19.7 81.8  3020 19.1 90.8 
8 β-CH2 symmetric stretch 3095 2903 22.9 146.4  3034 27.0 131.0  3014 24.4 185.6 
9 Si-H stretch 2311 2193 153.
7 
125.1  2244 155.
1 
126.5  2231 123.
0 
178.7 
10 β-CH2 deformation 1564 1470 0.5 3.3  1534 0.2 4.4  1505 1.3 1.1 
11 β-CH2 deformation 1556 1463 7.4 18.6  1524 4.8 20.1  1496 6.8 11.1 
12 α-CH2 deformation 1513 1423 14.7 5.7  1484 9.1 8.2  1456 10.4 4.6 
13 α-CH2 deformation 1508 1418 4.9 19.8  1480 4.8 19.4  1452 6.6 8.7 
14 β-CH2 wag
 1400 1329 2.1 3.5  1372 3.2 4.3  1351 1.4 1.7 
15 β-CH2 wag 1382 1312 1.0 1.2  1358 1.7 1.5  1340 0.8 0.7 
16 β-CH2 twist 1325 1259 3.6 6.1 (1295) 1.2 6.2 (1284) 2.4 3.7 
17 β-CH2 twist 1323 1255 1.1 9.3 (1297) 0.4 9.7 (1280) 0.6 5.1 
18 α-CH2 twist 1266 1202 0.3 1.4  1238 0.7 1.5  1224 0.6 1.8 
19 α-CH2 wag
 1230 1172 2.2 2.7  1197 1.5 2.4  1184 1.9 2.0 
20 α-CH2 wag 1147 1089 41.5 6.4  1118 32.9 8.6  1108 30.4 4.3 
21 α-CH2 twist 1084 1029 24.9 1.5  1063 27.9 1.6  1056 25.9 0.8 
22 ring deformation 1081 1026 11.4 6.2  1038 8.8 4.8  1028 10.7 4.2 
23 ring deformation 996 950 0.8 5.4    964 0.4 5.1    957 0.4 4.5 
24 β-CH2 rock 985 935 9.4 2.2    958 8.2 1.9    949 8.2 1.9 
25 ring deformation 923 885 21.1 1.3    891 27.8 2.5    882 26.8 1.6 
26 ring breathing 898 857 17.8 5.9   (861) 2.6 6.7   (858) 1.5 9.2 
27 α-CH2 rock 891 849 120.
3 
2.8   (870) 124.
2 
2.1   (853) 126.
5 
1.6 
28 β-CH2 rock 805 764 87.2 4.3    783 76.9 4.2    776 74.2 4.4 
  
 
 
1
2
0
 
29 α-CH2 rock 780 743 23.5 7.5    754 20.8 6.8    744 25.3 8.1 
30 Si-H parallel bend
* 729 694 28.3 4.2    703 26.3 4.7    699 24.2 4.6 
31 ring deformation 704 672 10.6 11.0    674 13.0 11.5    673 13.9 11.8 
32 Si-H perpendicular bend
* 649 618 14.7 6.3    621 14.3 6.2    619 14.8 7.4 
33 ring deformation 512 498 12.3 1.1    502 10.9 1.2    499 8.8 1.1 
34 ring deformation 471 459 32.6 2.2    461 35.9 2.6    453 38.3 2.3 
35 Si-Br stretch 389 373 19.7 5.8    368 15.5 6.2    356 23.8 7.7 
36 ring twist
 298 285 0.3 0.4    277 0.2 0.4    269 0.2 0.4 
37 Si-Br parallel bend
* 215 208 0.7 2.2    207 0.7 2.6    205 0.8 3.1 
38 Si-Br perpendicular bend
* 159 158 1.1 1.6    153 0.9 1.8    150 1.0 2.1 
39 ring puckering 63 60 0.5 0.8      63 0.5 1.0      61 0.5 1.0 
a MP2(full)/6-31G(d) ab initio calculations, B3LYP/6-31G(d) and B3LYP/6-311+G(d,p) density functional theory 
calculations, scaled frequencies, infrared intensities (km/mol), Raman activities (Å4/u). 
b Scaled frequencies with scaling factors of 0.88 for CH2 stretches and deformations and 0.90 for all other modes except 
heavy atom bends. 
c Values in parenthesis are reordered to match the MP2(full)/6-31G(d) ab initio values. 
*Bend parallel and perpendicular to the ring, respectively. 
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Table 4.3.  Calculateda frequencies (cm-1) for 1-bromo-1-silacyclopentane twisted (C1) form. 
Vib. 
No. 
Approx. description 
ab 
initio 
fixed 
scaledb 
P.E.D.c 
B3LYP 
6-31G(d)d 
P.E.D.c 
B3LYP 
6-311+G(d,p)d 
P.E.D.c 
1 α-CH2 antisymmetric 
stretch 
   3186 2988 47S1,39S2  3124 41S1,37S2,11S6,10S5  3101 41S1,36S2,11S6,10S5 
2 α-CH2 antisymmetric 
stretch 
3182 2985 52S2,42S1  3117 49S2,44S1  3095 49S2,44S1 
3 β-CH2 antisymmetric 
stretch 
3159 2963 92S3  3088 89S3  3067 88S3 
4 β-CH2 antisymmetric 
stretch 
3153 2957 85S4,11S8  3082 71S4,19S8  3062 68S4,21S8 
5 α-CH2 symmetric 
stretch 
3119 2926 50S5,46S6  3065 43S5,41S6  3045 42S5,40S6 
6 α-CH2 symmetric 
stretch 
3103 2911 42S6,39S5  3044 32S6,31S5,16S7  3024 29S6,29S5,20S7 
7 β-CH2 symmetric 
stretch 
3098 2906 88S7  3039 65S7,10S8  3020 66S7,10S8 
8 β-CH2 symmetric 
stretch 
3095 2903 82S8,11S4  3034 64S8,18S4,17S7  3014 63S8,22S4,12S7 
9 Si-H stretch 2311 2193 100S9  2244 100S9  2231 100S9 
10 β-CH2 deformation 1564 1470 94S10  1534 91S10  1505 92S10 
11 β-CH2 deformation 1556 1463 99S11  1524 97S11  1496 98S11 
12 α-CH2 deformation 1513 1423 78S12,19S13  1484 70S12,27S13  1456 64S12,32S13 
13 α-CH2 deformation 1508 1418 74S13,21S12  1480 66S13,29S12  1452 60S13,35S12 
14 β-CH2 wag
 1400 1329 62S14,23S16  1372 62S14,26S16  1351 61S14,28S16 
15 β-CH2 wag 1382 1312 88S15  1358 90S15  1340 90S15 
16 β-CH2 twist 1325 1259 47S16,33S20 1295 40S16,29S20 (1284) 44S16,32S20 
17 β-CH2 twist 1323 1255 51S17,19S21,18S19 1297 46S17,18S21,14S19 (1280) 52S17,21S21,15S19 
18 α-CH2 twist 1266 1202 36S18,32S24,12S20  1238 39S18,32S24,10S20,10S2
9 
 1224 40S18,31S24,10S20,10S29 
19 α-CH2 wag
 1230 1172 54S19,17S33,10S23,10S21  1197 61S19,15S33  1184 62S19,15S33 
20 α-CH2 wag 1147 1089 39S20,21S16,10S31,10S14  1118 46S20,20S16,15S14  1108 48S20,20S16,17S14 
21 α-CH2 twist 1084 1029 50S21,26S17  1063 59S21,31S17  1056 59S21,32S17 
22 ring deformation 1081 1026 41S22,20S31,16S14  1038 54S22,28S31,11S14  1028 55S22,29S31 
23 ring deformation 996 950 32S23,20S19,13S33,10S25    964 31S23,19S28,18S19,17S3
3 
   957 31S23,20S28,19S33,17S19 
24 β-CH2 rock 985 935 39S24,39S18    958 43S24,38S18    949 43S24,37S18 
25 ring deformation 923 885 53S25,29S28    891 46S25,30S28,10S23    882 50S25,29S28,10S23 
26 ring breathing 898 857 41S26,20S31,14S22   (861) 46S26,22S31,15S22   (858) 46S26,23S31,16S22 
27 α-CH2 rock 891 849 36S27,16S30,13S37   (870) 37S27,19S30,14S37,11S2
5 
  (853) 39S27,19S30,14S37 
28 β-CH2 rock 805 764 13S28,33S32,19S30,14S29    783 13S28,33S32,18S30,15S2
9 
   776 13S28,33S32,18S30,15S29 
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29 α-CH2 rock 780 743 21S29,23S30,12S26,11S31    754 20S29,26S30,13S27    744 18S29,28S30,12S27 
30 Si-H parallel bend
* 729 694 19S30,22S27,14S23,10S32    703 13S30,19S27,12S23,12S32    699 14S30,20S27,13S32,11S23 
31 ring deformation 704 672 21S31,22S26,17S25,10S23    674 23S31,21S26,19S25,11S2
3 
   673 20S31,22S25,18S26,14S23 
32 Si-H perpendicular 
bend* 
649 618 26S32,25S29,17S25,10S26    621 24S32,25S29,20S25    619 22S32,28S29,18S25 
33 ring deformation 512 498 53S33,18S28,15S39,10S23    502 57S33,16S28,15S39,11S2
3 
   499 58S33,17S28,14S39,11S23 
34 ring deformation 471 459 58S34,26S35    461 56S34,30S35    453 66S34,23S35 
35 Si-Br stretch 389 373 51S35,20S34,12S37    368 48S35,23S34,12S37    356 56S35,14S34,13S37 
36 ring twist
 298 285 80S36    277 83S36    269 83S36 
37 Si-Br parallel bend
* 215 208 36S37,19S39,13S35,12S30    207 36S37,20S39,14S35,12S3
0 
   205 36S37,19S39,16S35,12S30 
38 Si-Br perpendicular 
bend* 
159 158 87S38    153 89S38    150 89S38 
39 ring puckering 63 60 59S39,27S37      63 59S39,28S37      61 60S39,27S37 
a MP2(full)/6-31G(d) ab initio calculations, B3LYP/6-31G(d) and B3LYP/6-311+G(d,p) density functional theory calculations, scaled 
frequencies, and potential energy distributions (P.E.D.s). 
b Scaled frequencies with scaling factors of 0.88 for CH2 stretches and deformations and 0.90 for all other modes except heavy atom 
bends. 
c Symmetry coordinates with P.E.D. contribution less than 10% are omitted. 
d Values in parenthesis are reordered to match the MP2(full)/6-31G(d) ab initio values. 
*Bend parallel and perpendicular to the ring, respectively. 
 
 
 
 
 
  
123 
 
Conformational Stability and Vibrational Assignment 
 To determine the conformational stabilities, we first determined whether there was 
more than one conformer present in the fluid states. A comparison of the infrared spectrum 
of the gas and solid indicated that there was only one conformer present in the gas since all 
of the bands observed in the spectrum of the gas were also present in the spectrum of the 
polycrystalline solid (Fig. 1) which was obtained by repeated annealing of the sample until 
no changes were observed in the spectrum. Also, a comparison of the Raman spectrum of 
the liquid with that of the infrared spectra indicated that there were no Raman lines present 
which were not observed in the infrared spectrum. Once it was ascertained that there was 
only one conformer present in all of the physical states, the structure of this conformer was 
determined.  
 The predicted spectra were plotted for each of the three most likely conformers, i.e. 
envelope-axial (Cs), envelope-equatorial (Cs) and twisted form (C1) with the assumption 
that the planar conformer would be a high energy form. The simulated spectra from ab 
initio MP2(full)/6-31G(d) calculations with two scaling factors were compared with the 
spectrum of the solid and are shown in Fig. 4. The most definitive spectral region for 
determining the conformer(s) present is the region from 400 to 1000 cm-1, where five or 
six of the ring vibrations are expected. It is clear from these data that the predicted spectrum 
of the twisted (C1) conformer is the best fit to the observed spectrum of the solid as well as 
that for the gas (Fig. 1). This conclusion is also supported by the ab initio calculations 
where both of the envelope forms are predicted to be saddle points by a negative frequency. 
Therefore, it is concluded that the conformer present in all of the physical states is the 
twisted form. Since both envelope-axial and -equatorial forms have predicted lower 
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energies of ~1400 and ~900 cm-1, respectively, than the planar form which shows that 
transitions from one twisted form to another will not be through the planar form.  
Once the form of the stable conformer has been identified the vibrational 
assignment could be made which was aided significantly by the predicted information from 
the ab initio MP2(full)/6-31G(d) calculations. Of particular importance were the infrared 
band contours and intensities, the Raman activities and depolarization values, and of course 
the fundamental frequencies which were obtained with only two scaling factors of 0.88 for 
the CH2 stretches and deformations and 0.90 for the remaining vibrations except for the 
heavy atom bends. A significant number of the fundamental vibrations could be initially 
assigned from well known “group frequencies” particularly in the fingerprint region. The 
most uncertain assignments are for the CH2 stretches where eight normal modes are 
“bunched” together with significant Fermi resonance expected. More confident 
assignments could be made in this spectral region by utilizing deuterium substitution for 
the -CH2 groups and then the β-CH2 groups. 
 Most of the CH2 bending modes could be readily assigned with the predicted 
frequencies, band contours and intensities from the infrared spectra. The A-, C- or A/C- 
and B-type bands could be observed in the spectrum (Fig. 5). For example, the band at 
1157 cm-1 is obviously a B-type band and a fundamental is predicted at 1172 cm-1 with 
73% B-type contour which is due to a relatively weak -CH2 wag. The band at 1080 cm
-1 
is clearly an A-type band (predicted 82% A and 18% C), where, the 20 ( -CH2 wag) 
fundamental is predicted to be at 1089 cm-1 with an intensity of 41.5 km/mol. The band at 
1033 cm-1 has a pronounced shoulder at 1019 cm-1 with the latter one nearly a pure A-type 
band (99%) and the former one nearly an equal A/C type band (61% A and 38% C); these 
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bands are due to 21 ( -CH2 twist, 50% S21) and 22 (ring deformation, 41% S22, 20% 
S31), respectively. These assignments illustrate how most of the CH2 bends could be 
assigned but beginning at 1019 cm-1 and lower frequencies to 400 cm-1 the vibrations are 
due to heavy atom motions, the four CH2 rocks, and two SiH bends. It is fairly easy to 
identify the fundamental frequencies but a significant number of them are extensively 
mixed with the CH2 bends and heavy atom modes. Thus, the approximate descriptions are 
more for “bookkeeping” rather than the major molecular motion giving rise to the 
vibration.  
The most interesting vibrations are the heavy atom modes particularly the ring 
vibrations. Four of these modes are expected to be between 850 and 1030 cm-1 and the 
other modes in this spectral range are CH2 rocking modes. The ring deformation ( 25) is 
predicted to have the largest infrared intensity of these modes and is assigned at 871 cm-1 
with a weaker band (17.8 km/mol) at 851 cm-1 which is the ring breathing mode (41% S26). 
In addition to the first ring mode assigned earlier there is another very weak one at 941 cm-
1 (solid; 32% S23, 13% S33, 10% S25, all ring modes). Three other ring deformations are 
expected in the region from 700 to 400 cm-1 and two of them could readily be assigned at 
493 (53% S33) and 452 (58% S34) cm
-1 but the other one is difficult to assign although the 
band at 685 cm-1 (21% S31) seems to be the best choice. The two SiH bends can be assigned 
at 620 and 694 cm-1 with the latter one having contributions from five symmetry 
coordinates with only 19% S30 and the former one with contributions from four symmetry 
coordinates with only 26% of S32. Even though both of these modes are extensively mixed 
they are reasonable “group frequencies”.  
  
126 
 
Three of the five fundamentals predicted below 400 cm-1 were observed in the 
Raman spectrum (Fig. 2) of the liquid with the ring twisting mode at 268 cm-1 (80% S36) 
and the two SiBr bends are observed as distinct Raman lines at 210 and 160 cm-1 with 
predicted frequencies of 208 and 158 cm-1, respectively. The 37 mode is extensively 
mixed with contributions of greater than 10% from four symmetry coordinates.  
 
 
 
 
 
 
Table 4.4. Calculated electronic energies (hartree) and energy differences (cm-1) for the twisted 
(C1), envelope-axial (Cs), envelope-equatorial (Cs), and planar (Cs) forms of 1-bromo-
1-silacyclopentane. 
Method/Basis Set 
# of 
Basis 
Functi
ons 
Twist 
(C1) 
Axial 
(Cs)
a 
Equatorial 
(Cs)
 a 
Planar 
(Cs)
 a 
RHF/6-31G(d) 127 -3015.591261 1364 1630 2319 
RHF/6-31+G(d) 151 -3015.605360 1448 1569 2284 
MP2(full)/6-31G(d) 127 -3016.363603 1364 1722 2778 
MP2(full)/6-31+G(d) 151 -3016.386375 1351 1631 2606 
MP2(full)/6-311G(d,p) 196 -3019.536273 1363 1694 2494 
MP2(full)/6-311+G(d,p) 220 -3019.541142 1258 1667 2479 
MP2(full)/6-311G(2d,2p) 253 -3019.619863 1233 1678 2659 
MP2(full)/6-311+G(2d,2p) 277 -3019.622927 1187 1683 2643 
MP2(full)/6-311G(2df,2pd) 340 -3019.744369 1254 1703 2637 
MP2(full)/6-311+G(2df,2pd) 364 -3019.746926 1216 1715 2630 
MP2(full) average   1252  61 1690  17 2590  81 
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B3LYP/6-31G(d) 127 -3019.113573 1245 1453 2077 
B3LYP/6-31+G(d) 151 -3019.131730 1310 1394 2012 
B3LYP/6-311G(d,p) 196 -3021.616934 1221 1385 1860 
B3LYP/6-311+G(d,p) 220 -3021.618264 1215 1381 1860 
B3LYP/6-311G(2d,2p) 253 -3021.622659 1115 1288 1759 
B3LYP/6-311+G(2d,2p) 277 -3021.624140 1170 1358 1831 
B3LYP/6-311G(2df,2pd) 340 -3021.631479 1200 1363 1833 
B3LYP/6-311+G(2df,2pd) 364 -3021.632497 1188 1363 1829 
B3LYP/aug-cc-pVTZ 500 -3021.722449 1205 1367 1845 
B3LYP average   1188  36 1358  32 1831  34 
a Energy differences are relative to the twist conformer. 
 
 
 
 
 
 
 
 
Table 4.5. Structural parameters (å and degree), rotational constants (mhz) and dipole moment 
(debye) for 1-79bromo-1-silacyclopentane twisted (C1) form. 
Structural 
Parameters 
Internal 
Coordinates 
RHF/ 
6-31G(d) 
MP2(full)/ 
6-311+G(d, p) 
B3LYP/ 
6-311+G(d, p) 
Estimated r0 
r (Si1-C2) X1 1.892 1.883 1.894 1.882(5) 
r (Si1-C3) X2 1.889 1.878 1.892 1.877(5) 
r (C2-C4) Y1 1.548 1.546 1.551 1.549(5) 
r (C3-C5) Y2 1.546 1.543 1.549 1.546(5) 
r (C4-C5) Z 1.538 1.536 1.544 1.536(5) 
r (Si1-Br6) r1 2.236 2.242 2.270 2.232(5) 
r (Si1-H7) r2 1.471 1.474 1.483 1.482(2) 
r (C2-H8) r3 1.086 1.095 1.094 1.095(2) 
r (C3-H9) r4 1.089 1.098 1.097 1.098(2) 
r (C2-H10) r5 1.085 1.094 1.092 1.094(2) 
r (C3-H11) r6 1.084 1.092 1.092 1.092(2) 
r (C5-H12) r7 1.088 1.097 1.096 1.097(2) 
r (C4-H13) r8 1.088 1.097 1.097 1.097(2) 
r (C5-H14) r9 1.086 1.095 1.094 1.095(2) 
r (C4-H15) r10 1.085 1.094 1.094 1.094(2) 
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 C3Si1C2    96.5   96.5   96.5 96.8(5) 
 Si1C2C4 1 102.9 103.1 103.2 103.3(5) 
 Si1C3C5 2 102.7 102.1 103.1 102.3(5) 
 C2C4C5  1 108.9 108.4 109.0 108.3(5) 
 C3C5C4 2 108.6 107.7 108.8 107.6(5) 
 Br6Si1H7  105.5 106.1 105.2 106.1(5) 
 H8C2H10 1 107.1 107.4 107.2 107.4(5) 
 H9C3H11 2 107.2 107.8 107.3 107.8(5) 
 H13C4H15 1 106.7 107.2 106.7 107.2(5) 
 H12C5H14 2 106.9 107.3 106.8 107.3(5) 
 Br6Si1C2 1 112.3 111.2 112.0 111.2(5) 
 Br6Si1C3 2 112.7 110.9 112.6 110.9(5) 
 H 7Si1C3 3 115.3 116.0 115.7 116.0(5) 
 H7Si1C2 4 114.9 116.2 115.0 116.2(5) 
 H8C2Si1 1 110.1 109.5 109.4 109.5(5) 
 H9C3Si1 5 109.2 109.5 108.5 109.5(5) 
 H10C2Si1 3 114.2 114.2 113.7 114.2(5) 
 H11C3Si1 7 115.1 114.5 114.5 114.5(5) 
 H8C2C4 2 110.2 110.1 110.6 110.1(5) 
 H9C3C5 6 110.0 109.5 110.3 109.5(5) 
 H10C2C4 4 112.3 112.5 112.7 112.5(5) 
 H11C3C5 8 112.6 113.2 113.0 113.2(5) 
 H13C4C2 1 109.5 109.7 109.5 109.7(5) 
 H13C4C5 2 108.9 108.5 109.0 108.5(5) 
 H15C4C2 3 111.5 111.5 111.4 111.5(5) 
 H15C4C5 4 111.3 111.5 111.2 111.5(5) 
 H12C5C3 5 109.4 109.6 109.3 109.6(5) 
 H12C5C4 6 109.2 109.0 109.1 109.0(5) 
 H14C5C3 7 111.7 111.8 111.6 111.8(5) 
 H14C5C4 8 111.2 111.4 111.1 111.4(5) 
 Si1C2C4C5 1  -35.5  -34.6  -35.0  -34.6(5) 
 C2C4C5C3 2   50.4   52.1   49.1   52.1(5) 
A  4144.99 4197.99 4118.94 4039.24 
B    972.91 1545.68   953.27 1000.16 
C    904.20 1380.76   886.96 935.94 
|a|  2.387 2.554 2.535  
|b|  0.038 0.071 0.022  
|c|  0.356 0.477 0.290  
|t|  2.414 2.599 2.552  
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Figure 4.3. Planar (Cs) conformer of 1-bromo-1-silacyclopentane showing atom numbering and 
internal coordinates.
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Table 4.6.  Symmetry coordinates of 1-bromo-1-silacyclopentane. 
Description   Symmetry Coordinatea 
α-CH2 antisymmetric stretch S1 = r3 - r5 +  r4 - r6 
α-CH2 antisymmetric stretch S2 = r3 - r5 -  r4 + r6 
β-CH2 antisymmetric stretch S3 = r7- r9 - r8 + r10 
β-CH2 antisymmetric stretch S4 = r7- r9 + r8 - r10 
α-CH2 symmetric stretch S5 = r3 + r5 +  r4 + r6 
α-CH2 symmetric stretch S6 = r3 + r5 -  r4 - r6 
β-CH2 symmetric stretch S7 = r7 + r9 + r8 + r10 
β-CH2 symmetric stretch S8 = r7 + r9 - r8 - r10 
Si-H stretch S9 = r2 
β-CH2 deformation S10 = 41- 1- 2 - 3 - 4 + 42 - 5 - 6 - 7 - 8 
β-CH2 deformation S11 = 41- 1- 2 - 3 - 4 - 42 + 5 + 6 + 7 + 8 
α-CH2 deformation S12 = 41- 1- 2 - 3 - 4 + 42 - 5 - 6 - 7 - 8 
α-CH2 deformation S13 = 41- 1- 2 - 3 - 4 - 42 + 5 + 6 + 7 + 8 
β-CH2 wag S14 = 1- 2 + 3 - 4 - 5 + 6 - 7 + 8 
β-CH2 wag S15 = 1 - 2 + 3 - 4 + 5 - 6 + 7 - 8 
β-CH2 twist S16 = 1 - 2 - 3  + 4 + 5 - 6 - 7 + 8 
β-CH2 twist S17 = 1- 2 - 3 + 4 - 5 + 6 + 7 - 8 
α-CH2 twist S18 = 1 - 2 - 3 + 4 - 5 + 6 + 7 - 8 
α-CH2 wag S19 = 1 - 2 + 3 -  4 + 5 - 6 + 7 - 8 
α-CH2 wag S20 = 1 - 2 + 3 - 4 - 5 + 6 - 7 + 8 
α-CH2 twist S21 = 1 - 2 - 3 + 4 + 5 - 6 - 7 + 8 
ring deformation S22 = 4Z - X1 - X2 -Y1 -Y2 
ring deformation S23 = X1 - X2 -Y1+Y2 
β-CH2 rock S24 = 1+ 2 - 3 - 4 + 5 + 6 - 7 - 8 
ring deformation S25 = X1 - X2 + Y1 - Y2 
ring breathing S26 = Z + X1 + X2 + Y1 +Y2 
α-CH2 rock S27 = 1+ 2 - 3- 4 - 5 - 6 + 7 + 8 
β-CH2 rock S28 = 1+ 2 - 3 - 4 - 5 - 6 + 7 + 8 
α-CH2 rock S29 = 1+ 2 - 3 - 4 + 5 + 6 - 7 - 8 
Si-H parallel bend* S30 = 3 - 4 
ring deformation S31 = 4 - 1 - 2 - 1 - 2 
Si-H perpendicular bend* S32 = 4 - 1 - 2 - 3 - 4 
ring deformation S33 = X1+ X2 -Y1 -Y2 
ring deformation S34 = 1 - 2 + 1- 2 
Si-Br stretch S35 = r1 
ring twist S36 = 1+ 2 
Si-Br parallel bend* S37 = 1 - 2  
Si-Br perpendicular bend* S38 = 1 + 2 - 3 - 4 
ring puckering S39 = 1- 2 
a Not normalized. 
*Bend parallel and perpendicular to the ring, respectively.  
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Figure 4.4. Comparison of experimental and calculated infrared spectra of 1-bromo-1-
silacyclopentane: (A) observed infrared spectrum of solid; (B) simulated infrared 
spectrum of twist conformer; (C) simulated infrared spectrum of envelope-axial 
conformer; (D) simulated infrared spectrum of envelope-equatorial conformer. 
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Figure 4.5. Comparison of experimental and calculated infrared spectra (990-1200 cm-1) of 1-bromo-
1-silacyclopentane: (A) simulated spectra of twist (C1) conformer at 0.5 cm-1 and 4.0 cm-1 
resolutions; (B) observed infrared spectrum of the gas showing typical B-, A- and A/C-
type band contours at 1157, 1080 and 1033 cm-1, respectively, measured at 0.5 cm-1 
resolution. 
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Figure 4.6. Raman spectra (0-1550 cm-1) showing the polarized and the depolarized bands for 1-
bromo-1-silacyclopentane.
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Discussion 
 We investigated the changes in the predicted intensities of the infrared bands and 
the Raman activities when the basis set was increased, from 6-31G(d) to 6-311+G(d,p), by 
the B3LYP density functional theory method. In Table 6 the values are reported and many 
have very small changes but a few of them have rather large differences for Raman 
activities. For example, 8 has a Raman activity of 131.0 Å
4/u that increases to 185.6 Å4/u 
when the basis set increases and for 9 (Si-H stretch) the Raman activity increases from 
126.5 to 178.7 Å4/u. There are also significant differences such as 11 which drops ~50% 
from 20.1 to 11.1 Å4/u and 13 which decreases from 19.4 to 8.7 Å
4/u. However, as the 
vibrational frequencies decrease the differences decrease and are often nearly the same. 
The predicted intensities for the infrared bands are not nearly as varied as the Raman 
activities but they do follow the same trend to smaller differences at lower frequencies. 
The predicted depolarization (dp) ratios do not vary significantly with the change 
in basis sets from B3LYP calculations and these are quite similar to the values obtained 
from the MP2(full)/6-31G(d) calculations (Table 6). The P.E.D.s are very similar for both 
B3LYP predicted values, which, are also similar to those predicted from the MP2(full)/6-
31G(d) calculations (Table 5). 
The predicted dp ratios are quite good as compared to the experimental spectra (Fig. 
6). The predicted depolarization ratios differ significantly for only four of the 
fundamentals, 1250 (17), 1079 (20), 840 (27), and 693 (30) cm-1. The band at 1250 cm-1 
assigned as the fundamental 17 is predicted as having a dp ratio of 0.75 while the 
experimental ratio is 0.31, the fundamental can be described as a β-CH2 twist (51%) with 
some α-CH2 twist (19%) and α-CH2 wag (18%) character. At 1079 cm-1 the 20 (39% α-
  
135 
 
CH2 wag and 21% β-CH2 twist) fundamental has an experimental dp ratio of 0.25 as 
compared with 0.73 from the ab initio prediction. The fundamental at 840 cm-1 (27)  has a 
predicted dp ratio of 0.64 as compared to the experimentally determined ratio of 0.24, this 
band has 36% α-CH2 rock character with contributions of 16% Si-H parallel bend and 13% 
Si-Br parallel bend while the remaining 35% is composed of smaller (less than 10%) 
contributions. The fundamental 30 at 693 cm-1 is highly mixed with contributions from 
five different modes, it is described as the Si-H parallel bend (19%) but this should be 
considered “bookkeeping” rather than a meaningful description of this complex vibrational 
motion. The experimentally determined dp ratio is 0.28 compared to 0.61 from the ab initio 
predictions. This shows good utility for the ab initio predictions with the predicted 
depolarization ratios matching reasonably well with the experimentally observed 
depolarization ratios.  
The ab initio predicted frequencies are in good agreement with the observed 
fundamentals of the twist form with an average difference of 8 cm-1 which is 0.5% error 
where these errors arise mainly from the β-CH2 symmetric stretches, α-CH2 deformations, 
the α-CH2 wag, and the ring deformations. The fundamental frequencies were also 
calculated using the B3LYP density functional theory method at two different basis sets. 
The 6-31G(d) and 6-311+G(d,p) basis sets were used and gave an average difference of 32 
cm-1 (3.1% error) and 20 cm-1 (2.0% error), respectively, where the carbon-hydrogen 
stretching modes were not included as they differed by over a hundred wavenumbers from 
the observed frequencies. As noted the B3LYP calculations do significantly worse at 
predicting the fundamental frequencies. This is partially due to the B3LYP predicted 
frequencies having values that are sometimes higher and sometimes lower than the 
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observed values so any effort to scale the predictions becomes complicated at best. This 
highlights the advantage of the ab initio MP2(full)/6-31G(d) predictions in that the 
predicted frequencies are usually higher than the observed values or relatively close to the 
observed values. 
The twist conformer is relatively rigid with the predicted energy difference to the 
envelope-axial form (saddle point) of 1216 cm-1 from the MP2 calculations by utilizing the 
largest basis set with a similar value of 1188 ± 36 cm-1 from the average of all the B3LYP 
calculations which agrees with the value of 1205 cm-1 from the B3LYP/aug-cc-pVTZ (500 
basis functions). The next higher energy saddle point which is the envelope-equatorial 
form, has a predicted value nearly 500 cm-1 greater than the axial form from the MP2 
calculations with those from the B3LYP calculations only about 300 cm-1 higher. The 
energy difference at the planar position is about 900 cm-1 higher than the equatorial form 
from the MP2 calculations and about 500 cm-1 higher from the B3LYP calculations. These 
energy differences are relatively large compared to those of the corresponding carbon 
compounds. From the limited data that is currently available one would expect that 1-X-1-
silacyclopentane molecules will have the twisted form as the most stable conformer for this 
molecule which is very different from the carbon analogues. 
It should be possible to estimate structural parameters for the twist conformer of 1-
bromo-1-silacyclopentane by adjusting the MP2(full)/6-311+G(d,p) calculated structural 
parameters using similar molecules as a guideline. The CH bond distances predicted by 
MP2(full)/6-311+G(d,p) ab initio calculations can be used as a good prediction without 
any adjustment as we33 have shown that ab initio MP2/6-311+G(d,p) calculations predict 
the r0 CH distances for more than fifty substituted hydrocarbons to better than ± 0.002 Å 
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compared to the experimentally determined values from isolated CH stretching frequencies 
which were compared34 to previously reported values from earlier microwave studies.  
Therefore, all of the carbon-hydrogen distances can be taken from the MP2(full)/6-
311+G(d,p) predicted values for 1-bromo-1-silacyclopentane. The heavy atom ring 
parameters can be estimated by using the corresponding parameters in silacyclopentane35 
to adjust the MP2(full)/6-311+G(d,p) calculated parameters. For silacyclopentane the 
adjusted r0 Si-C distance is 0.005 Å shorter than the predicted value whereas the two side 
C-C distances are 0.003 Å longer and the unique “bottom” C-C distance has the same value 
as predicted. Therefore, we have predicted the two C-C distances for 1-bromo-1-
silacyclopentane to be 0.003 Å longer than the ab initio predicted value with the same value 
for the “bottom” C-C distance as predicted. The Si-C distance for silacyclopentane, while 
interesting for comparison purposes to 1-bromo-1-silacyclopentane, was not used to find 
the estimated r0 structural parameters as the parameters from trimethylbromide should give 
a more consistent value. The differences in the angle values with those obtained from the 
adjusted values to the predicted values for silacyclopentane were retained for the 
bromosubstituted molecule. This leaves the Si-Br and Si-C distances to be obtained from 
the values reported for trimethyl bromosilane36 and bromosilane37, while the Si-H distance 
can be obtained using the frequency of the isolated SiH stretching mode. 
It has been shown that SiH distances can be obtained from the frequencies of the 
isolated SiH stretching modes38. Therefore, from the observed frequency of 2176 cm-1 for 
the SiH stretch we have obtained a value of 1.482 Å for the SiH distance (Table 5) which 
is 0.008 Å longer than the corresponding distance from the ab initio predicted parameter. 
We believe that this value has at most an uncertainty of ± 0.002 Å. This longer distance 
  
138 
 
compared to the ab initio predicted value is the same difference found for many SiH 
distances in other organosilanes39,40. 
In the microwave study36 of trimethyl bromosilane the structure was determined 
though only the SiBr is a true rs parameter while the carbon parameters are approximate rs 
parameters. Therefore, we have again determined the structural parameters for trimethyl 
bromosilane by utilizing the three B rotational constants previously reported36. We have 
found that good structural parameters for hydrocarbons and many substituted ones can be 
determined by adjusting the structural parameters obtained from the ab initio MP2(full)/6-
311+G(d,p) calculations to fit the rotational constants obtained from microwave 
experimental data by using a computer program “A&M” (Ab initio and Microwave) 
developed41 in our laboratory. In order to reduce the number of independent variables, the 
structural parameters are separated into sets according to their types where bond distances 
in the same set keep their relative ratio, and bond angles and torsional angles in the same 
set keep their difference in degrees. This assumption is based on the fact that errors from 
ab initio calculations are systematic. Therefore, we obtained “adjusted r0” structural 
parameters using the previously reported rotational constants. The determined heavy atom 
structural parameters for trimethyl bromosilane are: the distances with MP2(full)/6-
311+G(d,p) values in brackets (Å) Si-C = 1.863(3) [1.864], Si-Br = 2.244(3) [2.252], and 
the angle in degrees (°) BrSiC = 106.9(5) [107.3]. These parameters give differences of 
-0.001 and -0.008 Å for the Si-C and Si-Br bonds, respectively, and -0.4° for the BrSiC 
angle. The Si-C distances were then obtained using the MP2(full)/6-311+G(d,p) 
calculations and adjusting them by -0.001 Å. This leaves the Si-Br distance to be 
determined. 
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The microwave study of bromosilane37 determined the r0 structural parameters for 
Si-Br and Si-H to be 2.2123(1) and 1.4743(2) Å, respectively. The corresponding 
MP2(full)/6-311+G(d,p) parameters were predicted to be 2.225 and 1.468 Å from which 
the differences of -0.013 and 0.006 Å can be determined. The Si-H bond distance 
determined from the frequency of the SiH isolated stretching mode compares favorably 
with this prediction again showing the systematic nature of ab initio errors. The Si-Br value 
was adjusted using the average of the difference between the r0 parameters and the 
corresponding MP2(full)/6-311+G(d,p) parameter for bromosilane and trimethyl 
bromosilane. This average gives an adjustment of -0.010 Å, thereby, giving the bond 
distance listed in Table 5. 
 For the angles, we retained the values from the ab initio calculation since the 
adjusted values of the angles of silacyclopentane differed by 0.3, 0.2, 0.1 and 0.1° and with 
the listed uncertainties of 0.5 we believe they should be within the experimentally 
determined values. All of these estimated parameters are listed in Table 5 along with those 
predicted from RHF/6-31G(d) and B3LYP/6-311+G(d,p) and those from the MP2 
calculations from which the adjusted parameters were obtained. It should be noted that the 
predictions from the RHF calculation provided good estimates for the C-C distances but 
the Si-C distances are very long. The B3LYP predictions for the Si-C distances are even 
longer than those from the RHF calculation and those for the C-C are also slightly too long. 
It is believed that the estimated r0 parameters reported herein for 1-bromo-1-
silacyclopentane have listed uncertainty values that should be within the experimentally 
determined parameters. Thus, the listed rotational constants given in Table 5 for the 79Br 
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atom should make it relatively easy to assign the microwave spectrum from which the 
experimental parameters could be obtained.  
It is clear that additional work to determine Si-Br distances would be of value where 
it would be interesting to see if the predicted parameter is consistent for several different 
types of Si-Br molecules. Also of interest would be a microwave study of a 5-membered 
ring which contains a silicon atom and four carbon atoms to obtain structural parameters 
by utilizing isotopic Si and 13C data which should give accurate heavy atom distances of 
the 1-X-1-silacyclopentane molecules.  
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PROJECT-2 
Infrared and Raman Spectra, Structural Parameters, Conformational Stability, 
Vibrational Assignment and ab initio Calculations of 2-cyanoethylphosphine 
Introduction 
 The conformational stability determination of 1,2-disubstituted ethylene molecules 
have provided some interesting challenges for the structural scientists over the years. The 
1,2-dihaloethane molecules provided good examples where it was shown by infra-red gas 
phase studies42 that the gauche conformer of 1,2-difluoroethane has lower energy than the 
trans form by 280  30 cm-1(3.35  0.36 kJ mol-1). However the trans conformer of 1,2-
dichloroethane, has lower energy than the gauche form by43 323  7 cm-1 (3.87  0.09 kJ 
mol-1). This value was obtained by Turner et al. from variable temperature infrared studies 
of xenon solutions. By utilizing an average of four gauche/trans conformer pairs. Eight 
years later the enthalpy difference was again determined44 for 1,2-dichloroethane for both 
the gas and two different noble gas solutions from variable temperature infrared studies. 
For the liquid xenon solution two conformer pairs were utilized44 which differed from those 
used earlier43 and a value of 272  11 cm-1 (3.26  0.13 kJ mol-1) was obtained. However 
from the krypton solution a value of 318  25 cm-1 (3.81  0.30 kJ mol-1) was obtained 
from only one conformer pair which differed from the two used for the xenon study. This 
value was much lower than the value of 410  13 cm-1 (4.90  0.15 kJ mol-1) obtained for 
the gas from one conformational pair. These results indicate that more than one conformer 
pair should be used to obtain enthalpy differences of conformers since underlining 
overtones and/or combination bands of the fundamentals can significantly affect the 
intensities when the temperature is varied. 
  
142 
 
Instead of XCH2CH2X (X = F, Cl) molecules, the XCH2CH2Y molecules are of 
even more interest since it is frequently difficult to determine the conformer with the lowest 
energy spectroscopically because of the low symmetry of the molecules. Also, the energy 
difference can be very small with 1,2-chlorofluoroethane as an example. The 
conformational stability of FCH2CH2Cl was obtained
44 from variable temperature infrared 
studies of both krypton and xenon solutions. The trans form was found to have lower 
energy by 17  8 cm-1 (0.20  0.10 kJ mol-1) from the krypton solution and the gauche form 
was determined to have lower energy by 20  10 cm-1 (0.24  0.12 kJ mol-1) from the xenon 
solution. These differences are so small that it is not possible to determine which form has 
the lower energy with possible solvent interference. From variable temperature infrared 
studies of the gas the trans form was reported44 to have lower energy by 126  8 cm-1 (1.51 
 0.09 kJ mol-1). These values indicate the variations that have been reported for these 
types of molecules with different solutions. 
 Of particular scientific interest, has been the conformational stability of the 2-
substituted ethylamines, XCH2CH2NH2, since a large number of molecules containing 
amines are very important biochemical materials. Therefore, we began such studies with 
an investigation45 of 2-fluoroethylamine where all five possible stable conformers were 
identified and their relative conformational stabilities determined. Additionally, the r0 
structural parameters were determined for the two conformers with permanent dipole 
moments and their rotational constants were determined from a previous microwave 
study46. We continued these studies with an investigation of the infrared spectra of the gas 
and variable temperature xenon solutions of ethylenediamine14 from which only three of 
the possible ten conformers were identified and their relative enthalpy differences obtained. 
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We have broadened our studies to include phosphines since some of the phosphines have 
been shown to have antitumor activity17,18 and, therefore, their conformational stabilities 
could be important in the selection of the compounds which could have the most potential 
as biochemical materials. 
The first organophosphine molecule initially studied was 2-cyanoethylphosphine, 
NCCH2CH2PH2. The infrared spectra of the gas, liquid and solid and the Raman spectrum 
of the liquid and solid of 2-cyanoethylphosphine have been recorded from which the 
conformational stability has been determined and a vibrational assignment of the 
fundamentals is reported. To support the conformational stability determination and aid in 
the vibrational assignment, predictions from calculation by ab initio MP2 level with full 
electron correlation and density functional theory by the B3LYP method have been 
obtained by using a variety of basis sets. The results of these spectroscopic and theoretical 
studies are reported herein.        
Experimental Methods 
 The sample of 2-cyanoethylphosphine was purchased from Strem Chemical 
Company. The purity was determined by gas chromatography to be greater than 96%. The 
sample was subjected to trap-to-trap transfers under vacuum prior to recording the spectra 
and stored at -78°C. 
 Infrared spectra of the solid from 3200 – 400 cm-1 were obtained from a Perkin-
Elmer 283B grating spectrophotometer and a liquid-nitrogen-cooled sampling cell with a 
CsI substrate. The spectra of the solids were recorded at a resolution of 2.0 cm-1. Infrared 
spectra of the crystalline solid was obtained by the process of annealing which was 
achieved by repetitive evaporation of the liquid nitrogen completely from the reservoir in 
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the solid cell, which resulted in a gradual increase in the temperature, which was then 
followed by sudden freezing of the sample by the addition of liquid nitrogen. This warming 
process allowed the molecules to form a crystalline structure. The spectrum of the liquid 
was obtained by sandwiching a drop of the sample between two KBr windows. The infrared 
spectra of the gas was recorded on a Nicolet 7199 Fourier transform interferometer 
equipped with a Ge/KBr beamsplitter and a liquid-nitrogen-cooled MCT detector with the 
sample contained in a 10 cm cell with KBr windows. The instrument was purged to remove 
the water and carbon dioxide by a commercial two column dryer with one column to 
remove the water and the other CO2. The resolution for the spectra of the gas was 0.5 cm
-
1 at ambient pressure of the gas. Typical spectra are shown in Fig. 7 and the wavenumbers 
of the observed bands from the spectra of the gas, liquid and solid are listed in Tables 7, 8, 
9 and 10.  
 Raman spectra were recorded from 3050 to 50 cm-1 on a Spex Ramalog DUV 
spectrometer with the 4880 Å line of a Spectra-Physics model 171 argon ion laser as the 
excitation source with laser power of 200 mW. Liquid samples were sealed in Pyrex 
capillaries under vacuum, and spectra of solid and variable temperature liquids were 
obtained by using a cell similar to one described by Miller and Harney47. All the Raman 
spectra were recorded at 3 cm-1 spectral bandwidths and frequencies are expected to be 
accurate to be better than 2 cm-1. Typical spectra are shown in Fig. 8.  
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Figure 4.7. Infrared spectra (3200-400 cm-1) of 2-cyanoethylphosphine: (A) liquid; (B) amorphous 
solid; (C) crystalline solid; (D) simulated IR spectrum of Gauche-trans conformer; (E) 
simulated IR spectrum of Trans-trans conformer. 
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Figure 4.8. Raman spectra (3050-50cm-1) of 2-cyanoethylphosphine: (A) liquid; (B) solid; (C) 
simulated Raman spectrum of Gauche-trans conformer; (D) simulated Raman spectrum 
of Trans-trans conformer.
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Table 4.7. Observed and calculateda frequencies (cm-1) and potential energy distributions (P.E.D.s) for the Gt (C1) conformer of 2-
cyanoethylphosphine. 
Vib. 
no. 
 Approximate 
description 
AB  
INITIO 
Fixed  
scaledb 
IR Raman 
P.E.D.c 
Contour 
gas liquid amorphous crystalline liquid solid 
A B C 
1 
CH2 antisymmetric 
stretch 
3182 2985 2970     2963 93S1 21 19 60 
2 
CH2 antisymmetric 
stretch 3161 
2965  2949 2946 2948 2949 2950 92S2 15 56 28 
3 
CH2 symmetric 
stretch 3122 
2929      2930 98S3 12 68 20 
4 
CH2 symmetric 
stretch 3108 
2916  2922 2920 2917 2922 2917 97S4 26 57 17 
5 
PH2 antisymmetric 
stretch 2511 
2315 2303   2310  2314 74S5, 26S6 26 59 15 
6 
PH2 symmetric 
stretch 2486 
2292 2298 2300 2297 2295 2296 2295 74S6, 26S5 - 2 98 
7 CN stretch 2222 2222  2247 2246 2243 2246 2243 89S7, 11S18 33 65 2 
8 CH2 deformation 1534 1443 1436   1435  1435 97S8 8 37 54 
9 CH2 deformation 1522 1431 1430 1425 1422 1420 1420 1420 99S9 8 33 59 
10 CH2 rock 1402 1331  1324 1322 1330 1325 1329 69S10, 16S13 63 2 35 
11 CH2 rock 1370 1300  1288 1288  1285 1290 65S11, 24S12 80 8 12 
12 CH2 twist 1275 1211 1209 1207 1205 1207 1207 1204 30S12,27S13,17S11,12S10 49 47 4 
13 CH2 twist 1230 1168  1173 1175 1176 1171 1175 40S13, 40S12 2 55 43 
14 PH2 deformation 1159 1100 1084 1081 1081  1082 1083 95S14 1 60 39 
15 C-C(P) stretch 1082 1030 1024 1020 1021 1023 1018 1020 44S15, 15S17, 10S16 9 44 47 
16 CH2 wag 1042 993 988 987 988 987 985 987 21S16,21S20,20S18,13S15 16 49 35 
17 CH2 wag 979 936 927 928 928 927 927 928 36S17, 19S19 99 - 1 
18 C-C(N) stretch 883 842 856 855 855 855 853 856 48S18, 16S20, 10S15 69 - 31 
19 PH2 rock 847 805 812 813 811 810 812 809 58S19, 22S17 26 2 72 
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20 PH2 twist 684 652  669 666 666 669 669 36S20, 36S16 - 94 6 
21 C-P stretch 665 632  633 634 638 631 640 78S21 48 39 13 
22 
C-CN in-plane 
bend 546 
537  544 546 548 541 548 33S22, 33S26, 14S16 53 47 - 
23 
C-CN out-of-
plane bend 
373 371     373 378 76S23, 13S27 24 5 71 
24 C-C-P bend 303 299     301 301 67S24, 16S26 68 - 31 
25 PH2 torsion 233 233      242 57S25, 15S26, 13S27 36 49 15 
26 C-C-C bend 159 159     190 191 31S26, 24S22, 35S25 5 21 74 
27 C-C(P) torsion 97 97      119 67S27 53 20 27 
a MP2(full)/6-31G(d) ab initio calculations, frequencies from scaled force constants and potential energy distributions (P.E.D.s). 
b Scaling factors of 0.88 for CH2 stretches and CH2 deformations, 0.85 for PH2 stretches and 0.90 for all other modes except torsions, heavy atom 
bends, and CN stretch. 
c Symmetry coordinates with P.E.D. contribution less than 10% are omitted. 
 
 
 
 
 
 
 
 
 
 
  
 
 
1
4
9
 
Table 4.8. Observed and calculateda frequencies (cm-1) and potential energy distributions (P.E.D.s) for the Tt (Cs) conformer of 2-
cyanoethylphosphine. 
Sym 
block Vib. 
no. 
 Approximate description 
AB  
INITIO 
Fixed  
scaledb 
IR     Raman 
P.E.D.c 
Contour 
gas liquid amorphous crystalline liquid solid 
A B 
A' 1 CH2 symmetric stretch 3129 2936 2930   2929   87S1, 13S2 4 96 
 2 CH2 symmetric stretch 3115 2922       87S2, 13S1 7 93 
 3 PH2 symmetric stretch 2482 2288       100S3 3 97 
 4 CN stretch 2219 2205   2235    89S4, 11S11 90 10 
 5 CH2 deformation 1537 1445       76S5, 22S6 4 96 
 6 CH2 deformation 1527 1435 1430 1425  1427   76S6, 23S5 34 66 
 7 CH2 rock 1403 1332       60S7, 30S8 29 71 
 8 CH2 rock 1302 1236  1229 1229  1229  62S8, 32S7 50 50 
 9 PH2 deformation 1155 1096 1094   1075 1076 1076 94S9 22 78 
 10 C-C(P) stretch  1079 1027       78S10 56 44 
 11 C-C(N) stretch 975 937       55S11, 11S16, 10S12 38 62 
 12 PH2 rock 870 827  835 834  833  59S12, 16S11, 15S13 53 47 
 13 C-P stretch 737 706  705 706  703  51S13, 19S12, 15S16 98 2 
 14 C-CN in-plane bend 493 484  496 494  493  45S14, 21S16, 20S13 95 5 
 15 C-C-P bend 281 276     282  64S15, 11S14, 10S13 72 28 
 16 C-C-C bend  149 148     160  45S16, 36S14, 18S15 7 93 
A" 17 CH2 antisymmetric stretch 3189 2992       80S17, 20S18 - - 
 18 CH2 antisymmetric stretch 3166 2970 2964   2962   80S18, 20S17 - - 
 19 PH2 antisymmetric stretch 2493 2298       100S19 - - 
 20 CH2 twist 1355 1286     1285  49S20, 42S21 - - 
 21 CH2 twist 1231 1170       41S21, 44S20 - - 
 22 PH2 twist 1070  1017  1008 1008  ~1010  29S22, 32S23, 31S24 - - 
 23 CH2 wag 843 802    755   755 42S23, 35S22, 10S21 - - 
 24 CH2 wag 666 635       53S24, 31S22 - - 
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 25 C-CN out-of-plane bend 377 376       84S25, 11S27 - - 
 26 PH2 torsion 207 207       95S26 - - 
 27 C-C(P) torsion 91 91       77S27 - - 
a MP2(full)/6-31G(d) ab initio calculations, frequencies from scaled force constants and potential energy distributions (P.E.D.s). 
b Scaling factors of 0.88 for CH2 stretches and CH2 deformations, 0.85 for PH2 stretches and 0.90 for all other modes except torsions, heavy atom 
bends, and CN stretch. 
c Symmetry coordinates with P.E.D. contribution less than 10% are omitted. 
 
 
 
 
 
 
 
Table 4.9. Observed and calculateda frequencies (cm-1) and potential energy distributions (P.E.D.s) for the Tg (C1) conformer of 2-
cyanoethylphosphine. 
Vib. 
no. 
 Approximate description 
AB  
INITIO 
Fixed  
scaledb 
IR 
Raman 
liquid 
P.E.D.c 
Contour 
gas liquid 
A B C 
1 CH2 antisymmetric stretch 3199 3001    93S1 3 1 96 
2 CH2 antisymmetric stretch 3163 2967    93S2 8 19 74 
3 CH2 symmetric stretch 3135 2941    95S3 6 94 - 
4 CH2 symmetric stretch 3112 2919    96S4 - 95 5 
5 PH2 antisymmetric stretch 2510 2314    83S5, 17S6 26 69 5 
6 PH2 symmetric stretch 2491 2297    83S6, 17S5 17 1 81 
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7 CN stretch 2222 2222    89S7, 11S17 93 7 - 
8 CH2 deformation 1542 1450    56S8, 41S9 4 95 1 
9 CH2 deformation 1534 1443    57S9, 42S8 41 47 12 
10 CH2 rock 1407 1336    66S10, 23S12 21 70 9 
11 CH2 twist 1354 1285    55S11, 34S13 79 19 2 
12 CH2 rock 1290 1224   1229 69S12, 25S10 14 85 1 
13 CH2 twist 1219 1159   1155 44S13, 37S11, 11S16 44 7 49 
14 PH2 deformation 1156 1096 1091   95S14 72 2 25 
15 C-C(P) stretch 1087 1035    73S15 8 92 - 
16 CH2 wag 1058 1005 992/996   29S16, 31S21, 17S19 41 4 55 
17 C-C(N) stretch 983 944 934   57S17 54 45 1 
18 PH2 twist 846 803    37S18, 20S16, 14S20 - 34 66 
19 PH2 rock 836 794  798 796 44S19, 18S16 30 35 35 
20 C-P stretch 755 722  727 725 40S20,12S26,12S19, 11S18 53 3 44 
21 CH2 wag 716 684    40S21, 15S18, 14S19 77 23 - 
22 C-CN in-plane bend 496 487    46S22, 21S26, 19S20 95 5 - 
23 C-CN out-of-plane bend 375 374    85S23 9 1 91 
24 C-C-P bend 267 262   267 61S24, 12S22, 11S20 - 62 38 
25 PH2 torsion 174 173    84S25 30 60 10 
26 C-C-C bend 146 145    38S26, 29S22, 23S24 25 74 1 
27 C-C(P) torsion 88 87    81S27 1 4 95 
a MP2(full)/6-31G(d) ab initio calculations, frequencies from scaled force constants and potential energy distributions (P.E.D.s). 
b Scaling factors of 0.88 for CH2 stretches and CH2 deformations, 0.85 for PH2 stretches and 0.90 for all other modes except 
torsions, heavy atom bends, and CN stretch. 
c Symmetry coordinates with P.E.D. contribution less than 10% are omitted. 
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Table 4.10. Observed and calculateda frequencies (cm-1) for the Gg (C1) conformer 
of 2-cyanoethylphosphine. 
Vib. 
No. 
 Approximate Description 
AB  
INITIO 
Fixed  
scaledb 
IR 
 int. 
Raman 
act. 
1 CH2 antisymmetric stretch 3193 2995 5.0 53.2 
2 CH2 antisymmetric stretch 3167 2971 1.4 75.7 
3 CH2 symmetric stretch 3127 2933 9.6 96.6 
4 CH2 symmetric stretch 3115 2922 4.6 91.9 
5 PH2 symmetric stretch 2516 2387 70.9 95.5 
6 PH2 antisymmetric stretch 2501 2373 72.1 157.4 
7 CN stretch 2220 2220 0.7 31.2 
8 CH2 deformation 1534 1439 7.8 9.5 
9 CH2 deformation 1531 1436 7.6 16.0 
10 CH2 rock 1402 1330 1.1 7.3 
11 CH2 rock 1362 1292 7.5 1.5 
12 CH2 twist 1268 1203 0.7 11.8 
13 CH2 twist 1215 1153 8.3 5.7 
14 PH2 deformation 1160 1100 16.1 34.7 
15 C-C(P) stretch 1083 1027 6.3 5.2 
16 C-C(N) stretch 1032 979 22.0 7.1 
17 CH2 wag 984 934 5.7 11.2 
18 CH2 wag 881 836 1.4 7.3 
19 PH2 twist  831 788 14.2 6.3 
20 PH2 rock 734 696 2.7 3.7 
21 C-P stretch 672 638
c 4.5 17.1 
22 C-C-C bend 547 547 1.5 0.8 
23 C-CN out-of-plane bend 372 372 0.1 2.9 
24 C-C-P bend 289 289 4.7 2.5 
25 C-CN in-plane bend 219 219 1.4 1.9 
26 PH2 torsion 160 160 9.8 1.4 
27 C-C torsion 88 88 3.8 1.0 
a MP2(full)/6-31G(d) ab initio calculations, frequencies from scaled force constants, 
infrared intensities (km mol-1), Raman activities (Å4 u-1). 
b Scaling factors of 0.88 for CH2 stretches and CH2 deformations, 0.85 for PH2 
stretches and 0.90 for all other modes except torsions, heavy atom bends, and CN 
stretch. 
cOnly one band was observed for Gg form at 638 cm-1 in the Raman liquid. 
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Theoretical Methods 
 The ab initio calculations were performed with the Gaussian 03 program19 with 
Gaussian-type basis functions. The energy minima with respect to nuclear coordinates were 
obtained by the simultaneous relaxation of all geometric parameters by the gradient method 
of Pulay20. Several basis sets as well as the corresponding ones with diffuse functions were 
employed with the Møller-Plesset perturbation method21 to the second order (MP2(full)) 
as well as with the density functional theory by the B3LYP method.  
In order to obtain a complete description of the molecular motions involved in the 
fundamental modes of 2-cyanoethylphosphine, normal coordinate analyses were carried 
out. The force field in Cartesian coordinates was obtained with the Gaussian 03 program19 
with the 6-31G(d) basis set. The internal coordinates used to calculate the G and B matrices 
are given in Table 11 with the atomic numbering shown in Fig. 9. By using the B matrix29, 
the force field in Cartesian coordinates was converted to a force field in internal 
coordinates. Subsequently, scaling factors of 0.88 for CH2 stretches and CH2 deformations, 
0.85 for PH2 stretches and 0.90 for other coordinates except for the heavy atom bends, 
torsions, and C≡N stretch which were not scaled were used, along with the geometric 
average of the scaling factors for the interaction force constants, to obtain the fixed scaled 
force field and resultant wavenumbers. A set of symmetry coordinates was utilized (Table 
15) to determine the corresponding potential energy distributions (P.E.D.s). The calculated 
infrared intensities, Raman activities, depolarization ratios and potential energy 
distributions for the Gt, Tt, Tg and Gg conformers are listed in Tables7, 8, 9 and 10, 
respectively. Rotation about the C-C bond gives rise to Trans (T) and Gauche (G) forms 
which are indicated by capital letters and rotation around the C-P bond also results in trans 
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(t) and gauche (g) forms indicated by lower case letters. There are a total of five possible 
stable conformers that can exist for the NCCH2CH2PH2 molecule which are Gauche-trans 
(Gt), Trans-trans (Tt), Trans-gauche (Tg), Gauche-gauche (Gg) and Gauche-gauche' (Gg') 
as shown in Fig. 10.  
The frequencies from the scaled force constants were used together with a 
Lorentzian function to obtain the simulated spectra. Infrared intensities were obtained 
based on the dipole moment derivatives with respect to Cartesian coordinates. The 
derivatives were transformed with respect to normal coordinates by (u/Qi) =
j
(u/Xj)Lij, where Qi is the ith normal coordinate, Xj is the jth Cartesian displacement 
coordinate, and Lij is the transformation matrix between the Cartesian displacement 
coordinates and the normal coordinates. The infrared intensities were then calculated by 
(N)/(3c2) [(x/Qi)2 + (y/Qi)2 + (z/Qi)2]. A comparison of experimental and 
simulated infrared spectra of 2-cyanoethylphosphine is shown. Infrared spectra of the 
liquid, amorphous solid, crystalline solid and the predicted infrared spectra for the pure Gt 
and Tt conformers are shown in Fig. 7 (A-E), respectively. The predicted spectrum, which 
included the frequencies and intensities, greatly aided in making the initial assignment of 
the fundamentals for each conformer.  
Additional support for the vibrational assignments was obtained from the simulated 
Raman spectra. The evaluation of Raman activity by using the analytical gradient methods 
has been developed30–32 and the activity Sj can be expressed as: Sj = gj(45αj2 + 7βj2), where 
gj is the degeneracy of the vibrational mode j, αj is the derivative of the isotropic 
polarizability, and βj is the anisotropic polarizability. To obtain the Raman scattering cross 
sections, the polarizabilities are incorporated into Sj by multiplying Sj with (1-ρj)/ (1+ρj) 
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where ρj is the depolarization ratio of the jth normal mode. The Raman scattering cross 
sections and calculated wavenumbers obtained from the Gaussian 03 program were used 
together with a Lorentzian function to obtain the simulated Raman spectra. Comparison of 
experimental Raman spectra of the liquid, solid and the predicted Raman spectra for the 
pure Gt and Tt conformers are shown in Fig. 8 (A-D). The predicted spectrum is in 
reasonable agreement with the experimental spectrum which indicates the utility of the 
predicted Raman spectra for aiding the vibrational assignments.  
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Figure 4.9.  Trans-trans (Cs) conformer of 2-cyanoethylphosphine showing atom numbering and 
internal coordinates. 
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Vibrational Assignment 
The assignment of the vibrational spectra is essential in order to be able to obtain 
the enthalpy difference among the conformers. The fundamentals for at least the three 
conformers having lowest energies need to be assigned since the microwave spectra have 
been assigned for all three. For the conformer having the lowest energy the predicted 
amount is 62% from ab initio calculations. It will give the most dominant spectra, in most 
cases, except where the molar absorption coefficients predict the intensities to be 
significantly different for either the second or the third conformer. The most interesting 
vibrational frequencies will be for the P-H motions as well as the heavy atom modes. The 
frequencies for the CH2 stretching vibrations are well known from “group frequencies”. 
The PH2 antisymmetric and symmetric stretches are clearly identified in the infrared 
spectra of the gas and also as overlapping bands in the spectra of the liquid and amorphous 
solid. The predicted frequencies of the PH2 stretches for the conformers with higher 
energies have essentially the same frequencies and it is not possible to distinguish them. 
The other vibration in this region is the C≡N stretch which has a significantly lower 
frequency and is well characterized with no question of its assignment. The CH2 bending 
modes, for the most part, are also readily assigned based on the predictions from the ab 
initio calculations as well as from well known “group frequencies” particularly for the 
deformations and CH2 wagging modes. One of the CH2 twisting modes is extensively 
mixed with the CH2 rock but both the twists were readily assigned. The PH2 deformation 
is nearly a pure mode at 1084 cm-1. Even though the corresponding PH2 deformations for 
the other two conformers are predicted to be near the same frequencies as that for the Gt 
conformer, distinct frequencies could be assigned for them.  
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The assignments of the most interest are the heavy atom vibrations, especially the 
stretches. The C-C(P) stretch is readily assigned at 1024 cm-1 in the spectrum of the gas 
with similar frequencies for the amorphous and crystalline solids. The other C-C(N) stretch 
is assigned at 856 cm-1 with the two CH2 wags falling between the C-C stretches. One of 
the CH2 wags is so mixed that the band at 988 cm
-1 although appropriately assigned as this 
mode, has equal contributions from a PH2 motion and a C-C stretch. The other two PH2 
bending modes are assigned at 812 cm-1 as the PH2 rock which is a relatively strong band 
and the weaker one at 669 cm-1 to the PH2 twist in the infrared spectra. The C-P stretch is 
a very strong band in the Raman spectra and it is observed at 631 cm-1 with the C-C≡N 
bends at 541 and 373 cm-1. Four of the remaining fundamentals are readily assigned based 
upon the predicted frequencies and the Raman data provide the most definitive bands for 
their assignments. Once the assignments had been made for the Gt conformer the next task 
was to obtain bands that could be used for the determination of the enthalpy differences. 
Consequently, their assignment was to relatively strong bands in the region where the 
fundamentals are expected based upon their predicted values. Of particular interest were 
the C-P stretches which was relatively easily assigned for the Gt conformer and are 
assigned at 703 and 725 cm-1 for the Tt and Tg conformers, respectively. This fundamental 
for the Tt form was readily assigned at similar frequencies in the infrared spectra of the 
liquid and solid.  
Once the fundamentals had been assigned for the Gt conformer the assignments for 
the other conformers were fairly limited to the region below 800 cm-1 since it was almost 
impossible to obtain well defined bands above this spectral region for the other conformers. 
After the C-P stretching band for the Gt form, the second band utilized for the enthalpy 
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determination was the 541 cm-1 which is a weak band and the corresponding fundamental 
for the Tt form is a pronounced band at 493 cm-1 which can be confidently assigned. The 
C-C≡N bend for the Tg conformer is predicted to be at a slightly higher frequency and 
appears as a weak shoulder on the high frequency side of the 493 cm-1 band but does not 
interfere with obtaining the intensity of this band for the determination of the enthalpy 
difference.  
There was one additional band at 669 cm-1 which was sufficiently away from any 
other bands and not predicted for the other conformers so it could be assigned as the PH2 
twist for the Gt form. Thus, there are three fundamentals for the Gt conformer that could 
be used for the determinations of the enthalpy differences. For the most part other 
fundamentals for the two Trans conformers are significantly overlapped by the 
fundamentals from the Gt conformer so that individual frequencies were difficult to 
measure or obtain for these Trans conformers. Therefore, the vibrational assignment is 
primarily for the Gt conformer and the lower frequency bands were identified based upon 
their significant change in intensities and the predicted frequencies. 
 
 
 
 
 
      Gt                          Tt                            Tg                         Gg                            Gg' 
Figure 4.10. Newmann projections of the five conformers of 2-cyanoethylphosphine. 
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Table 4.11. Structural parameters (å and °) and rotational constants (mhz) for the Gt, Tt and Tg conformer of 2-cyanoethylphosphine. 
Structural 
parameters 
Internal 
coordinates 
Gt Tt Tg 
MP2(full)/ 
6-311+G(d,p) 
B3LYP/ 
6-311+G(d,p) 
Microwavea Adjusted r0 
MP2(full)/ 
6-311+G(d,p) 
Adjusted r0 
MP2(full)/ 
6-311+G(d,p) 
Adjusted r0 
r (P1-C2) R1 1.859 1.877 1.880 1.860(3) 1.858 1.858(3) 1.864 1.864(3) 
r (C2-C3) R2 1.535 1.543 1.530 1.535(3) 1.533 1.535(3) 1.535 1.535(3) 
r (C3-C4) R3 1.464 1.462 1.474 1.464(3) 1.465 1.465(3) 1.463 1.463(3) 
r (C4-N5) R4 1.174 1.153 1.157 1.160(3) 1.174 1.160(3) 1.174 1.160(3) 
r (P1-H6) r1 1.410 1.422 1.414 1.410(3) 1.412 1.412(3) 1.412 1.412(3) 
r (P1-H7) r2 1.413 1.425 1.414 1.413(3) 1.412 1.412(3) 1.410 1.410(3) 
r (C2-H8) r3 1.094 1.093 1.093 1.094(2) 1.094 1.094(2) 1.092 1.092(2) 
r (C2-H9) r4 1.095 1.093 1.093 1.095(2) 1.094 1.094(2) 1.094 1.094(2) 
r (C3-H10) r5 1.094 1.094 1.093 1.094(2) 1.094 1.094(2) 1.095 1.095(2) 
r (C3-H11) r6 1.095 1.096 1.093 1.095(2) 1.094 1.094(2) 1.095 1.095(2) 
 P1C2C3 A1 116.6 118.1 117.0(15)
b 117.1(5) 114.9 114.9(5) 110.2 110.0(5) 
 C2C3C4 A2 112.3 113.5 110.5 112.5(5) 112.1 112.1(5) 111.8 111.8(5) 
 H6P1C2 α2   96.7   97.4 95.5 96.7(5) 96.2 96.2(5) 96.4 96.4(5) 
 H7P1C2 α3   96.0   96.9 95.5 96.0(5) 96.2 96.2(5) 96.7 96.7(5) 
 H8C2P1 1 107.8 107.0 108.0 107.8(5) 107.8 107.8(5) 112.2 112.2(5) 
 H9C2P1 1 107.2 106.5 106.6 107.2(5) 107.8 107.8(5) 107.9 107.9(5) 
 H8C2C3 2 109.6 109.9 109.5 109.6(5) 109.7 109.7(5) 109.5 109.5(5) 
 H9C2C3 2 108.5 108.3 109.5 108.5(5) 109.7 109.7(5) 109.1 109.1(5) 
 H10C3C2 3 110.4 110.4 109.5 110.4(5) 110.3 110.3(5) 110.6 110.6(5) 
 H10C3C4 3 108.1 108.2 109.5 108.1(5) 108.4 108.4(5) 108.1 108.1(5) 
 H11C3C2 4 110.5 110.0 109.5 110.5(5) 110.3 110.3(5) 110.6 110.6(5) 
 H11C3C4 4 107.9 107.7 109.5 107.9(5) 108.4 108.4(5) 108.3 108.3(5) 
 H6P1H7 α1   94.4   93.8 93.4 94.4(5) 94.0 94.0(5)   94.6   94.6(5) 
 H8C2H9 β1 106.7 106.4 109.5 106.7(5) 106.5 106.5(5) 107.9 107.9(5) 
 H10C3H11 β2 107.5 106.9 109.5 107.5(5) 107.1 107.1(5) 107.2 107.2(5) 
 C3C4N5 A3 178.8 179.4 180.0 178.8(5) 178.3 178.3(5) 178.6 178.6(5) 
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 P1C2C3C4 1 64.5 65.6 66(3)
c 63.4(5) 180.0 180.0(5)   176.8 176.8(5) 
a Ref.48. 
b Structural parameters kept fixed for Gt, Tt and Tg conformers except for  P1C2C3 which is 114.0(15) for Tt and 109.0(15) for Tg conformer. 
c Fitted PCCC dihedral angle for Gt conformer. 
 
 
 
 
 
 
Table 4.12. Temperature and intensity ratios of the conformational bands of 2-cyanoethylphosphine from the Raman spectra of the liquid. 
a The average values of H and the statistical uncertainty (1σ) was obtained by utilizing all of the data as a single set. 
T(°C) 1/T (10-3K-1) 
Gt/Tta Tt/Tga  Gt/Tga 
I631/I493 I541/I703 I541/I493 I669/I493 I703/I725 I493/I725 I631/I725 I541/I725 I669/I725 
29.0 3.311 2.07 0.17 0.12 0.07 2.07 3.00 6.21 0.36 0.21 
10.0 3.533 2.26 0.15 0.12 0.12 2.79 3.50 7.92 0.42 0.42 
-5.0 3.731 2.31 0.15 0.13 0.11 3.20 3.80 8.80 0.50 0.40 
-10.0 3.802 2.33 0.16 0.12 0.10 3.37 4.31 10.05 0.53 0.42 
-29.0 4.098 2.41 0.19 0.15 0.13 3.65 4.59 11.06 0.71 0.59 
-50.0 4.481 2.43 0.19 0.17 0.11 4.57 5.00 12.14 0.86 0.57 
-70.0 4.926 2.85 0.21 0.20 0.13 4.40 4.73 13.47 0.93 0.60 
-85.0 5.319 2.55 0.18 0.17 0.11 7.10 7.80 19.90 1.30 0.90 
-95.0 5.618 2.68 0.19 0.18 0.13 6.73 7.09 19.00 1.27 0.91 
-100.0 5.775 2.69 0.19 0.19 0.17 7.40 7.20 19.40 1.40 1.20 
-108.0 6.060 2.75 0.19 0.19 0.14 7.90 7.70 21.20 1.50 1.10 
           
H, cm-1 61 ± 10 53 ± 19 130 ± 21 113 ± 37 309 ± 24 228 ± 23 289 ± 22 357 ± 23 347 ± 42 
          
H average, cm-1(kJmol-1) 89 ± 12 (1.07 ± 0.15) 268 ± 19 (3.21 ± 0.22) 331 ± 18 (3.96 ± 0.21) 
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Conformational Stability 
 To determine the enthalpy differences among the three conformers with the lowest 
energies of NCCH2CH2PH2, the Raman spectra of the liquid sample was recorded as a 
function of different temperatures from 29 to -108°C. When the sample was cooled to -
118°C it crystallized and only one conformer was observed which is consistent with the Gt 
form. Once confident assignment for the three conformers having the lowest energies, Gt 
< Tt < Tg, were made, the next step was in finding a pair or pairs of bands from which the 
enthalpy determination could be carried out. For this determination, it is desirable to have 
the lowest frequency pair(s) in the spectra to minimize the effect of combination and 
overtone bands. The bands should also be sufficiently resolved to allow for accurate 
intensity measurements. After taking into consideration these requirements, a good 
selection of band pairs could be made relatively easily as most of the peaks that were used 
for the enthalpy determinations are heavy atom stretching and bending modes. The C-P 
stretch which is a relatively strong band in the Raman spectra but is of a medium or weak 
intensity in the infrared spectra was of primary interest. This fundamental which appears 
at 631, 703 and 725 cm-1 in the spectra and was assigned to the Gt, Tt and Tg conformers, 
respectively, were used. Additionally, the C-C≡N in-plane bends at 541 and 493 cm-1 for 
the Gt and Tt forms, respectively, were also used. Apart from the heavy atom vibrations, 
the shoulder at 669 cm-1 which is due to the PH2 twisting mode for the Gt conformer was 
also considered for possible use in the enthalpy determination. By combining these peaks, 
a total of nine pairs were obtained with four of them for Gt/Tt, three for Gt/Tg and 
remaining two for Tt/Tg conformer pairs.  
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Initially, the relative intensities of the above indicated pairs for the three stable 
conformers were measured as a function of temperature and their ratios were determined. 
Eleven temperatures were chosen to obtain the spectral data for these pairs and by 
application of the van’t Hoff equation, –lnK = H/(RT) – S/R, the enthalpy differences 
were determined from a plot of –lnK versus 1/T, where, H/R is the slope of the line and 
K is substituted with the appropriate intensity ratios, i.e. Iconf-1/Iconf-2. It was assumed that 
H, S and the ratio of the molar absorption coefficients conf-1/conf-2 are not a function of 
temperature in the range studied.  
After utilizing the four band pairs for the Gt/Tt conformers, the enthalpy differences 
ranged from a low value of 53 ± 19 cm-1 (0.63 ± 0.23 kJ mol-1) to a high value of 130 ± 21 
cm-1 (1.55 ± 0.25 kJ mol-1) (Table 12). The average of the uncertainties is 25%. However, 
by utilizing the data from all the pairs as a single set and by using the statistical standard 
deviation of one sigma the enthalpy difference is 89 ± 12 cm-1 (1.07 ± 0.15 kJ mol-1).  
 To determine the enthalpy difference between the lowest energy conformer Gt and 
the Tg form having third lowest energy, the three band pairs that were used give enthalpy 
differences that ranged from 289 ± 22 cm-1 (3.46 ± 0.26 kJ mol-1) to 357 ± 23 cm-1 (4.27 ± 
0.27 kJ mol-1), with the average of the uncertainties being 9%. Similar to the Gt/Tt 
conformers when the data from all the pairs of the Gt/Tg conformers were utilized as a 
single set with a statistical deviation of one sigma for the error limits a H value of 331 ± 
18 cm-1 (3.96 ± 0.21 kJ mol-1) was obtained. Similarly, for the determination of the H 
value between the Tt conformer having second lowest energy and Tg form, the two pairs 
that were utilized gave an average value of 268 ± 19 cm-1 (3.21 ± 0.22 kJ mol-1) as the 
enthalpy 
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difference (Table 12). The predicted conformational energy differences from ab initio 
calculations employing the MP2(full) and B3LYP methods are listed in Table 13, which 
can be compared to the experimentally determined H values.  
 
 
Table 4.13. Calculated energies (hartree) and energy differencesa (cm-1) for the five conformers of 2-
cyanoethylphosphine. 
Method / basis set 
# of  
basis sets 
Gt 
Tt 
E 
Tg 
E 
Gg 
E 
Gg' 
E 
MP2(full)/6-31G(d) 91 -512.923708 -85 119 108 487 
MP2(full)/6-31+G(d) 111 -512.936135 -126 159 127 496 
MP2(full)/6-311G(d,p) 134 -513.235293 -77 255 190 514 
MP2(full)/6-311+G(d,p) 154 -513.241668 -70 298 225 542 
MP2(full)/6-311G(2d,2p) 177 -513.305911 2 361 281 566 
MP2(full)/6-311+G(2d,2p) 197 -513.311170 -24 346 303 596 
MP2(full)/6-311G(2df,2pd) 242 -513.391002 18 355 276 578 
MP2(full)/6-311+G(2df,2pd) 262 -513.395502 2 346 294 604 
MP2(full)/aug-cc-pVTZ 372 -513.323508 77 313 240 551 
       
B3LYP/6-31G(d) 91 -514.007178 -168 92 229 532 
B3LYP/6-31+G(d) 111 -514.015706 -239 23 191 498 
B3LYP/6-311G(d,p) 134 -514.084163 -166 102 208 496 
B3LYP/6-311+G(d,p) 154 -514.087487 -178 99 219 502 
B3LYP/6-311G(2d,2p) 177 -514.092537 -158 128 233 487 
B3LYP/6-311+G(2d,2p) 197 -514.095918 -185 103 242 500 
B3LYP/6-311G(2df,2pd) 242 -514.100039 -164 114 228 476 
B3LYP/6-311+G(2df,2pd) 262 -514.103178 -189 93 238 491 
B3LYP/aug-cc-pVTZ 372 -514.110133 -188 69 212 467 
a Energy differences with respect to the Gt conformer. 
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Table 4.14. Symmetry coordinates for 2-cyanoethylphosphine w.r.t. Tt conformer. 
Sym. 
Block 
Description   Symmetry Coordinatea 
A' CH2 symmetric stretch S1 = r3 + r4 
CH2 symmetric stretch S2 = r5 + r6 
PH2 symmetric stretch S3 = r1 + r2 
CN stretch S4 = R4 
CH2 deformation S5 = 4β1 – π1 – π2 – σ1 – σ2 
CH2 deformation S6 = 4β2 – π3 – π4 – σ4 – σ3 
CH2 rock S7 = π1 – π2 + σ1 – σ2  
CH2 rock S8 = π3 – π4 + σ4 – σ3 
PH2 deformation S9 = α1 
CC(P) stretch  S10 = R2 
CC(N) stretch S11 = R3 
PH2 rock S12 = α2 + α3 
CP stretch S13 = R1  
CCN in-plane bend S14 = A3  
CCP bend S15 = A1 
CCC bend  S16 = A2 
A" CH2 asymmetric stretch S17 = r3 – r4 
CH2 asymmetric stretch S18 = r5 – r6 
PH2 asymmetric stretch S19 = r1 – r2 
CH2 twist S20 = π1 + π2 – σ1 – σ2 
CH2 twist S21 = π3 + π4 – σ4 – σ3 
PH2 twist S22 = α2 – α3 
CH2 wag S23 = π1 – π2 – σ1 + σ2 
CH2 wag S24 = π3 – π4 – σ4 + σ3 
CCN out-of-plane bend S25 = τ3 
PH2 torsion S26 = τ2 
CC torsion S27 = τ1 
a Not normalized. 
 
 
 
  
166 
 
Structural Parameters 
In the initial microwave study48 only one angle (PCC) for each conformer and the 
dihedral angle (τPCCC) for the Gt form were determined for the three identified 
conformers. The remaining structural parameters were estimated from the corresponding 
ones from related compounds. Thus, there were only four structural parameters determined 
from the earlier microwave study so more extensive determination of the structural 
parameters of these three molecules is desirable. Therefore, we embarked upon a study to 
determine all of the structural parameters for all three conformers.  
We have found that good structural parameters for hydrocarbons and many 
substituted ones can be determined by adjusting the structural parameters obtained from 
the ab initio MP2(full)/6-311+G(d,p) calculations to fit the rotational constants obtained 
from microwave experimental data by using a computer program “A&M” (Ab initio and 
Microwave) developed41 in our laboratory. In order to reduce the number of independent 
variables, the structural parameters are separated into sets according to their types where 
bond distances in the same set keep their relative ratio and bond angles in the same set keep 
their difference in degrees. This assumption is based on the fact that errors from ab initio 
calculations are systematic49. Additionally, we have also shown that the differences in 
predicted distances and angles from the ab initio calculations for different conformers of 
the same molecule can usually be used as one parameter with the ab initio predicted 
differences except for some dihedral angles.  
We33 have also shown that ab initio MP2(full)/6-311+G(d,p) calculations predict 
the r0 structural parameters for more than fifty carbon-hydrogen distances in substituted 
hydrocarbons to at least 0.002 Å compared to the experimentally determined values from 
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isolated CH stretching frequencies34. Therefore, all of the carbon-hydrogen distances can 
be taken from the MP2(full)/6-311+G(d,p) predicted values for Gt, Tt and Tg conformers 
of 2-cyanoethylphosphine. Therefore, it should be possible to obtain “adjusted r0” 
structural parameters for heavy atoms for all three conformers of 2-cyanoethylphosphine 
by utilizing the previously reported seven well determined rotational constants from the 
earlier microwave study48. For the Tt and Tg forms only the B and C rotational constants 
were well determined and the A rotational constants could not be used for obtaining the 
adjusted r0 parameters due to their large uncertainties.  
The fit of the seven determined rotational constants (Table 15) by the structural 
parameters for the Gt, Tt and Tg conformers is remarkably good with six of the differences 
having values of 0.4 and 0.3 MHz and the other one 0.02 MHz. The only adjusted heavy 
atom parameter which required a significant adjustment for all three conformers was the 
C≡N distance which is always predicted much larger from MP2 ab initio calculations than 
the experimental value. The B3LYP calculations, on the other hand, predicted a slightly 
smaller value. Bond distances for triple bonds seldom vary significantly with substitutions. 
The other three heavy atom distances vary a maximum of 0.002 Å from the ab initio 
predicted values. Only two of the angles, PCC and CCC were adjusted to slightly larger 
values than the MP2 calculations for the Gt form. For the Tg form PCC got smaller by 
just 0.2°.  
The heavy atom distances along with the P-H distances have estimated accuracies 
to ± 0.003 Å and the angles should be within ± 0.5°. The resulting adjusted parameters are 
listed in Table 11. Therefore, it is believed that the suggested uncertainties are realistic 
values and the determined structural parameters are probably as accurate as can be obtained 
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for the molecule in the gas phase by either electron diffraction or microwave substituted 
methods. 
 
 
 
 
Table 4.15. Comparison of rotational constants (MHz) obtained from ab initio MP2(full)/6-
311+G(d,p) predictions, experimental values from microwave spectra, and from the 
adjusted r0 structural parameters for 2-cyanoethylphosphine. 
 
Isotopomer 
Rotational 
constants 
MP2(full)/ 
6-311+G(d,p) 
Experimentala Adjusted r0  || 
Gt A 7545.8 7555.25(1) 7554.9 0.3 
 B 2252.1 2257.927(6) 2257.5 0.4 
 C 1867.6 1868.707(6) 1869.1 0.4 
Tt A 22697.3 22607 (117) 22708.3 - 
 B 1443.7 1448.061(6) 1447.8 0.3 
 C 1396.9 1400.310(6) 1400.7 0.4 
Tg A 22922.6 23271 (1274) 22946.5 - 
 B 1453.5 1459.52(3) 1459.5 0.0 
 C 1404.2 1410.16(4) 1409.9 0.3 
a Ref.48. 
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Discussion 
It was possible to confidently assign the P-C stretch at 638 cm-1 for the Gg 
conformer having fourth lowest energy which was predicted and observed on the high 
frequency side of the lowest energy Gt form at 631 cm-1 in the Raman spectra of the liquid. 
The band at 638 cm-1 was observed to be a weak shoulder on the band at 631 cm-1 which 
made it difficult to obtain the relative intensity as a function of temperature particularly as 
the temperature of the sample was lowered. Nevertheless, this region of the Raman 
spectrum did not have other fundamentals interfering with the observation of this vibration 
at ambient temperature. Based on the relative intensity also at ambient temperature, Gg is 
estimated to be 5% abundant with an enthalpy difference of 387 cm-1 (4.63 kJ mol-1) with 
respect to Gt. The abundance of the Gt form itself is calculated to be 62% with the 
remainder values of 20% for the Tt and 13% for the Tg form at ambient temperature. The 
ab initio prediction was for Gg conformer to be having third lowest energy but the 
experimental data indicates that it has fourth lowest energy.  
There were slight discrepancies that were observed in the theoretical energy values 
involving MP2(full) and B3LYP methods. While the experimentally determined order of 
energies for 2-cyanoethylphosphine was Gt < Tt < Tg < Gg < Gg′, the predicted values 
from the MP2(full) calculations follow the order: Gt < Tt < Gg < Tg < Gg′, where, some of 
the basis sets predict the Tt form to be having lower energy than Gt. On the other hand, 
conformational stability obtained from the B3LYP calculations minimally varies with the 
size of the basis set and the order was predicted to be Tt < Gt < Tg < Gg < Gg′.  
 The predicted frequencies for the fundamental vibrations with three scaling factors 
compare favorably with the observed values with an average error of 10 cm-1 which 
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represents a percentage error of 0.8% for the Gt conformer. This error cannot be obtained 
for the Tt and Tg conformers since many of the vibrations of these conformers seem to be 
nearly the same as the corresponding ones for the Gt form or they simply could not be 
observed in the spectra; thus, only a few fundamentals for these two conformers were 
confidently identified. Nevertheless, it is clear from the few normal modes that were 
assigned that the error is probably similar for the predicted frequencies.  
 Since the fit of the seven rotational constants were excellent it is believed that the 
adjusted r0 structural parameters for the Tt and Tg conformers should predict their A 
rotational constants to within a very few megahertz. It should be noted that the 
experimental value of 22607  117 MHz is within the 22708.3 MHz obtained from the r0 
structural parameters of the Tt conformer. Similarly, for the Tg conformer the determined 
structural parameters predict the A rotational constant to within 324 MHz to the 
experimentally determined value which had an uncertainty of 1274 MHz.  
 In the microwave study, the P-C bond distance was fixed at 1.880 Å for all three 
isotopes which is quite long compared to the r0 distances of 1.860(3) Å for the Gt conformer 
with similar values of 1.858(3) and 1.864(3) Å for the Tt and Tg forms, respectively. The 
estimated distance for the C-C(N) bond of 1.474 Å is also considerably longer than the 
corresponding values from this study where they differed with similar values of 1.463, 
1.464, and 1.465 Å. However, the remaining estimated distances are as good as the 
determined ones in the current study.   
The ab initio predicted heavy atom angles were adjusted by 0.5° and 0.2° for PCC 
and CCC for the fit of the rotational constants for the Gt conformer and no adjustment 
for the Tt form and a decrease of 0.2° for the PCC angle for the Tg conformer. Thus, only 
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minor adjustments were made from the ab initio MP2(full)/6-311+G(d,p) predicted 
parameters for the three conformers of 2-cyanoethylphosphine. 
 The experimentally determined values of PCC for the three conformers were 
117.0, 114.0 and 109.0° for the Gt, Tt, and Tg conformers, respectively, which have 
differences of 0.1, 0.9, and 1.0 degrees, respectively, from the values of these angles 
obtained in this study. Since the listed uncertainties of the angles were reported to be 1.5° 
they all are in agreement with the experimentally determined values reported herein. 
 The results of this study indicate that the ab initio MP2(full)/6-311+G(d,p) 
calculations provide very good predictions of the structural parameters for the 
organophosphorus molecules which include both the heavy atoms and the PH2 parameters. 
This is a small sample and it would be of interest to study a few more organophosphorus 
molecules to see if the predictions from these ab initio calculations also provide good 
values.  
From early vibrational studies of some XCH2CH2Y molecules conformer having 
the lowest energy was determined where many of the results were obtained for all three 
physical states. Of particular interest in the current study was the results obtained when Y 
= CN and X = Cl, Br50. These investigators concluded that when the X and Y groups were 
in the trans position for these molecules, the carbon-halogen bond stretching frequencies 
were significantly affected by the electronegativity of the Y group as the result of the 
inductive effect. This relationship was further developed by an empirical relationship in 
which the force constants were found to be proportional to the electronegativity product of 
the bound atoms51. Thus, from these results it was possible to identify the trans and gauche 
conformers of the ClCH2CH2CN and BrCH2CH2CN molecules
52. With this background we 
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investigated whether the conformations of the NCCH2CH2PH2 molecule obeyed these C-
C(N) stretching frequencies for the two conformers, and they did. Therefore, these 
frequencies of the C-X and C-Y stretches can be used to identify the conformer when the 
electronegativities of these substituents are utilized which provides a rather simple method 
for identifying the conformation. Although this method does not indicate which conformer 
has the lowest energy, it should be very useful for identifying the spectral bands for 
XCH2CH2Y molecules with trans and gauche conformers. For example, the 
H2PCH2CH2PH2 molecule will have ten possible conformers with four of them being trans 
conformers and the remaining six being gauche forms and it should be possible to 
vibrationally distinguish them. There are several other XCH2CH2PH2 molecules where this 
method could be valuable for the identification of trans and gauche conformers. 
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PROJECT-3 
Conformational Stabilities from Variable Temperature Raman Spectra, r0 
Structural Parameters and Vibrational Assignments of  
1,2-diphosphinoethane 
Introduction 
The 1,2-disubstituted ethane (YCH2CH2X) molecules are of interest since most of 
them have two conformers trans (anti) and gauche, present in the fluid states and their 
relative stabilities are believed to depend on the electronegativity and size of the 
substituents. For example, 1,2-difluoroethane has the gauche conformer lower in energy 
than the trans form by 280  30 cm-1(3.35  0.36 kJ mol-1)42, whereas, 1,2-dichloroethane 
has the trans conformer lower in energy than the gauche form43 by 323  7 cm-1 (3.87  
0.09 kJ mol-1) from variable temperature infrared studies of xenon solutions. When Y is a 
methyl group and X is a fluorine atom (1-fluoropropane) the gauche conformer has lower 
energy53 than the trans form by 104 ± 6 cm-1 (1.24 ± 0.07 kJ mol-1). One might expect the 
1-chloro-2-fluoroethane molecule to have the gauche conformer with lower energy since 
the fluorine and chlorine atoms are highly electronegative and the chlorine atom has a van 
der Waal’s radius nearly the same as that of the methyl group. However, it has been 
reported that the 1-chloro-2-fluoroethane molecule has the trans form with lower energy 
than the gauche by 287 ± 58 cm-1 (3.43 ± 0.69 kJ mol-1) from a determination of the 
enthalpy difference from the variable temperature Raman spectra of the gas54 as well as 
from a variable temperature study of rare gas solutions44. Thus, it is clear that there are 
additional factors than just size and electronegativity that determines which conformer has 
the lowest energy. 
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 As a continuation of our studies of 1,2-substituted ethanes, we have investigated 
the conformational stability of 1,2-diaminoethane (ethylenediamine)14 and 1,2-
diphosphinoethane (ethylenediphosphine) to determine whether there is a significant 
difference in the conformer stabilities of these two molecules since both ethylamine15 and 
ethylphosphine55 have the trans conformers as the lower energy forms. We were 
particularly interested in the phosphine molecule since some of the phosphines have been 
shown to have anticancer properties17,18. 
We initiated the investigation of the vibrational spectra of 1,2-diphosphinoethane 
with a study of the infrared spectra of the gas, amorphous and crystalline solid. 
Additionally, we have investigated the Raman spectra of the liquid and solid. Variable 
temperature Raman spectra of the liquid have been obtained from which enthalpy 
differences between the various conformers were determined. Rotation about the C-C bond 
gives rise to Trans (T) and Gauche (G) forms which are indicated by capital letters and 
rotation around both of the C-P bonds also results in trans (t) and gauche (g) forms which 
are indicated by lower case letters. There are a total of ten possible stable conformers that 
can exist for the H2PCH2CH2PH2 molecule which are shown in Fig. 11.  
To support the vibrational study, we have carried out ab initio calculations with 
basis sets up to aug-cc-pVTZ as well as those with diffuse functions up to 6-
311+G(2df,2pd). We have also carried out density functional theory (DFT) calculations by 
the B3LYP method with the same basis sets. We have calculated optimized geometries, 
conformational stabilities, harmonic force constants, infrared intensities and Raman 
activities. By utilizing the previously reported56 microwave rotational constants along with 
ab initio MP2(full)/6-311+G(d,p) predicted structural values, adjusted r0 parameters have 
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been obtained for two C-C Trans and two C-C Gauche conformers. The results of these 
spectroscopic, structural, and theoretical studies are reported herein.  
 
 
 
 
 
      tTt    g′Tt                      g′Tg′       g′Tg                        tG′g′ 
 
 
        tG′t                          g′G′t                       gG′g′         g′G′g′                     g′G′g 
 
Figure 4.11. Newmann projections of the ten conformers of 1,2-diphosphinoethane. 
 
 
  
176 
 
Experimental Methods 
 The sample of 1,2-diphosphinoethane was purchased from Strem Chemicals, Inc., 
Newburyport, MA. The purity was determined by gas chromatography to be greater than 
96%. The sample was subjected to trap-to-trap transfers under vacuum prior to recording 
spectra and stored at -78°C. 
 Infrared spectra of the solid in the 3600-500 cm-1 region were obtained with a 
Perkin-Elmer 283B grating spectrophotometer and a liquid-nitrogen-cooled sampling cell 
with a CsI substrate. The spectra of the solids were recorded at a resolution of 2.0 cm-1. 
Infrared spectrum of the crystalline solid was obtained by the process of annealing which 
was achieved by repetitive evaporation of the liquid nitrogen completely from the reservoir 
in the solid cell, which resulted in a gradual increase in the temperature, which was then 
followed by sudden freezing of the sample by the addition of liquid nitrogen. This warming 
process allowed the molecules to form a crystalline structure. Gaseous phase infrared 
samples were contained in a 10 cm cell fitted with KBr windows, and the spectra were 
recorded on a Nicolet 7199 Fourier transform interferometer equipped with a Ge/KBr 
beamsplitter and a liquid-nitrogen-cooled MCT detector. The instrument was purged to 
remove the water and carbon dioxide by a commercial two column dryer with one column 
to remove water and the other carbon dioxide. The resolution for the spectra of the gas was 
0.5 cm-1 at ambient pressure of the gas. The infrared spectra of the gas, amorphous and 
crystalline solid are shown in Fig. 12(A-C), respectively.  
 Raman spectra were recorded from 3000-200 cm-1 on a Spex Ramalog DUV 
spectrometer set to use the 4880 Å line of a Spectra-Physics model 171 argon ion laser as 
the excitation source with a laser power of 200 mW. Liquid samples were sealed in Pyrex 
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capillaries under vacuum, and spectra of solids and variable temperature liquids were 
obtained by using a cell similar to one described by Miller and Harney47. All of the Raman 
spectra were recorded at 3 cm-1 spectral bandwidths and frequencies are expected to be 
accurate to better than 2 cm-1. The Raman spectra of the liquid and the solid are shown in 
Fig. 13A and 13B, respectively.
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Table 4.16. Observed and calculateda frequencies (cm-1) and potential energy distributions (P.E.D.s) for the tTt (C2h) conformer of 1,2-
diphosphinoethane. 
Sym. 
Block 
Vib. 
No. 
Approximate Description 
AB 
INITIO 
fixed 
scaledb 
IR 
gas 
IR 
amorphous 
IR 
annealed 
Raman 
liquid 
Raman 
solid 
contour 
P.E.D.c 
A B C 
Ag 1 CH2 symmetric stretch 3106 2914    2899 2896 5 95 - 100S1 
 2 PH2 symmetric stretch 2481 2287    2284 2283 2 98 - 100S2 
 3 CH2 deformation 1523 1429    1415 1415 5 95 - 99S3 
 4 CH2 wag 1373 1303    - 1313 84 5 11 93S4 
 5 PH2 deformation 1158 1099    1078 1075 13 87 - 91S5 
 6 CC stretch 1090 1037    1037 1035 79 19 2 76S6 
 7 PH2 wag 918 876    863 865 22 77 1 58S7, 19S8, 15S9 
 8 CP stretch 696 666    655 656 98 2 - 43S8, 29S7, 21S9 
 9 CCP bend 290 282    283 291 - 7 93 55S9, 35S8 
Au 10 CH2 antisymmetric stretch  3176 2980 2948 2929 2931   - - 100 100S10 
 11 PH2 antisymmetric stretch  2493 2298 2302 2284 2286   - - 100 100S11 
 12 CH2 twist  1214 1151 1143 1129 1129   - - 100 84S12, 13S13 
 13 PH2 twist 883 838 838 838 838   - - 100 63S13, 21S14, 16S12 
 14 CH2 rock  647 613 621 611 611   - - 100 78S14, 22S13 
 15 PH2 torsion  195 195 - - -   - - 100 93S15 
 16 CC torsion  103 103      - - 100 94S16 
Bg 17 CH2 antisymmetric stretch  3156 2961    2940 - - - 100 100S17 
 18 PH2 antisymmetric stretch  2492 2297    2297 2292 - - 100 100S18 
 19 CH2 twist 1354 1285    1264 1260 - 1 99 89S19, 11S20 
 20 CH2 rock 1070 1015    1028 1027 16 9 75 51S20, 45S21 
 21 PH2 twist 699 664    655 656 8 1 91 55S21, 36S20 
 22 PH2 torsion  227 227      9 90 1 99S22 
Bu 23 CH2 symmetric stretch 3115 2922 2920 2901 2902   5 95 - 100S23 
 24 PH2 symmetric stretch 2481 2287 2302 2276 2278   2 98 - 100S24 
 25 CH2 deformation  1528 1433  1430 1410 1410   5 95 - 100S25 
 26 CH2 wag 1283 1218 1190 1192 1192   52 48 - 93S26 
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 27 PH2 deformation 1152 1093 1082 1064 1064   12 88 - 97S27 
 28 PH2 wag  856 812 815 806 805   56 44 - 90S28 
 29 CP stretch 716 680 676 672 674   89 11 - 96S29 
 30 CCP bend 204 202      15 85 - 99S30 
aMP2(full)/6-31G(d) ab initio calculations, frequencies from scaled force constants, and potential energy distributions (P.E.D.s) 
 bScaling factors of 0.88 for CH2 stretches and CH2 deformations, 0.85 for PH2 stretches, 0.90 for all other modes except torsions and heavy 
atom bends. 
 cSymmetry coordinates with P.E.D. contribution less than 10% are omitted. 
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Table 4.17. Observed and calculateda frequencies (cm-1) for the g′Tt (C1) conformer of 1,2-
diphosphinoethane. 
 
Vib. 
No. 
 Approx. Description 
AB  
INITIO 
fixed  
scaledb 
IR  
gas 
IR 
amorphous 
Raman 
liquid Raman 
solid 
1 CH2 antisymmetric stretch 3183 2986 2979 2968   
2 CH2 antisymmetric stretch 3158 2962     
3 CH2 symmetric stretch 3120 2927  2901   
4 CH2 symmetric stretch 3106 2913   2919 2916 
5 PH2 antisymmetric stretch 2497 2302     
6 PH2 antisymmetric stretch 2493 2298     
7 PH2 symmetric stretch 2485 2291     
8 PH2 symmetric stretch 2481 2287     
9 CH2 deformation 1536 1441     
10 CH2 deformation 1528 1433     
11 CH2 wag 1374 1305    1263 
12 CH2 twist 1353 1284     
13 CH2 wag 1274 1209     
14 CH2 twist 1200 1144     
15 PH2 deformation 1157 1097 ~1086 1071 1081 1082 
16 PH2 deformation 1154 1095 ~1086 1071 1081 1082 
17 CC stretch 1096 1043     
18 CH2 rock 1061 1022   1000 995 
19 PH2 wag 915 874 869    
20 PH2 twist 878 836 838    
21 PH2 wag 847 804 ~815  808  
22 PH2 twist 749 721 716   697 
23 CP stretch 715 682     
24 CP stretch 691 660     
25 CH2 rock 665 635     
26 CCP bend 282 275   276  
27 CC torsion 221 221     
28 CCP bend 199 197     
29 PH2 torsion 170 170     
30 PH2 torsion 99 99     
aMP2(full)/6-31G(d) ab initio calculations, frequencies from scaled force constants,. 
bScaling factors of 0.88 for CH2 stretches and CH2 deformations, 0.85 for PH2 stretches, 0.90 for all 
other modes except torsions and heavy atom bends. 
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Table 4.18. Observed and calculateda frequencies (cm-1) for the g′Tg′ (C2) form of 1,2-
diphosphinoethane. 
 
Sym. 
block Vib. 
No. 
 Approximate Description 
AB  
INITIO 
fixed  
scaledb 
IR 
gas IR 
amorphous 
Raman 
liquid 
Raman 
solid 
A 1 CH2 antisymmetric stretch 3184 2987 2979 2968   
2 CH2 symmetric stretch 3112 2919     
3 PH2 antisymmetric stretch 2497 2302     
4 PH2 symmetric stretch 2485 2291     
5 CH2 deformation 1537 1442     
6 CH2 wag 1350 1302     
7 CH2 twist 1188 1127     
8 PH2 deformation 1158 1099     
9 CC stretch 1100 1047     
10 PH2 twist 915 873     
11 PH2 wag 872 828 824  826  
12 CH2 rock 717 681   673 676 
13 CP stretch 693 661     
14 CCP bend 270 263   265  
15 PH2 torsion 171 171     
16 CC torsion 96 96     
B 17 CH2 antisymmetric stretch 3166 2970     
18 CH2 symmetric stretch 3120 2927     
19 PH2 antisymmetric stretch 2497 2302     
20 PH2 symmetric stretch 2483 2289     
21 CH2 deformation 1539 1444 1382 1382   
22 CH2 twist 1371 1281 1276 1270   
23 CH2 wag  1265 1201 1168 1168 1169  
24 PH2 deformation 1154 1095     
25 CH2 rock 1052 998 986  990  
26 PH2 twist 844 801     
27 PH2 wag 759 720     
28 CP stretch 714 677     
29 PH2 torsion 216 215     
30 CCP bend 176 175     
aMP2(full)/6-31G(d) ab initio calculations, frequencies from scaled force constants. 
bScaling factors of 0.88 for CH2 stretches and CH2 deformations, 0.85 for PH2 stretches, 0.90 for all 
other modes except torsions and heavy atom bends. 
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Table 4.19. Observed and calculateda frequencies (cm-1) for the g′Tg (Ci) form of 1,2-
diphosphinoethane. 
 
Sym. 
block Vib. 
No. 
Approximate Description 
AB  
INITIO 
fixed  
scaledb 
IR 
gas IR 
amorphous 
Raman 
liquid 
Ag 1 CH2 antisymmetric stretch 3170 2974    
2 CH2 symmetric stretch 3109 2917    
3 PH2 antisymmetric stretch 2500 2305    
4 PH2 symmetric stretch 2487 2293    
5 CH2 deformation 1535 1456    
6 CH2 wag 1372 1302    
7 CH2 twist 1352 1283    
8 PH2 deformation 1158 1099    
9 CC stretch  1101 1045    
10 CH2 rock 1052 998   990 
11 PH2 twist 903 857    
12 PH2 wag 752 713   714 
13 CP stretch  683 648    
14 CCP bend 275 275   276 
15 PH2 torsion 197 197    
Au 16 CH2 antisymmetric stretch 3188 2991    
17 CH2 symmetric stretch 3118 2925 2948   
18 PH2 antisymmetric stretch 2501 2306    
19 PH2 symmetric stretch 2486 2292    
20 CH2 deformation 1537 1458 1393   
21 CH2 wag 1268 1203    
22 CH2 twist 1183 1122 1130 1114  
23 PH2 deformation 1154 1095    
24 PH2 wag 872 827    
25 PH2 twist 841 798    
26 CH2 rock 740 702    
27 CP stretch  697 661    
28 CCP bend  181 181    
29 PH2 torsion 147 147    
30 CP torsion 96 96    
aMP2(full)/6-31G(d) ab initio calculations, frequencies from scaled force constants. 
bScaling factors of 0.88 for CH2 stretches and CH2 deformations, 0.85 for PH2 stretches, 0.90 
for all other modes except torsions and heavy atom bends. 
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Table 4.20. Observed and calculateda frequencies (cm-1) for the tG′g′ (C1) form of 1,2-
diphosphinoethane. 
 
Vib. 
No. 
 Approximate Description 
AB  
INITIO 
fixed  
scaledb 
IR 
gas IR 
amorphous 
Raman 
liquid 
1 CH2 antisymmetric stretch 3172 2976    
2 CH2 antisymmetric stretch 3159 2964    
3 CH2 symmetric stretch 3109 2917    
4 CH2 symmetric stretch 3103 2911    
5 PH2 antisymmetric stretch 2510 2314    
6 PH2 antisymmetric stretch 2498 2303    
7 PH2 symmetric stretch 2495 2300    
8 PH2 symmetric stretch 2481 2287    
9 CH2 deformation 1529 1434 1361 1369  
10 CH2 deformation 1521 1427 1350 1346  
11 CH2 wag  1372 1302    
12 CH2 wag  1364 1295 1290   
13 CH2 twist 1263 1200   1176 
14 CH2 twist 1197 1139 1134  1130 
15 PH2 deformation 1166 1107    
16 PH2 deformation 1153 1094    
17 CC stretch 1089 1039    
18 CH2 rock  1014 973   982 
19 CH2 rock  985 943 944   
20 PH2 wag 864 821    
21 PH2 twist 844 802    
22 PH2 wag 755 720    
23 CP stretch  711 677    
24 PH2 twist 647 626    
25 CP stretch  631 601   593 
26 CCP bend 358 352   348 
27 PH2 torsion  267 266    
28 CCP bend  218 216    
29 PH2 torsion  172 172    
30 CP torsion 100 100    
aMP2(full)/6-31G(d) ab initio calculations, frequencies from scaled force 
constants. 
bScaling factors of 0.88 for CH2 stretches and CH2 deformations, 0.85 for PH2 
stretches, 0.90 for all other modes except torsions and heavy atom bends. 
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Table 21. Observed and calculateda frequencies (cm-1) for the tG′t (C2) form of 1,2-
diphosphinoethane. 
 
Sym. 
block 
Vib
. 
No. 
 Approximate Description 
AB  
INITIO 
fixed  
scaledb 
IR 
gas IR 
amorphous 
Raman 
liquid 
A 1 CH2 antisymmetric stretch 3152 2956    
2 CH2 symmetric stretch 3103 2910    
3 PH2 antisymmetric stretch 2512 2316    
4 PH2 symmetric stretch 2484 2290    
5 CH2 deformation 1523 1429    
6 CH2 wag 1367 1296    
7 CH2 twist 1272 1206   1188 
8 PH2 deformation 1163 1104    
9 CC stretch 1086 1031    
10 CH2 rock 1020 967   959 
11 PH2 wag 865 819    
12 PH2 twist 707 671    
13 CP stretch 621 589   601 
14 PH2 torsion 281 277    
15 CCP bend 193 191    
16 CC torsion 94 94    
B 17 CH2 antisymmetric stretch 3161 2964    
18 CH2 symmetric stretch 3097 2905    
19 PH2 antisymmetric stretch 2501 2306    
20 PH2 symmetric stretch 2484 2290    
21 CH2 deformation 1520 1426 1350 1346  
22 CH2 wag 1371 1301    
23 CH2 twist 1215 1151 1156 1152  
24 PH2 deformation 1156 1097    
25 PH2 twist 989 941 939 929  
26 PH2 wag 869 824    
27 CP stretch 711 674    
28 CH2 rock 629 597   ~604 
29 CCP bend 363 356    
30 PH2 torsion 174 174    
aMP2(full)/6-31G(d) ab initio calculations, frequencies from scaled force constants. 
bScaling factors of 0.88 for CH2 stretches and CH2 deformations, 0.85 for PH2 stretches, 
0.90 for all other modes except torsions and heavy atom bends. 
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Theoretical Methods 
 The ab initio calculations were performed with the Gaussian 03 program19 with Gaussian-
type basis functions. The energy minima with respect to nuclear coordinates were obtained by the 
simultaneous relaxation of all geometric parameters by the gradient method of Pulay20. Several 
basis sets as well as the corresponding ones with diffuse functions were employed with the Møller-
Plesset perturbation method21 to the second order (MP2(full)) as well as with the density functional 
theory (DFT) by the B3LYP method.  
In order to obtain a complete description of the molecular motions involved in the 
fundamental vibrations of 1,2-diphosphinoethane, normal coordinate analyses were carried out. 
The force field in Cartesian coordinates was obtained with the Gaussian 03 program19 with the 6-
31G(d) basis set. The internal coordinates used to calculate the G and B matrices along with the 
atomic numbering are shown in Fig. 14. By using the B matrix29, the force field in Cartesian 
coordinates was converted to a force field in internal coordinates. Subsequently, scaling factors 
were applied of 0.88 for the force constants of the CH2 stretches and CH2 deformations, 0.85 for 
the force constants of the PH2 stretches and 0.90 for all other force constants except for the heavy 
atom bends, torsions, and C≡N stretch which were not scaled. For the interaction force constants, 
the geometric average of the scaling factors was used. From the fixed scaled force field the 
predicted wavenumbers were obtained and a set of symmetry coordinates was used (Table 25) to 
determine the corresponding potential energy distributions (P.E.D.s). The calculated infrared 
intensities, Raman activities and potential energy distributions for the tTt, g′Tt, g′Tg′, g′Tg, tG′g′ and 
tG′t conformers are listed in Tables 10, 8S-12S, respectively.  
The vibrational spectra were predicted from the MP2(full)/6-31G(d) calculations.  The 
predicted frequencies from the scaled force constants were used together with a Lorentzian 
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function to obtain the simulated spectra. Infrared intensities were obtained based on the dipole 
moment derivatives with respect to Cartesian coordinates. The derivatives were transformed with 
respect to normal coordinates by (u/Qi) =
j
(u/Xj)Lij, where Qi is the ith normal coordinate, 
Xj is the j
th Cartesian displacement coordinate, and Lij is the transformation matrix between the 
Cartesian displacement coordinates and the normal coordinates. The infrared intensities were then 
calculated by (N)/(3c2) [(x/Qi)2 + (y/Qi)2 + (z/Qi)2]. A comparison of experimental 
infrared spectra of the gas, amorphous and crystalline solid and simulated infrared spectra of tTt 
and g′Tt forms of 1,2-diphosphinoethane are shown in Fig. 12 (A-E), respectively. The predicted 
spectrum is in good agreement with the experimental spectrum which shows the utility of the 
predicted frequencies from the scaled force constants and predicted intensities for supporting the 
vibrational assignment.  
Additional support for the vibrational assignments was obtained from the simulated Raman 
spectra. The evaluation of Raman activity by using the analytical gradient methods has been 
developed30–32 and the activity Sj can be expressed as: Sj = gj(45αj2 + 7βj2), where gj is the 
degeneracy of the vibrational mode j, αj is the derivative of the isotropic polarizability, and βj is 
the anisotropic polarizability. To obtain the Raman scattering cross sections, the polarizabilities 
are incorporated into Sj by multiplying Sj with (1-ρj)/ (1+ρj) where ρj is the depolarization ratio of 
the jth normal mode. The Raman scattering cross sections and calculated wavenumbers obtained 
from the Gaussian 03 program were used together with a Lorentzian function to obtain the 
simulated Raman spectra. A comparison of experimental Raman spectra of the liquid and solid 
and simulated Raman spectra of tTt and g′Tt forms of 1,2-diphosphinoethane are shown in Fig. 13 
(A-D), respectively. The predicted spectra are in reasonable agreement with the experimental 
spectrum but there are a few bands where the predicted bands are significantly weaker than the 
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corresponding experimental bands. Nevertheless, the relative activities of the Raman bands can 
provide some support for making the vibrational assignments.  
Vibrational Assignment 
To be able to obtain the enthalpy differences of the conformers it is necessary to assign 
fundamentals for each conformer which has a reasonable amount present at ambient temperature. 
Since four conformers have been identified from the microwave spectra56 and two additional 
conformers, without a permanent dipole, are predicted to have relatively small energy differences 
from the ab initio calculations, there should be six conformers that can be identified for enthalpy 
difference determinations. Additionally, the ab initio calculations performed on 1,2-
diphosphinoethane support this estimate as the energies of these six conformers are predicted 
within ~560 cm-1. Thus, searches were made initially for the fundamentals of the conformers with 
C2h and Ci symmetry, which were not identified from the microwave study
56. 
The infrared and Raman spectra of the solid are quite simple and there is obvious mutual 
exclusion between the two spectra, so there is a center of symmetry for the conformer remaining 
in the solid. Of the ten possible conformers, only the g′Tg (Ci) and tTt (C2h) forms have symmetry 
centers and the g′Tg conformer is predicted to be 489 cm-1 higher in energy, so the conformer in 
the crystal must be the tTt form. The predicted infrared and Raman spectra for this conformer are 
shown in Fig. 12 and Fig. 13, respectively, and the agreement clearly supports the conclusion that 
these bands are due to the tTt form.  
Once the fundamentals that were observed in the infrared and Raman spectra of the solid 
arising from the tTt form were assigned, it was relatively simple to make complete assignments 
for all of the fundamentals for this conformer. With the predicted frequencies from ab initio 
calculations along with the predicted intensities for the infrared and Raman bands, the 
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corresponding fundamental bands in the spectrum of the gas and amorphous solid were also readily 
assigned. The complete assignment of the fundamentals for the tTt conformer is listed in Table 16.   
After the bands from the Raman spectra of the solid were identified for the tTt form, a few 
bands remained due to the solid not being able to be completely annealed, unlike the infrared 
spectrum of the solid, which were then assigned to the other lower energy forms. Thus, the Raman 
spectrum of the solid did not correspond solely to the C2h symmetry form.  
The assignment for the Ci conformer (g′Tg) was then attempted since a second group of 
bands should have mutual exclusion but they are expected to be relatively weak compared to the 
corresponding bands of the C2h form. To obtain the enthalpy difference between the C2h conformer 
and the Ci form, at least one band of the Ci form needs to be confidently assigned which is free 
from extensive overlap from bands of the other conformers. Fortunately, there is a band at 714 cm-
1 in the Raman spectrum of the liquid which does not have a corresponding infrared band and 
disappears from the Raman spectrum of the solid. Therefore, this Raman band is assigned as ν12 
of the Ci conformer. Further fundamentals of this conformer were difficult to confidently assign 
except for the bands at 990 and 276 cm-1. However, these bands could not be used for enthalpy 
difference determination since the former band was too weak and the latter band was not well 
separated.  
With the complete assignment of the conformer with lowest energy it seems most pertinent 
to attempt to assign as many fundamentals as possible for the two lowest energy conformers 
identified from the microwave study. Both of these are Trans conformers and vibrational 
assignments of these were made with assistance from the predicted frequencies as well as the 
infrared and Raman intensities but not the infrared band contours which provide little information. 
Also, since we were mainly interested in obtaining bands that are not significantly overlapped or 
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readily assigned without other fundamentals affecting the intensities, we emphasized the region 
below 1000 cm-1. For the g′Tt conformer, the PH2 wag (21) was predicted to be at 804 cm-1 and 
there was a clear Raman band at 808 cm-1 which has an activity consistent with the 4.6 Å4 u-1 
predicted value from the ab initio calculations (Table 17). The bands for the next Trans form were 
also readily assignable in this spectral region. For example, the PH2 wag (11) for the g′Tg′ form 
was predicted at 828 cm-1 and to have a strong infrared band and weak Raman band. This was 
consistent with both the observed intensities of the infrared and Raman band.  
The in-plane C-P stretches for the two Gauche conformers are predicted to be about 60 cm-
1 lower than the corresponding values for any of the Trans forms. Additionally, they are expected 
to have significantly pronounced Raman activity. Therefore, they were expected to be observed 
within that difference in the Raman spectrum of the liquid and were observed at 593 and 601 cm-
1. With the exception of the two Trans forms with lowest energy, very few fundamentals were 
observed for the remaining four conformers and they are listed in Tables 18-21.  
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Figure 4.12. Comparison of experimental and calculated infrared spectrum of 1,2-
diphosphinoethane: (A) observed spectrum of gas; (B) observed spectrum of 
amorphous solid; (C) observed spectrum of crystalline solid; (D) simulated 
spectrum of tTt form; (E) simulated spectrum of g′Tt form. 
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Figure 4.13. Comparison of experimental and calculated Raman spectrum of 1,2-
diphosphinoethane: (A) observed spectrum of liquid; (B) observed spectrum of 
solid; (C) simulated spectrum of tTt form; (D) simulated spectrum of g′Tt form. 
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Conformational Stability 
After all of the fundamentals that could be assigned for the six conformers, the next step 
was to find a pair or pairs of bands from which the enthalpy difference determination could be 
carried out. For this study, it is desirable to have the lower frequency pair(s) in the spectra to 
minimize the effect of combination and overtone bands. Also, the bands should be sufficiently 
resolved to allow for accurate intensity measurements. By identifying six of the ten possible 
conformers, the resulting vibrational spectra were complex. But the task of selecting band pairs 
for H determinations was not as arduous as expected, since the heavy atom stretching and bending 
modes were used. With combining the peaks of the lowest energy tTt conformer with each of the 
remaining five lower energy forms (g′Tt, g′Tg′, g′Tg, tG′g′, tG′t), a total of ten pairs of bands were 
obtained, with each combination contributing two pairs. 
Six temperatures (-38 to 30°C) were chosen to obtain the spectral data for these pairs and 
by application of the van’t Hoff equation, –lnK = H/(RT) – S/R, the enthalpy differences were 
determined from a plot of –lnK versus 1/T, where, H/R is the slope of the line and K is substituted 
with the appropriate intensity ratios, i.e. Iconf-1/Iconf-2. It was assumed that H, S and the ratio of 
the molar absorption coefficients conf-1/conf-2 are not a function of temperature in the range studied.  
With the utilization of two band pairs of the g′Tt and tTt conformers, the H values 
obtained were 210 ± 63 cm-1 (2.51 ± 0.75 kJ mol-1) and 333 ± 33 cm-1 (3.98 ± 0.39 kJ mol-1). 
However, by utilizing these data from both band pairs as a single set, and by using the statistical 
standard deviation of one sigma for this conformer pair, the enthalpy difference obtained was 272 
± 39 cm-1 (3.25 ± 0.47 kJ mol-1). The determination of the H values was also carried out in a 
similar manner between the remaining two Trans and two Gauche conformers. The results 
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obtained for each band pair as well as those when treated as a single set of data, are reported in 
Table 22.  
 
 
 
Figure 4.14. tTt conformer of 1,2-diphosphinoethane showing atom numbering and internal 
coordinates.
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Table 4.22. Temperature and intensity ratios of the conformational bands of 1,2-diphosphinoethane from the Raman spectra of the liquid. 
 
aThe average values of H and the statistical uncertainty (1σ) was obtained by utilizing all of the data as a single set. 
 
 
 
 
 
 
T(°C) 
1/T 
(103 K-1) 
g′Tt /tTt g′Tg′/tTt g′Tg/tTt tG′g′/tTt tG′t/tTt 
I808/I655 I808 /I863 I673/I863 I673/I655 I714/I863 I714/I655 I593/I655 I593/I863 I601/I655 I601/I863 
-38.0 4.2526 0.030 0.078 0.516 0.200 0.234 0.091 0.055 0.141 0.103 0.266 
-30.0 4.1127 0.034 0.090 0.522 0.200 0.254 0.097 0.057 0.149 0.114 0.299 
-15.0 3.8737 0.037 0.094 0.594 0.232 0.281 0.110 0.073 0.188 0.140 0.359 
0.0 3.6610 0.043 0.113 0.663 0.252 0.325 0.124 0.076 0.200 0.167 0.438 
15.0 3.4704 0.041 0.117 0.833 0.296 0.400 0.142 0.112 0.317 0.201 0.567 
30.0 3.2987 0.040 0.125 1.025 0.325 0.475 0.151 0.119 0.375 0.238 0.750 
H, cm-1 210 ± 63 333 ± 33 496 ± 66 373 ± 31 505 ± 45 382 ± 13 602 ± 71 725 ± 95 609 ± 14 733 ± 56 
H average, cm-1 272 ± 39 434 ± 40 443 ± 30 663 ± 60 671 ± 34 
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Table 4.23. Calculated energies (hartree) and energy differencesa (cm-1) for the ten conformers of 1,2-diphosphinoethane.  
 
Method / Basis set 
# of 
Basis Sets 
tTt  
 
g'Tt  
E 
g'Tg'  
E 
g'Tg  
E 
tG'g'  
E 
tG't  
E 
g'G't  
E 
gG'g'  
E 
g'G'g'  
E 
g'G'g  
E 
MP2/6-31G(d) 84 -762.3111661 206 353 343 584 606 690 619 644 929 
MP2/6-31+G(d) 100 -762.3207757 269 476 477 703 677 834 797 825 1078 
MP2/6-311G(d,p) 136 -762.7277772 288 523 528 674 619 773 807 859 1129 
MP2/6-311+G(d,p) 152 -762.7315808 297 546 542 682 594 797 836 911 1165 
MP2/6-311G(2d,2p) 180 -762.8027328 306 549 558 567 504 686 760 835 1042 
MP2/6-311+G(2d,2p) 196 -762.8052335 310 559 564 578 507 701 760 849 1064 
MP2/6-311G(2df,2pd) 248 -762.8813122 283 502 512 494 453 626 674 759 992 
MP2/6-311+G(2df,2pd) 264 -762.8835243 285 510 516 504 457 638 677 769 1004 
MP2/aug-cc-pVTZ 376 -762.7336880 209 351 359 286 372 447 416 499 732 
MP2 average   273 485 489 563 532 688 705 772 1015 
B3LYP/6-31G(d) 84 -763.7118653 291 509 503 762 612 811 908 942 1152 
B3LYP/6-31+G(d) 100 -763.7172045 283 491 496 803 689 867 919 958 1179 
B3LYP/6-311G(d,p) 136 -763.7941691 272 476 484 733 604 794 866 904 1135 
B3LYP/6-311+G(d,p) 152 -763.7952159 269 472 479 725 594 785 853 899 1130 
B3LYP/6-311G(2d,2p) 180 -763.8034707 270 471 481 694 584 773 845 895 1094 
B3LYP/6-311+G(2d,2p) 196 -763.8043915 267 466 476 696 587 776 838 898 1102 
B3LYP/6-311G(2df,2pd) 248 -763.8097777 264 456 468 680 573 760 830 876 1079 
B3LYP/6-311+G(2df,2pd) 264 -763.8106750 262 455 465 685 578 766 831 884 1089 
B3LYP/ aug-cc-pVTZ 376 -763.8164273 243 413 425 668 592 749 789 844 1048 
B3LYP average   269 468 475 716 601 787 853 900 1112 
a Energy differences with respect to the tTt conformer. 
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Table 4.24. Structural parameters (å and °) and rotational constants (mhz) for the g′tt, g′tg′, tg′g′, and tg′t conformer of 1,2-diphosphinoethane. 
 
Structural 
parameters 
Internal 
coordinates 
g′Tt g′Tg′ tG′g′ tG′t 
MP2(full)/ 
6-
311+G(d,p) 
B3LYP/ 
6-
311+G(d,p) 
Adjusted 
r0 
MP2(full)/ 
6-
311+G(d,p) 
Adjusted 
r0 
MP2(full)/ 
6-
311+G(d,p) 
Adjusted 
r0 
MP2(full)/ 
6-
311+G(d,p) 
Adjusted 
r0 
r (P1-C2) R1 1.865 1.887 1.870(3) 1.862 1.866(3) 1.858 1.858(3) 1.864 1.859(3) 
r (C2-C3) R2 1.527 1.531 1.535(3) 1.530 1.536(3) 1.531 1.534(3) 1.537 1.536(3) 
r (C3-P4) R3 1.858 1.878 1.863(3) 1.862 1.866(3) 1.865 1.866(3) 1.864 1.859(3) 
r (P1-H5) r1 1.412 1.425 1.412(3) 1.412 1.412(3) 1.411 1.411(3) 1.402 1.402(3) 
r (P1-H6) r2 1.412 1.424 1.412(3) 1.412 1.412(3) 1.413 1.413(3) 1.405 1.405(3) 
r (C2-H7) r3 1.095 1.094 1.095(2) 1.095 1.095(2) 1.096 1.096(2) 1.086 1.086(2) 
r (C2-H8) r4 1.093 1.092 1.093(2) 1.094 1.094(2) 1.096 1.096(2) 1.088 1.088(2) 
r (C3-H9) r5 1.096 1.095 1.096(2) 1.095 1.095(2) 1.094 1.094(2) 1.086 1.086(2) 
r (C3-H10) r6 1.096 1.095 1.096(2) 1.094 1.094(2) 1.096 1.096(2) 1.088 1.088(2) 
r (P4-H11) r7 1.412 1.425 1.412(3) 1.412 1.412(3) 1.411 1.411(3) 1.402 1.402(3) 
r (P4-H12) r8 1.412 1.425 1.412(3) 1.412 1.412(3) 1.410 1.410(3) 1.405 1.405(3) 
 P1C2C3 A1 110.9 111.7 110.5(5) 110.7 110.4(5) 117.5 117.0(5) 119.1 118.5(5) 
 C2C3P4 A2 115.9 116.8 115.5(5) 110.7 110.4(5) 113.2 113.7(5) 119.1 118.5(5) 
 H5P1H6 α1 94.5 93.5 94.5(5) 94.5 94.5(5) 94.1 94.1(5) 108.0 108.0(5) 
 H5P1C2 α2 96.5 97.2 96.5(5) 97.7 97.7(5) 97.3 97.3(5) 119.1 119.1(5) 
 H6P1C2 α3 97.6 97.2 97.6(5) 96.5 96.5(5) 96.4 96.4(5) 100.1 100.1(5) 
 H7C2H8 β1 107.3 107.2 107.3(5) 107.4 107.4(5) 106.1 106.1(5) 114.7 114.7(5) 
 H7C2P1 1 107.5 106.4 106.4(5) 107.4 107.4(5) 106.9 106.9(5) 108.8 108.8(5) 
 H8C2P1 1 111.6 110.9 113.0(5) 111.3 111.3(5) 106.1 106.1(5) 105.8 105.8(5) 
 H7C2C3 2 109.6 109.9 109.6(5) 109.8 109.8(5) 110.1 110.1(5) 98.4 98.4(5) 
 H8C2C3 2 109.9 110.5 109.9(5) 110.1 110.1(5) 109.4 109.4(5) 110.4 110.4(5) 
 H9C3H10 β2 106.0 105.9 106.0(5) 107.4 107.4(5) 109.2 109.2(5) 114.7 114.7(5) 
 H9C3C2 3 110.4 110.6 110.4(5) 109.8 109.8(5) 110.2 110.2(5) 98.4 98.4(5) 
 H10C3C2 3 110.3 110.7 110.3(5) 110.1 110.1(5) 108.8 108.8(5) 110.4 110.4(5) 
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 H9C3P4 4 107.0 106.2 106.0(5) 107.4 107.4(5) 111.5 111.5(5) 108.8 108.8(5) 
 H10C3P4 4 106.7 105.9 108.1(5) 111.3 111.3(5) 105.7 105.7(5) 105.8 105.8(5) 
 H11P4H12 α4 93.9 93.3 93.9(5) 94.5 94.5(5) 94.4 94.4(5) 108.0 108.0(5) 
 H11P4C3 α6 96.5 97.3 96.5(5) 97.7 97.7(5) 96.3 96.3(5) 119.1 119.1(5) 
 H12P4C3 α5 96.4 97.2 96.4(5) 96.5 96.5(5) 98.8 98.8(5) 100.1 100.1(5) 
 P1C2C3P4 1 176.8 177.1 175.3(5) 174.0 171.1(5) 68.1 66.9(5) 60.9 74.6(5) 
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Table 4.25. Symmetry coordinates for the tTt conformer of 1,2-diphosphinoethane. 
 
Sym. 
Block 
Description   Symmetry Coordinatea 
Ag CH2 symmetric stretch S1 = r3 + r4 + r5 + r6 
 PH2 symmetric stretch S2 = r1 + r2 + r7 + r8 
 CH2 deformation S3 = γ1 + γ2 
 CH2 wag S4 = π1 + π2 – σ1 – σ2 – θ1 – θ2 + φ1 + φ2 
 PH2 deformation S5 = α1 + α2 
 CC stretch S6 = R2 
 PH2 wag S7 = β1 + β2 + β3 + β4 
 CP stretch  S8 = R1 + R3 
 CCP bend S9 = ε1 + ε2 
Au CH2 antisymmetric stretch S10 = r3 – r4 + r5 – r6 
 PH2  antisymmetric stretch S11 = r1 – r2 + r7 – r8  
 CH2 twist S12 = π1 – π2 – σ1 + σ2 – θ1 + θ2 + φ1 – φ2 
 PH2 twist S13 = β1 – β2 + β3 – β4 
 CH2 rock  S14 = π1 – π2 + σ1 – σ2 + θ1 – θ2 + φ1 – φ2 
 PH2 torsion S15 = τ1 + τ2 
 CC torsion S16 = τ3 
Bg CH2 antisymmetric stretch S17 = r3 – r4 – r5 + r6 
 PH2 antisymmetric stretch S18 = r1 – r2 – r7 + r8  
 CH2 twist S19 = π1 – π2 – σ1 + σ2 + θ1 – θ2 – φ1 + φ2  
 CH2 rock S20 = π1 – π2 + σ1 – σ2 – θ1 + θ2 – φ1 + φ2 
 PH2 twist S21 = β1 – β2 – β3 + β4 
 PH2 torsion S22 = τ1 – τ2 
Bu CH2 symmetric stretch S23 = r3 + r4 – r5 – r6 
 PH2 symmetric stretch S24 = r1 + r2 – r7 – r8 
 CH2 deformation S25 = γ1 – γ2 
 CH2 wag S26 = π1 + π2 – σ1 – σ2 + θ1 + θ2 – φ1 – φ2 
 PH2 deformation S27 = α1 – α2 
 PH2 wag S28 = β1 + β2 – β3 – β4 
 CP stretch  S29 = R1 – R3 
 CCP bend S30 = ε1 – ε2 
a Not normalized. 
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Structural Parameters 
From the microwave study56 carried out on H2PCH2CH2PH2, rotational constants for two 
Trans (g′Tt, g′Tg′) and two Gauche (tG′g′, tG′t) conformers out of the ten stable forms were 
obtained, but no structural parameters were estimated for any of these forms. This made an 
extensive determination of the structural parameters of these four conformers of primary interest. 
Thus, we embarked on this study to determine all of the structural parameters for these four 
conformers. 
We have found that good structural parameters for hydrocarbons and many substituted ones 
can be determined by adjusting the structural parameters obtained from the ab initio MP2(full)/6-
311+G(d,p) calculations to fit the rotational constants obtained from microwave experimental data 
by using a computer program “A&M” (Ab initio and Microwave) developed41 in our laboratory. 
In order to reduce the number of independent variables, the structural parameters are separated 
into sets according to their types where bond distances in the same set keep their relative ratio and 
bond angles in the same set keep their difference in degrees. This assumption is based on the fact 
that errors from ab initio calculations are systematic. Additionally, we have also shown that the 
differences in predicted distances and angles from the ab initio calculations for different 
conformers of the same molecule can usually be used as one parameter with the ab initio predicted 
differences except for some dihedral angles.  
We33 have also shown that ab initio MP2(full)/6-311+G(d,p) calculations predict the C-H 
r0 structural parameters for more than fifty carbon-hydrogen distances in substituted hydrocarbons 
to at least 0.002 Å compared to the experimentally determined values from isolated C-H stretching 
frequencies34. Therefore, all of the carbon-hydrogen distances can be taken from the MP2(full)/6-
311+G(d,p) predicted values for the g′Tt, g′Tg′, tG′g′ and tG′t conformers of 1,2-
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diphosphinoethane. Thus, it should be possible to obtain “adjusted r0” structural parameters for 
heavy atoms for all four conformers of 1,2-diphosphinoethane by utilizing the twelve well 
determined rotational constants from the previously reported microwave study56. 
The three heavy atom distances vary a maximum of 0.008 Å from the ab initio predicted 
values. The P-C and C-C distances were adjusted to be longer than those from MP2 calculations 
for all four conformers except for tG′t which had slightly smaller values. On the other hand, 
P1C2C3 and C2C3P4 were adjusted to slightly smaller values than the MP2 calculations for g′Tt, 
g′Tg′, tG′t conformers except tG′g′ form which was adjusted to a slightly smaller value for 
P1C2C3 and a slightly larger value for C2C3P4, whereas, two angles of HCP for only g′Tt 
conformer were adjusted to slightly larger values than the MP2 calculations. The heavy atom 
distances along with the P-H distances have uncertainties of ± 0.003 Å and the angles should be 
accurate within ± 0.5°. The resulting adjusted parameters are listed in Table 24.  
The fit of the twelve determined rotational constants (Table 26) by the structural parameters 
for the g′Tt, g′Tg′, tG′g′ and tG′t conformers is remarkably good with values of 0.2, 0.3 and 0.4 
MHz for eleven of the differences and one with 0.7 MHz. Therefore, it is believed that the 
suggested uncertainties are realistic values and the determined structural parameters are probably 
as accurate as can be obtained for the molecule in the gas phase by either electron diffraction or 
microwave rs substitution methods. 
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Table 4.26. Comparison of rotational constants (MHz) obtained from ab initio MP2(full)/6-
311+G(d,p)  predictions, experimental values from microwave spectra, and from the 
adjusted r0 structural parameters for 1,2-diphosphinoethane. 
 
Isotopomer 
Rotational 
Constants 
MP2(full)/ 
6-311+G(d,p) 
Experimentala Adjusted r0  || 
g′Tt A 20915.4 20731.28(3) 20732.0 0.7 
 B 1414.4 1409.968(1) 1410.3 0.3 
 C 1375.5 1371.259(1) 1370.9 0.4 
g′Tg′ A 20966.6 20778.23(2) 20778.4 0.2 
 B 1429.7 1427.185(3) 1427.6 0.4 
 C 1387.5 1385.593(3) 1385.2 0.4 
tG′g′ A 8668.3 8596.864(4) 8597.1 0.2 
 B 2061.1 2071.659(1) 2072.0 0.3 
 C 1797.8 1802.283(1) 1801.9 0.4 
tG′t A 9330.4 9244.29(1) 9244.1 0.2 
 B 1898.8 1904.980(8) 1904.8 0.2 
 C 1708.2 1709.118(8) 1709.3 0.2 
a Ref.56. 
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Discussion 
 The predicted frequencies of the fundamental vibrations for the tTt conformer, from which 
a complete vibrational assignment was obtained from force constants with three scaling factors, 
compare favorably with the observed values with an average error of 12 cm-1 which represents a 
percentage error of 0.8%. This error cannot be obtained for the remaining five observed forms 
since many of the vibrations of these conformers are nearly the same as the corresponding ones 
for the tTt form or they simply could not be observed in the spectra. Thus, only a few fundamentals 
for these five conformers were confidently identified. Nevertheless, it is clear from the few 
fundamental modes that were assigned for the other conformers that the error for the predicted 
frequencies is similar to that for the tTt form. 
 In the infrared spectrum of the crystalline solid of the tTt conformer two of the 
fundamentals, 1064 cm-1 (27, PH2 deformation) and 805 cm-1 (28, PH2 wag) have distinctive 
doublets at 1071 cm-1 and 802 cm-1, respectively. The differences in frequencies are consistent 
with factor group splitting which indicate that there are at least two molecules per unit cell. There 
is a third doublet at 844 cm-1 and 838 cm-1 (13, PH2 twist) which is well separated and was 
observed very early in the crystallization of the sample. Initially, it was thought that it could be 
due to Fermi resonance but with further crystallizing and the observation of the other fundamentals 
being doublets and the small frequency differences, it was clear that it was also due to factor group 
splitting. It is rather interesting that only the fundamentals of the PH2 group show observable factor 
group splitting.   
Based on the relative intensities at ambient temperature, the abundance of the tTt form was 
calculated to be 46 ± 5% with the remainder values of 25 ± 2% for the g′Tt form and 11 ± 1% each 
for the g′Tg′ and g′Tg forms. Additionally, the abundances of the tG′g′ and tG′t forms are estimated 
  
203 
 
to be 4 ± 1% and 3%, respectively. There are no discrepancies observed in the theoretical energy 
values involving MP2(full) and B3LYP methods (Table 23). Thus, the experimentally determined 
order of energy for 1,2-diphosphinoethane was tTt < g′Tt < g′Tg′ ~ g′Tg < tG′g′ < tG′t, which was 
found to be in accordance with the ab initio and DFT predictions. 
 The only structural parameters previously reported for 1,2-diphosphinoethane was from 
the earlier microwave studies56, where the parameters were predicted at the MP2/6-31G** (frozen 
core) level. Some of the heavy atom parameters calculated at this level were found to be in closer 
agreement with the corresponding r0 parameters obtained in this study than at the MP2(full)/6-
311+G(d,p) level. For example, the adjusted r0 C-P distances and those from the microwave study 
vary by only 0.002 Å on an average for the g′Tt, g′Tg′, and tG′t conformers. The C-C distances, on 
the other hand, were predicted more accurately with the higher level calculation. For the g′Tg′  
form, it is interesting to note that despite this conformer having C2 symmetry, the PCC angles were 
not predicted to be equal from the 6-31G** calculations. 
 The investigation of ethylenediamine14, from variable temperature xenon solutions, had 
indicated that the three lowest energy forms were identified as the Gauche conformers. This is 
remarkably different from the results for the phosphorus analogue in the current study, wherein, 
the Trans conformers are the lowest energy forms. One of the primary reasons for the lower 
energies of two of the Gauche forms of ethylenediamine is attributed to the presence of 
intramolecular hydrogen bonds which is not observed in the lower energy forms of 1,2-
diphosphinoethane. The tendency for the P-C-C-P skeleton to prefer Trans conformations over the 
Gauche forms could possibly be due to the following reasons: (1) the “gauche effect” states that 
the tendency to prefer a X-C-C-X Gauche arrangement increases with the electronegativity of the 
substituent X. Since the nitrogen atom is significantly more electronegative than the phosphorus 
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atom, the Gauche forms has preferably lower energy than the Trans forms in ethylenediamine; (2) 
the large size of the phosphorus atom, the low polarity of the P-H bond makes the formation of 
hydrogen bond less favorable in 1,2-diphosphinoethane than in the nitrogen analogue. 
From the conformational study of ethylphosphine55, the enthalpy difference between the 
lower energy trans form and the gauche conformer was determined to be 196 ± 21 cm-1 (2.34 ± 
0.25 kJ mol-1). When the hydrogen atom is replaced by a methyl moiety for n-propylphosphine57, 
the PH2 form with lowest energy is the trans conformer but the enthalpy difference is a larger 
value of 351 ± 20 cm-1 (4.20 ± 0.24 kJ mol-1) from variable temperature Raman studies for the 
liquid. In the current study on 1,2-diphosphinoethane, the trans form for PH2 has lower energy 
than the gauche form by 272 ± 39 cm-1 (3.25 ± 0.47 kJ mol-1). Thus, the replacement of a hydrogen 
atom on the methyl group in ethylphosphine did not seem to have any effect on the PH2 
conformational stability. It would be of interest to learn what the effect would be when the 
hydrogen atom is replaced by a halogen atom.  
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